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Abstract 
Mutations in the human BRCA2 gene are a leading cause of susceptibility to breast, ovarian 
and prostate cancers. Its protein equivalent BRCA2, is the key mediator in repair of double-
stranded DNA breaks and interstrand crosslinks – the most dangerous forms of DNA dam-
age, via RAD51 effected homologous recombination. Thereby, preferably the sister 
chromatid, or homologous chromosome is utilised to drive the repair. Described here is the 
first structural and related mechanistic characterisation of full-length (384 kDa) BRCA2, and 
its complex with RAD51 and DNA. Electron microscopy reconstruction reveals that BRCA2 
exists as a dimer in head-to-tail conformation, which binds two oppositely directed sets of 
RAD51 molecules. Single-stranded DNA (derived from exonucleolytic processing of dou-
ble-strand breaks) binds BRCA2 along its long axis, such that one set of RAD51 monomers 
always binds thereon regardless of its binding polarity. These then self-assemble into 
RAD51–ssDNA nucleoprotein filaments that catalyse the main reaction, having been nucle-
ated and primed for growth by BRCA2. In complementary work, it is shown that BRCA2 
increases the frequency of RAD51–ssDNA filament formation, but does not impact filament 
length itself. It is also shown that BRCA2 initiates monodirectional (3’→5’) extension of the 
RAD51 filament on single-stranded DNA from nucleation sites (thence at the 3’ end). Fur-
thermore, BRCA2 initiates such nucleations at multiple sites along individual ssDNA 
molecules, suggesting that these extend and merge into a single nucleoprotein filament, 
which would be most capable of catalysing the subsequent homologous pairing and strand 
exchange reactions. Together, the structures and biochemical data define the molecular 
mechanism via which BRCA2 orchestrates the formation of RAD51 nucleoprotein filaments, 
which constitute the central reaction intermediate in the repair of DNA double-strand breaks. 
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1 Introduction 
1.1 BRCA2 and the cancer link 
An estimated 1.7 million women are diagnosed with, and 0.5 million die of breast cancer 
worldwide each year1. As such, breast cancer constitutes the most common malignancy 
among women, with a lifetime risk in excess of 10%2. 
Whilst most breast cancers are sporadic, some are the result of inherited predisposition, 
primarily due to mutations in one of the two tumour-suppressor breast cancer susceptibility 
genes, BRCA1 and BRCA2 (breast cancer 1 and 2, early onset)2.  
Women born with mutations in either gene are at a 10- to 20-fold risk relative to the gen-
eral population of developing breast (and ovarian) cancer3. In fact, the lifetime risk of breast 
cancer among female mutation carriers now exceeds 80%2. 
And while both BRCA1 and BRCA2 mutation carriers display markedly increased inci-
dences of breast and ovarian cancers, the latter also exhibit increased risks of male breast, 
prostate and pancreatic cancers4. Furthermore, other cancers (e.g. laryngeal cancer), may also 
be elevated in carriers of BRCA2 mutations5. 
Risk variants of BRCA2 result in inactivation of the encoded protein, predominantly by 
causing premature protein truncation (for instance as a consequence of disruption to the open 
reading frame of the transcriptional unit), or nonsense-mediated RNA decay3. 
 Although BRCA1 and BRCA2 act as recessive genes at the cellular level, cancer suscep-
tibility is transmitted as an autosomal dominant trait in families harbouring mutations. This 
is because heterozygous mutations get converted to homozygosity in the cancers that they 
cause, typically by loss of the wild-type allele.3 
These findings bear huge clinical ramifications for affected women. Options facing these 
women include medical surveillance (screening starting at a very early age), chemopreven-
tion, and often pre-emptive prophylactic mastectomy and risk-reducing removal of the 
ovaries2,6. 
The genetic basis for inherited predisposition towards breast cancer has been intensively 
studied since the last decade of the 20th century, with several years of biological research 
having firmly implicated BRCA1 and BRCA2 in the repair of DNA double-strand breaks3. 
1.1.1 Other breast cancer susceptibility genes 
Three distinct classes of breast cancer susceptibility genes with different magnitudes of 
risk have been recognised3. 
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BRCA1 and BRCA2 constitute the two major high-penetrance alleles. Mutations in TP53 
(tumour protein p53) confer a high risk for breast and other cancers, but these mutations are 
very rare and account for a much smaller fraction of the familial risk.3  
A group of moderate-penetrance susceptibility alleles has been identified based principal-
ly on the participation of the encoded proteins in pathways that incorporate BRCA1 and 
BRCA2. This includes ATM and CHEK1 (checkpoint kinases involved in DNA repair that 
phosphorylate BRCA1 and p53), BRIP1 (a binding partner of BRCA1 implicated in some of 
its DNA repair activities), and PALB2 (partner and localiser of BRCA2 – a high affinity 
BRCA2 binding protein). Mutations in these genes confer a two- to four-fold relative risk of 
developing breast cancer.3 
Finally, a cohort of low-penetrance alleles has been recognised. Mutant genes of this type 
extend a relative breast cancer risk of up to ~1.25-fold for heterozygotes and 1.65-fold for 
homozygotes. Examples include CASP8, FGFR2, TOX3, MAP3K1, and LSP1.3  
1.2 DNA damage 
Life’s fundamental objective is the preservation, and conveyance of its genetic material, 
intact and unchanged to the next generation. 
This has to be accomplished in spite of the perpetual damage being inflicted upon DNA, 
both by exogenous agents such as ionising radiation and genotoxic chemicals, as well as en-
dogenous sources like free radicals generated as by-products of normal cellular activities. 
Furthermore, DNA itself being a dynamic structure with high energy is prone to a degree of 
physicochemical instability that leaves the potential for such and spontaneous damages to 
occur7. 
In fact, each of the ~10 trillion cells in the human body incurs tens of thousands of DNA 
lesions per day8. 
A variety of lesions arise in DNA at significant rates in vivo, with the most common types 
and their respective instances in a single cell per day being as follows: 20,000 single-
stranded breaks; 10,000 base-hydrolysis events; 5,000 alkylating lesions; 2,000 oxidising 
lesions; and 10-20 double-strand breaks9. 
Most ubiquitous of the environmental DNA-damaging agents is ultraviolet light. UV ex-
posure in strong sunlight can induce ~100,000 lesions per exposed cell per hour. Some 
ionising damage also results from the decay of naturally occurring radioactive substances, 
e.g. uranium and its radioactive decay product radon gas. Presently, the most widespread 
DNA-damaging chemicals are those contained in tobacco products. However, they can also 
be found in certain foods, such as heterocyclic amines in overcooked meats.8 
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DNA damage arises via physiological processes as well, e.g. base mismatches that occa-
sionally get introduced during DNA replication. A further thousands of base lesions per cell 
per day are caused by hydrolytic reactions and non-enzymatic methylations. DNA lesions are 
also created by reactive oxygen compounds, arising for instance as by-products of oxidative 
respiration. White blood cells too yield reactive oxygen and nitrogen compounds at sites of 
infections and inflammation. Such agents can attack DNA, leading to adducts that impair 
base pairing and/or block DNA replication and transcription, cause base loss or single-
stranded DNA breaks. And when two DNA single-strand breaks arise in close proximity to 
each other, or the DNA replication apparatus encounters a single-strand break (or certain 
other types of DNA lesion), double-strand breaks are formed.8 
 These DNA lesions besides blocking genome replication and transcription, if mis- or dis-
repaired can lead to mutations and wider-scale genomic aberrations, which threaten cell and 
organism viability – and underpin, and are the hallmark of cancer8. 
1.2.1 DNA damage and cancer 
Cancer and DNA damage are intimately related, and genomic instability is an elemental 
driver and feature of cancer. That damage to DNA is the root cause of all cancer has been 
established since early in the last decade of the 20th century.10 Both exogenous and endoge-
nous carcinogens act by creating DNA damage and inducing mutations8.  
Two major kinds of genomic instability are associated with cancer cells. The mutational 
instability phenotype is typified by point mutations or small deletions, while the chromoso-
mal instability phenotype is characterised by gross rearrangement of chromosomes.11 
Mutations may promote carcinogenesis by the activation of proto-oncogenes, or the inac-
tivation of tumour suppressor genes8,10. 
Proto-oncogenes are normal genes that operate as positive growth regulators, involved in 
promoting the proliferation and differentiation of normal cells. A variety of them are impli-
cated in various crucial steps of a cell’s growth, and change in a proto-oncogene’s sequence 
or in the amount of protein its produces can interfere with its normal role in cell growth regu-
lation. Runaway cellular growth may ensue, leading to the formation of a cancerous 
tumour.12,13  
An oncogene is an altered or mutated version of a proto-oncogene. The latter can get 
transformed into the former in three ways. Point mutations can arise spontaneously or due to 
endogenous or environmental influences, resulting in the production of an altered protein 
that cannot be properly regulated. A second means of oncogenesis takes place via the process 
of chromosomal translocation, whereby a segment of a chromosome breaks off and attaches 
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to another chromosome. Should the dislocated chromosome contain a proto-oncogene, it 
could be removed from its regulatory controls and be continually produced. This excess pro-
duction of protein molecules stimulates the cellular process under their control, upsetting the 
balance of the mechanisms of cell growth. The third route entails an amplification of the 
number of copies of a proto-oncogene, which also results in an overproduction of the protein 
– and its accompanying effects.13 
Tumour suppressor genes, also called anti-oncogenes, are also a class of normal genes. 
They encode proteins that regulate cell growth by inhibiting the proliferation of cells, which 
too is critical for regular cell development and differentiation; repair DNA mistakes and 
damage; and instruct cells when to die (the process of apoptosis, also known as programmed 
cell death). Hence, tumour suppressor genes also act to curb the uncontrolled growth of can-
cer cells. Cancer-causing alterations in these genes are acquired by very similar methods to 
proto-oncogenes, and too act to disrupt the balance between restraint and activation of the 
molecular processes that regulate a cell’s life cycle – contributing to the uncontrolled cell 
growth characteristic of cancerous tumours.12,14 
Normally, cells detect DNA injury by blocked transcription, replication or specialised 
sensors, trigger cell-cycle arrests at specific checkpoints in the G1, S, G2 and M phases, and 
repair the lesions before they get converted into permanent mutations10. If the damage is too 
significant, cell death can result, which can happen in two different ways. Cells may enter a 
state of irreversible growth arrest (replicative cell death), or opt for the ultimate mode of res-
cue by initiating apoptosis at the expense of the whole cell11. However, if the mutation is not 
repaired, and the cell does not die, a person may develop cancer, which is much more likely 
if the mutation is in a tumour suppressor gene12. 
1.2.2 DNA double-stranded breaks 
Of all kinds of DNA damage, the DNA double-strand break constitutes the most danger-
ous form of lesion that can occur in DNA, and its repair one that poses the greatest challenge 
to cells15. The former because a double-strand break involves the risk of losing a whole part 
of a chromosome and potentially hundreds or thousands of genes alongside, and the latter as 
unlike in most other sorts of damage both strands of the double-helix are affected such that 
there is no immediately available template in the form of an intact complementary strand to 
use for correcting the lesion. In addition, to properly heal such a break the cell has to know 
which ends of the break belong together, an especially difficult task given the size of larger 
genomes such as those of humans10. As a result, DNA double-strand breaks are potent induc-
ers of the chromosomal instability phenotype11. 
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Despite not occurring as frequently as other lesions, DNA double-strand breaks are the 
most lethal of all the types of DNA damage8. While cells can adapt to low levels of unre-
paired or irreparable lesions of other kinds, a single residual DNA double-strand break can 
kill a cell if it inactivates an essential gene or triggers apoptosis16. 
DNA double-strand breaks could be induced by any of the factors mentioned before or 
from mechanical stress on the chromosomes16, however provided the comparative stability of 
double-stranded DNA they would unlikely be caused as a direct consequence of the usual 
physical and chemical carcinogens – a notion perhaps reflected in the relatively low frequen-
cy of these breaks. Instead, double-strand breaks are far more likely to be caused as a 
consequence of the fragility of the DNA replication machinery itself, for instance when a 
replication fork traverses a template containing a single-strand break, it will be converted 
into a double-strand break on one of the sister chromatids in the process11, with it possibly 
likewise being the case for certain other forms of unrepaired lesion8 – particularly inter-
strand crosslinks10,17,18. 
Frequent chromosomal aberrations induced by double-stranded DNA breaks include the 
loss, gain, and exchange of chromosome segments11. Loss of a chromosome fragment can 
inactivate tumour suppressor genes (e.g. by loss of heterozygosity), whereas amplification 
can activate proto-oncogenes, should the respective regions encode such genes – thus leading 
to carcinogenesis11,16. Chromosomal translocations, which often occur in a balanced (recipro-
cal) fashion, can lead to the dysregulation of gene expression or fusion of two genes that then 
acquire oncogenic potential – and are thought to emerge from double-stranded breaks on the 
two participating chromosomes11,16. Moreover, inactivated tumour suppressor genes and acti-
vated oncogenes, ensue DNA replication stress with double-stranded break formation, 
fuelling chromosomal instability continuously8. 
DNA double-stranded breaks also pose problems, and are especially toxic, if they occur 
during mitosis – as intact chromosomes are imperative for correct chromosome segregation 
during cell division10. Proper genomic replication is obstructed by double-stranded breaks, 
and should broken chromosomes be carried through mitosis, the acentric chromosome frag-
ments would not partition equally between daughter cells11. 
1.3 DNA repair 
In view of the diversity of DNA damage, evolution has invested significantly in imple-
menting a tapestry of sophisticated repair mechanisms that each target a subset of different 
lesions – and between them counteract the deleterious effect of the various types of damage 
inflicted on an organism’s genomic information10. The main kinds of repair pathways and 
their roles, in increasing order of the complexity of the problem are: base-excision repair – 
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targeting small chemical alterations of bases; nucleotide-excision repair – dealing with helix-
distorting damage to bases; mismatch repair – correcting mispaired bases; interstrand cross-
link and double-strand break repairs respectively10. 
While some DNA repair systems entail a direct enzyme-mediated reversal of the lesion 
(e.g. O6-methylguanine methyltransferase, which removes non-native O6-methyl groups from 
guanine residues), most progress by a sequence of catalytic reactions mediated by multiple 
proteins8,10. In base-excision repair, the damaged base is usually recognised by a DNA glyco-
sylase enzyme that catalyses its removal, before nuclease, polymerase and ligase proteins 
finish the repair8. The nucleotide-excision repair pathway, acts by way of one of two sub-
pathways, which differ in the manner of lesion detection: transcription-coupled repair that 
targets transcription-blocking lesions, and global genome nucleotide-excision repair8. As a 
key aspect of nucleotide-excision repair, the damage is excised as a several base oligonu-
cleotide, which gets operated upon by DNA polymerases and accompanying factors, before 
ensuing ligation8. With mismatch repair, the recognition of a mismatched base pair, or an 
insertion/deletion loop, prompts a single-stranded incision that is then acted upon by nucle-
ase, polymerase and ligase enzymes8 (cf. base-excision repair). Common to all these repair 
processes, is a ‘cut-and-patch’-style reaction, whereby the lesion (with or without flanking 
sequences), is extracted and the consequential single-strand gap filled-in, by making use of 
the undamaged complementary strand as template10. 
Double-strand break repair on the other hand, is more problematic as both strands are af-
fected. Two chief, distinct and complementary mechanisms have evolved to tackle this 
problem. These are non-homologous end-joining, and homologous recombination.10 
1.3.1 DNA double-stranded break repair 
The importance and difficulty of repairing double-stranded DNA breaks is highlighted by 
the fact that all eukaryotic cells have developed several pathways for dealing with this type 
of injury. The two major repair modes, homologous recombination and non-homologous 
end-joining, differ in their requirement for a homologous DNA template and fidelity of the 
repair reaction. While the former requires such a template and guarantees accurate repair, the 
latter does not.11 
The relative contribution of these two double-strand break repair processes is likely to 
differ depending on the stage of the cell cycle11. Homologous recombination is most effi-
cient, and seems to dominate in the S and G2 phases, whereby the DNA is replicated 
providing a pristine second copy of the sequence (sister chromatid), for aligning the breaks 
and mediating faithful repair10,11. By contrast, the less accurate end-joining is more relevant 
in G1, when such a copy is unavailable10. 
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1.3.1.1 Non-homologous end-joining 
Non-homologous end-joining occurs without a template, and involves simply the re-
ligation of the broken termini in what is a very efficient splicing reaction19 – see Fig. 1. 
However, therein lies a potential problem, in that in the event of a DNA double-strand break 
the exposed ends of the break are vulnerable to attack from other enzymes within the cell 
and there exists a non-trivial possibility of DNA at the break-site losing several bases – that 
this pathway links together with little or no regard for what the true sequence should be. 
Since end-joining is typically accompanied by a modification of the sequence information 
at the break site, this pathway is inherently mutagenic11. However, so long as the modifica-
tion is in a non-coding region of the DNA – it should constitute a ‘silent mutation’. 
A core set of enzymes mediate repair via this process. They include the 70K and 80K 
subunits of the KU heterodimer (KU70/KU80); the catalytic subunit of DNA-dependent pro-
tein kinase (DNA-PKCS); X-ray repair cross-complementing protein 4 (XRCC4); and DNA 
ligase IV (LIG4).20 
Upon double-strand break formation, a KU heterodimer binds each of the broken DNA 
ends20. Once bound, KU attracts DNA-PKCS11, which performs a regulatory role in the pro-
cess involving its protein kinase activity20 – leading to the recruitment of end-processing 
enzymes, polymerases and DNA ligase IV8. The two KU heterodimers then associate to form 
a bridging complex that enlists further proteins, and acts as an alignment factor to promote 
end-joining20. Polymerases μ and λ fill in gaps, while nucleases such as Artemis trim excess 
ends as necessary to create flush-ended DNA – before an XLF-XRCC4-DNA ligase IV 
complex finishes the repair8,20–23.  
Cells in G1 have only the homologous chromosome, and not the sister chromatid for re-
combinational repair. This may be difficult to find in the complex genome, and could even 
be detrimental as a template for repair – by virtue of causing homozygosity for recessive mu-
tations10. Hence, in certain circumstances, the non-homologous end-joining pathway may 
indeed be advantageous. 
1.3.1.1.1 Alternative end-joining 
Another, less well known and characterised KU-independent variant of non-homologous 
end-joining called microhomology-mediated end-joining (or alternative end-joining) also 
exists, but always results in sequence deletions8.  
The defining feature of this repair mechanism is the use of extensive (~5-25) base pairs of 
microhomologous sequences for the alignment of broken ends prior to annealing, therefore 
resulting in large deletions flanking the original break23.  
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By contrast, non-homologous end-joining exploits short (<5) nucleotide microhomolo-
gies, leading to if anything small deletions or insertions in the repair product23. 
 
 
 
Figure 1. Double-stranded DNA break repair by non-homologous end-joining. After double-
strand break formation, the KU–DNA-PKCS complex is involved in the initial recogni-
tion of the break and the juxtaposition of the DNA ends11. Thereby, the signalling 
function is thought to be performed by the DNA-PKCS component10 (purple), whilst the 
KU70/KU80 heterodimer (dark/pale orange) binds with avidity to the DNA termini – 
as contacts between the two subunits lead to the formation of a highly charged pore 
through which DNA passes19. KU can also promote end-alignment, likely by confining 
DNA movement to a singular path19. The ends may be processed by other proteins, 
such as Artemis (pale blue) or Pol μ and λ (yellow), which results in the removal or 
addition of a few base-pairs if internal microhomologies are used for annealing before 
sealing8,10,11. This is followed by an end-to-end ligation by the XLF-XRCC4-DNA lig-
ase IV (dark blue, green, & red respectively) complex that terminates the process8,11, 
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resulting in any sequences lost at the break-site being fixed as a mutation or deletion 
in the rejoined product19. 
 
1.3.1.2 Homologous recombination 
Homologous recombination is a most important mechanism for the repair of DNA dou-
ble-strand breaks and inter-strand crosslinks, preventing the demise of stalled or broken 
replication forks, and several other dimensions of chromosome maintenance24. Accordingly, 
it is imperative for genomic integrity24, as impairment in repairing such complex DNA dam-
age and resolving DNA replication stress, contributes to chromosomal instability and leads 
to tumour aetiology25. Therefore, dysfunction or deficiency in this process, brought about by 
mutations in proteins that play a mediator role therein – yields the cancer phenotype24. 
The homologous recombination pathway acts to restore double-stranded breaks in DNA, 
by employing an intact and undamaged homologous DNA molecule as template, which 
could either be the sister chromatid (preferably) or homologous chromosome – thus entailing 
an error-free reaction24. 
Furthermore, faithful duplication of the genome is intimately linked to homologous re-
combination, as imperfections in the DNA template often present a strong impediment to the 
replication machinery, and cause an arrest and breakdown of the replication fork24,26. As 
such, the issuing DNA intermediates get acted upon by recombinatory factors that then rein-
stitute a functional replication fork26. 
Interstrand crosslinks it has been established are first converted into double-strand breaks 
in a replication-dependent manner18. Although potentially dangerous, the latter are needed to 
remove the former and facilitate subsequent homology-directed recombinational repair18. 
Homologous recombination mutants are extremely sensitive to interstrand crosslink-inducing 
drugs, suggesting it is the main pathway for double-strand break-associated interstrand cross-
link repair18. Moreover, human cells defective for non-homologous end-joining components 
are insensitive to interstrand crosslinking agents, showing end-joining is not required for 
their repair17. 
All organisms ranging from bacteria to mammals utilise the highly conserved family of 
RecA and RAD51-like recombinases to catalyse the DNA-DNA interactions required for 
homologous recombination27. It so happens that in humans, the BRCA2 protein mediates the 
central enzyme RAD51 that carries out this process27. And while mutations in BRCA2 do not 
remove the whole pathway, they seriously impair its efficiency27. 
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1.3.1.2.1 End-resection 
The initial cellular response is carried out by the MRE112-RAD502-NBS1 (MRN or 
N/M/R) complex11, which senses the double-strand break – and rapidly relocates to the dam-
age site28.  
Thereby, the MRE11 dimer can facilitate short-range synapsis of the two broken termini 
that were once contiguous28. Each MRE11 molecule binds a single copy of RAD5028, which 
possesses two coiled-coil regions that act as flexible ‘arms’ that protrude away from the 
DNA28,29. Through a zinc-‘hook’ located at the distal terminus of their coiled-coil arms, the 
two RAD50 molecules are able to dimerise with RAD50 subunits from an MRN complex 
assembled on the sister chromatid (or homologous chromosome) – thus serving as long-
range tethers between the two28,29 (see Fig. 2i). NBS1 (Nijmegen breakage syndrome 1) or 
Nibrin, by virtue of its nuclear localisation signal and binding to MRE11, is responsible for 
recruiting the MRE112-RAD502 core complex from the cytoplasm into the nucleus28.  
Then, the CtIP protein binds MRN, and catalyses or confers upon it 5’→ 3’ exonuclease 
activity to create 3’-OH ending single-stranded DNA tails at either side of the break – in a 
process termed end-resection28 (Fig. 2ii). Following initial nucleolytic processing by 
MRN/CtIP of ~100 nucleotides, further resection is exercised by ExoI in conjunction with 
BLM (Bloom syndrome) helicase – that results in ~2-3 kilobase stretches of single-stranded 
DNA28 (Fig. 2iii). 
1.3.1.2.2 Presynapsis 
These 3’ overhangs are first bound and coated by replication protein A (RPA)24,25. RPA is 
an abundant heterotrimeric nuclear complex (composed of 70, 32 and 14 kDa subunits), 
which is implicated in every DNA metabolic process involving single-stranded DNA25,30–32. 
Its role in homologous recombination is a complex one, whereby it serves to stimulate re-
combination by eliminating secondary structure in the single-strand tails25,32. However, an 
amount that is required to saturate the available single-stranded DNA (i.e. ~25 nucleotides 
per RPA molecule), also acts to suppress the nucleation of RAD51 filaments thereon24,32 – 
that are to form the centrepiece of this repair reaction.  
This inhibitory effect is overcome by RAD51 cofactors, together dubbed mediator en-
zymes25,32. Recombination mediators share common properties in that they are all capable of 
interacting with their cognate recombinase, and preferentially bind single-stranded over dou-
ble-stranded DNA32. In some cases, an interaction with RPA is also noticed32. A large body 
of evidence points to such a function for BRCA2 amongst humans. Specifically, BRCA2 
binds single-stranded but not double-stranded DNA, physically interacts with the RAD51 
recombinase, and is necessary for the formation of DNA damage-induced nuclear RAD51 
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foci on resected double-strand breaks32. Only catalytic quantities are essential to negate RPA 
impediment, probably as the addition of recombinase molecules to a nascent filament on sin-
gle-stranded DNA (i.e. filament growth), is adequate to displace RPA from DNA32. 
Additionally, unlike its prokaryotic orthologue RecA, which exhibits a kinetic delay in bind-
ing double-stranded compared with single-stranded DNA; RAD51 displays only little 
specificity for the latter over the former25. It is hereby again that BRCA2 enacts its part by 
differentially targeting RAD51 to single-stranded DNA (see Fig. 2iv).  
Another BRCA2-associated protein is PALB2 or FANCN (Fanconi anaemia complemen-
tation group N), which promotes its proper localisation and stability in key nuclear 
structures, e.g. the chromatin and nuclear matrix. Stability is endowed in part by preventing 
BRCA2 from getting stranded in the nuclear soluble fraction, whereby it would be inherently 
less stable due partly to the effects of proteasome-mediated degradation. But compatible with 
the existence of at least two nuclear localisation signals within BRCA2, PALB2 is not need-
ed for its entry into the nucleus.33 
RAD52, whose orthologue in yeast is the primary recombination mediator therein34, 
seems only to have subsidiary role as such amongst vertebrates and humans24,32. It appears to 
provide an independent and secondary pathway, albeit less efficient, for RAD51-effectuated 
homology-directed repair – especially in the absence of BRCA234. The simultaneous loss 
however, of RAD52 and BRCA2, results in synthetic lethality34. 
1.3.1.2.3 Synapsis 
The formation of RAD51 upon single-stranded DNA nucleoprotein filament, called the 
‘presynaptic filament’ – is the first rate-limiting stage in homologous recombination32. This 
is a slow process as it is susceptible to disruption by the single-stranded DNA binding pro-
tein RPA, and so requires the intervention of mediator proteins such as BRCA2 for 
enhancement. However, once assembled it has the remarkable ability to capture a duplex 
DNA molecule and search for homology therein32.  
It is believed that this occurs via random collisions between the presynaptic filament and 
the duplex molecule32. Segments of the duplex are bound and reiteratively tested until ho-
mology is located. Once found, the presynaptic filament forms initially a ‘paranemic’, and 
then a ‘plectonemic’ joint with the duplex DNA molecule35. In the former, an internal region 
of the single-stranded DNA is paired with the duplex molecule through canonical Watson-
Crick hydrogen bonds, but the two are not topologically intertwined. This entails predomi-
nantly the formation of A-T base pairs between the recombining DNA molecules32. The 
triple-stranded, paranemically linked nucleoprotein intermediate is referred to as the ‘synap-
tic complex’.  
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Though transient, it facilitates the free DNA end being held in homologous registry with 
the duplex, to institute the establishment of a plectonemic joint – whereby the participating 
DNA strands are bound by Watson-Crick hydrogen bonds, and are topologically linked32. 
Thereby, the would-be non-template strand is extruded, and the invading single-stranded 
DNA forms a joint molecule with the complementary strand of the host undamaged DNA, 
leading to the generation of the so-termed displacement (D)-loop structure (see Fig. 2v). This 
emergent plectonemic joint/D-loop can be lengthened by the DNA strand exchange being 
catalysed by the presynaptic filament32.  
Several accessory factors also assist this phase of the process. HOP2-MND1 complex af-
fords strong amplification of the recombinase activity of RAD51 in a bipartite manner32. 
Firstly, it stabilises the presynaptic filament; and secondly works with the latter to capture 
the duplex DNA molecule and aid the assembly of the synaptic complex32. RAD54 also in-
teracts with RAD51, and the two mutually augment each other’s enzymatic activities, 
including the facilitation of homology search, and promotion of strand exchange/D-loop 
formation32. RAD54B, a paralogue of RAD54, has similar biochemical activities as the latter. 
Expressly, RAD51 supplements the activity of RAD54B, and the latter stimulates D-loop 
formation by the former32. There exist five RAD51 paralogues as well, namely RAD51B, 
RAD51C, RAD51D, XRCC2 and XRCC3. They associate as two major functionally distinct 
complexes in vivo, i.e. RAD51B-RAD51C-RAD51D-XRCC2 (BCDX2) and RAD51C-
XRCC3 (CX3)36,37. The former helps recruit RAD51 to damage sites and stabilise the pre-
synaptic complex, whereas the latter exhibits strand exchange/homologous pairing 
activity36,38. Both of these complexes are epistatic with BRCA236,37, and synthetically lethal 
with RAD52 inactivation36. 
 Cohesins, four-subunit complexes that entrap DNA fibres within their ring-shaped struc-
tures, promote use of the sister chromatid as template, preventing inaccurate repair that 
might lead to loss of heterozygosity by recombination between homologous 
chromosomes10,39,40 (Fig. 2i). 
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Figure 2. Double-stranded DNA break repair by homologous recombination. (i) The dam-
age (red DNA) is recognised by MRE112-RAD502-NBS1 (MRN) complex. MRE11 
dimers (orange) can promote short-range synapsis of the broken ends, while RAD50 
(blue) helps tether the sister or homologous chromosomes together (black DNA)28 – 
see text, §1.3.1.2.1. Cohesins (green) may further promote interactions between sister 
chromatids, i.e. as opposed to homologous chromosomes10. (ii) MRN acts too as a sig-
naller, recruiting CtIP (yellow) that through its 5’→3’ exonuclease activity exposes 3’ 
ssDNA tails at either end of the break28. (iii) Further resection is performed by ExoI 
(pale purple) with BLM helicase28, and the resulting single-stranded DNA coated by 
RPA (purple)27. (iv) These RPA-bound 3’ overhangs provide a substrate for BRCA2 
(pink), which laden with a cargo of RAD51 molecules (pale yellow) loads them onto 
the ssDNA. The nucleated RAD51 then self-assembles about the ssDNA into a fila-
ment, subsequently displacing both RPA and BRCA227. BRCA2 also associates with 
PALB2 (pale blue), but this is not required for its recombination mediator activity in 
vitro33. (v) The RAD51-ssDNA complex is able to catalyse invasion of the ssDNA into 
the intact duplex DNA, to first form a triple-stranded nucleoprotein filament and 
search for homology therein24. (vi) Once located, the complementary strand is exclud-
ed to form a displacement (D-) loop and the template strand used to repair the 
damage via polymerase and ligase action, with the uptaken ssDNA strand serving as a 
primer11,24,32. RAD52, RAD51 paralogues, RAD54, RAD54B, and the HOP2-MND1 
complex assist at various stages of the process32. 
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1.3.1.2.4 Synthesis and ligation 
The capture of homologous duplex DNA and formation of the synaptic complex is thus 
the second rate-limiting stage of homologous recombination, and is overcome by the HOP2-
MND1 complex32. Subsequent homology search and aligning of sequences, followed by 
strand exchange and D-loop formation, presents a 3’ end that is used as a primer for DNA 
polymerisation41. This results in transfer of information from the unbroken donor to the bro-
ken recipient, called ‘gene conversion’41. Vigorous DNA synthesis from the invading single-
stranded DNA is carried out by DNA polymerase eta (POLη), which exhibits specific D-
loop recognition42,43. RAD51 synergises with POLη, and facilitates primer extension by the 
latter by elongation of the D-loop bubble42. Continuity of the strands is then established by 
DNA ligase I (LIG1)21,26 – see Fig. 2vi. 
1.3.1.2.5 End-product resolution 
Afterwards, the joint molecules so formed may proceed down one of two routes. They 
can either dissociate, with the broken chromosome being rejoined through synthesis-
dependent strand annealing; or engage the other resected broken end, creating Holliday junc-
tions to then be dissolved or resolved by helicases/topoisomerases and structure-specific 
endonucleases (i.e. resolvases) respectively44. The former involves essentially a migrating D-
loop that never captures the second end. Rather, the invading strand gets displaced and an-
neals with this end32 (see Fig. 3a). Hereby, RAD54 due to its branch migration activity, 
causes dissociation of the D-loop44. 
Alternatively, the second resected double-strand break end can be captured by annealing 
to the extended D-loop, generating cruciform DNA structures called Holliday junctions that 
link the recombining duplexes32,45. These have to be removed, as the cell would otherwise be 
unable to undergo division if the repaired pair of chromosomes remain intertwined in this 
topology, and cannot be separated to opposite poles of the mitotic spindle. In somatic cells, 
the primary mechanism is dissolution of the junctions via the BLM-TOPOIIIα-RM1-RM2 
complex45 (Fig. 3b). This entails convergent migration of the two Holliday junctions pro-
moted by BLM helicase, creating hemicatenane that is dissociated by topoisomerase action 
of TOPOIIIα45. 
Both the above processes culminate in non-crossover recombination products, whereby 
an exchange of arms between participant chromosomes does not take place. This is indeed 
the preferred outcome of homology-directed repair46, as it prevents any loss of heterozygosi-
ty that may drive carcinogenesis.  
However, Holliday junction resolvases provide backup for the two above pathways by 
cleaving persistent junctions45. Depending on whether cleavage occurs across the inside or 
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outside pair of strands, the result is a non-crossover or crossover product respectively (Fig. 
3c). The two are similar or identical operations owing to four-way symmetry of these struc-
tures. Despite the potential for resolvases to induce genome-destabilising rearrangements, 
they serve to safeguard cell viability – as residual or unresolved Holliday junctions present a 
blockade to chromosome segregation during mitosis45. Human cells devoid of resolvase 
components exhibit defects such as anaphase bridges, and high frequencies of lagging chro-
mosomes and cell mortality45,47. Such phenotypes likely arise from accumulation of 
unresolved Holliday junctions, giving rise to chromosomal nondisjunction at mitosis. Simi-
larly, cells from BLM-mutated individuals display elevated levels of chromosome 
exchanges, deficiencies in their segregation and genomic instability45. There exist three Hol-
liday junction resolvases in humans, i.e. GEN1, SLX1-SLX4 and MUS81-EME1. These 
constitute two different pathways for resolution, one mediated by GEN1, and another by 
SLX1-SLX4-MUS81-EME1 (SLX-MUS)45. To prevent undue crossovers, their activities are 
limited during S phase, due to regulation either temporally (in case of MUS81-EME1) or by 
nuclear exclusion (GEN1)48. For instance, human cells promote an association between 
SLX1-SLX4 and MUS81-EME1 during prometaphase in order to stimulate Holliday junc-
tion resolution, as SLX-MUS is a more potent resolvase than either of its components45. 
Mitotic homologous recombination is most frequently associated with non-crossovers. 
However, in meiosis it effects exchange of information between maternal and paternal alleles 
within gamete precursor cells after deliberate initiation of double-strand breaks by SPO11, 
generating genetic diversity among progeny derived from common parents. DMC1, a meio-
sis-specific recombinase, is found in almost all eukaryotes including humans, and is active 
only during meiosis – where its acts in concert with RAD51. HOP2-MND1 complex and 
RAD54B function with DMC1 in the same way as RAD51. And likewise, BRCA2 also in-
teracts with DMC1, whose ablation leads to meiotic recombination defects.32 
In general however, mitotic recombination factors are better characterised than meiosis-
specific ones. 
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Figure 3. Resolution of recombinational repair products. The homologous recombination 
process results in the formation of DNA joints connecting the recombining DNA mole-
cules that need then to be separated. This can be achieved through synthesis-
dependent strand annealing32 (a), whereby the D-loop is unwound and the freed ssD-
NA strand anneals with the complementary ssDNA from the other side of the double-
stranded break. The reaction is concluded via gap-filling DNA synthesis and ligation, 
and exclusively non-crossover products are formed. Or else, the second break end can 
be captured and result in the formation of Holliday junctions32 (b, c). They are prefer-
ably then dissolved by an outward migration of the junctions mediated by BLM-
TOPIIIα complex32 (b), which too leads solely to non-crossovers – that are indeed the 
preferred outcome of HR. However, should these fail, the HJs may be resolved via en-
donucleolytic cleavage of either the inner (black) or outer (grey) pair of bases (by 
MUS81-EME1 and/or SLX1-SLX4, or GEN1)45, resulting in a non-crossover (black 
arrow) and crossover (grey) respectively32 (c). Probability of the two is thence equally 
divided. 
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1.4 The RAD51 recombinase 
The 339-amino acid (~37 kDa) human RAD51 protein is the eukaryotic homologue of the 
prokaryotic RecA, the archaeal RadA, and the meiosis-specific eukaryotic recombinase 
DMC1 – and is the central recombinase enzyme amongst eukaryotes19,49,50. It polymerises as 
filaments onto DNA and promotes strand invasion and exchange between sister chromatids 
or homologous chromosomes. 
1.4.1 Cell viability and chromosome stability 
In vertebrate organisms, the loss of RAD51 function engenders cell inviability32. For in-
stance, the mouse Rad51-/- genotype is an embryonic lethal51,52.  
In one experiment51, mice heterozygous for the Rad51 null mutation were generated using 
gene targeted embryonic stem cells, whereby a small deletion had been introduced corre-
sponding to a region carrying the ATP-binding motif of the protein that is essential for its 
recombinogenic functions. Nine Rad51+/- mice (6 males & 3 females) were intercrossed, and 
their offspring genotyped. Thereby, Rad51+/+ and Rad51+/- mice were observed in the ratio 
1:2 respectively. Tissue samples from heterozygous animals revealed one-half the amount of 
RAD51 protein compared to wild-type, but such mice themselves appeared normal and were 
fertile. On the other hand, of the (148) offspring examined no Rad51-/- homozygote was 
found, strongly indicating that the homozygous embryos suffer growth cessation during their 
development. Analysis of the embryos’ early stages showed that only a marginal fraction of 
the Rad51-/- genotype was viable, i.e. 1 out of 109 embryos at the 4- to 8-cell stage and 2 out 
of 65 at the blastocyst stage – exceedingly low ratios in light of Mendelian genetics. These 
rare cases of relative development of Rad51-/- embryos could have been being sustained by 
residual RAD51 of maternal origin. Furthermore, reduction in levels of RAD51 by antisense 
transfection led to severe growth retardation in the m5S mouse cell line.  
In a second study52, mouse Rad51 was similarly disrupted by embryonic stem cell gene 
targeting, in this case having introduced an out-of-frame deletion in the gene. Rad51-/- mutant 
embryos arrested in development early after implantation. The decreased cellular prolifera-
tion was followed by programmed cell death. Such cells accumulated severe chromosome 
loss by the end of their lives. They also exhibited extreme sensitivity to gamma radiation. 
Again, no Rad51 null mutant mice were observed. 
In a later experiment53, RAD51-/- clones of the chicken B cell DT40 line were created, car-
rying a human RAD51 transgene under the control of a tetracycline (tet)-repressible 
promoter. The tet- (i.e. HsRAD51+) cells possessed proliferative properties indistinguishable 
from wild-type DT40 cells, and the two displayed much the same response pattern to gamma 
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irradiation. Subsequently, endogenous (non-induced) RAD51 repair foci were disrupted by 
an inhibition of the transgene’s expression, via addition of tetracycline to the medium. The 
cells ceased proliferating and arrested at the G2/M boundary, having accumulated large num-
bers of cytologically visible chromosome breaks – see Fig. 4, before dying. In contrast, 
chromosomal aberrations were scarcely detectable in both tet- clones and wild-type cells. 
Such studies highlight the vital role of RAD51 orthologues in repairing spontaneously 
occurring and exogenous chromosome breaks in proliferating higher eukaryotic cells, and 
hence their very viability. 
 
Figure 4. Representative karyotype analysis of 4-Gy-irradiated Rad51-deficient (chicken) 
DT40 cells, after incubation in a tetracycline (tet+) medium for 21 hours (see text, 
§1.4.1). Macrochromosomes 1–5 and Z are indicated. Isochromatid gaps and breaks 
are identified by small and large arrows respectively. Reproduced from Sonoda et al. 
(EMBO J., 1998). 
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1.4.2 RAD51 orthologues 
Human RAD51 (and mouse Rad51), specify proteins that show a high degree of amino-
acid similarity to the yeast Rad51 protein (83%), DMC1 being less so (64%). They are all 
also homologous to the E. Coli RecA protein, specifically from residues 33 to 240 of the lat-
ter (see Fig. 5). This common region constitutes the ‘homologous core’ of these proteins, and 
harbours the ATP-binding and hydrolysis domains. As such, the mammalian and RecA pro-
teins share 51% similarity between their homologous cores. The RAD51 homologues are 
~90 amino acids shorter in the C-terminal region, and 63 to 121 residues longer at the N-
terminus. These extended N-termini comprise ~95 amino-acid sequences that are common 
amongst the eukaryotic proteins. Human and mouse RAD51, differ in fact by only 4 amino 
acids (hence 99% identical); while chicken and human RAD51 proteins are 95% identical.50 
The level of homology between human, yeast and bacterial recombinases is suggestive of 
the marked similarity between their respective homologous recombination pathways51. Yeast 
and mammalian RAD51-mutant cells exhibit similar phenotypes, i.e. both display loss of 
chromosomes, impaired proliferation, and hypersensitivity to DNA-damaging agents52. 
However, E. Coli recA and yeast RAD51 mutations do not impart cell lethality51–53. This re-
flects vertebrate genomes being hundreds of times larger than yeast’s, incurring double-
strand breaks as much more frequently – and thus a proportionally greater requirement for 
their repair52,53. The sensitivity however is the same when the two’s relative genomic sizes 
are accounted for52. 
Analysis of DNA-PKCS and KU80-deficient cells reveals that they do have similarities to 
mouse RAD51-deficient cells. All are highly sensitive to ionising radiation, and KU80-
deficient cells are prematurely senescent52. Ku80-/- mice show growth retardation, and adults 
are 40-60% the normal size54. But nonetheless KU80 and DNA-PKCS-deficient mice and 
cells are both viable, whereas MmRAD51-deficient cells are not. These observations illus-
trate that the consequences of removing the homologous recombination pathway for repair of 
DNA double-strand breaks, are much greater than removal of the nonhomologous pathway. 
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Figure 5. RAD51 protein sequence and orthologues (human and mouse RAD51, ScRad51 
and E. Coli RecA). All recombinases share a core ATPase domain. The eukaryotic 
proteins share a common ~95 a.a. N-terminal region, while RecA has a ~90 a.a. C-
terminal extension. Each of these binds DNA. ScRad51 harbours a further 55 a.a. N-
terminal extension that is unique to yeast50. Homologous domains are like-coloured. 
Type A (ATP binding) and Type B (hydrolysis) Walker motifs are indicated. The de-
picted locations and sizes of the sections are accurate and exactly to scale. 
1.4.3 RAD51 filament structure 
All recombinases can occur as either rings or right-handed nucleoprotein filaments55. 
Rings form most often in the absence of DNA, and usually also nucleotide-cofactors55,56. 
They may be hexameric (RecA)57, heptameric (RAD51)56 or octameric (DMC1)58. For exam-
ple, RadA (the closely related archaeal homologue of Rad51), forms heptameric rings with 
the ATP-binding sites occluded56. As such, rings constitute an inactive state of these proteins, 
but might still be physiologically relevant as ‘storage forms’ that prevent futile cycling of 
ATP56. A flexible segment connecting the N-terminal extension of Rad51 and its ATPase 
core, comprises a single β-strand (i.e. β0) that serves as the primary interaction motif in pol-
ymeric assemblies – by packing onto the edge (β3) of the neighbouring protomer’s central β-
sheet, and forming a β-zipper56 (see Fig. 6b). This interdomain linker protrudes from the rest 
of the molecule and provides the flexibility necessary for changes in quaternary structure. 
Analogously, in the RecA filament, such an intermolecular β-sheet is formed by β 0 from one 
subunit contacting β3 from the adjacent monomer59. Recombination-competency follows 
from the filamentous form, and these filaments exhibit marked conformational variability; in 
their helical pitch (sometimes even within different regions of the same filament), and exten-
sion of the enclosed DNA – in response to the type of cofactor and DNA bound49,55. 
However, inactive filaments (those formed with ADP or without DNA) generally display 
lower pitches (~65–85 Å), than active ones (~90–130 Å)49.  
The crystal structure of a ScRad51 filament formed in the presence of single-stranded 
DNA and ATPγS49, revealed the nucleotide-binding pocket of one protomer (Walker A) to 
be in direct contact with the ATPase domain of the next (Walker B), and a pitch of 130 Å 
(Fig. 6a, c) – compatible with previously obtained electron microscopy structures of active 
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forms of recombinase filaments60. An excess 79-residue N-terminal extension unique to yeast 
had been truncated, corresponding to the point where the NMR structure of human RAD51’s 
N-terminus becomes well-ordered61. This truncated variant was nonetheless fully capable of 
DNA binding and strand exchange in vitro. Another important feature of the structure is the 
pseudo six-fold helical (P61) symmetry, the true symmetry being only three-fold (P31) – as 
alternating subunit-subunit interfaces are slightly different, due to slight rigid body move-
ments between the N- and C-terminal (ATPase) domains. Inter-subunit interactions between 
ATPase domains thus alternate between two arrangements, which vary substantially at the 
nucleotide-binding pocket. In one configuration, the His352-bearing helix from the ATPase 
site of the adjacent monomer lies close to the phosphate-binding loop of the first, whereas in 
the other it is occluded by Phe187 of the first and shifted away from this pocket (Fig. 6c). 
Such a scheme also happens to be consistent with the observation that RecA-DNA filaments 
in solution show two different affinities for ATP62. While it is possible that the histidine, 
which is highly conserved across all eukaryotic recombinases, directly catalyses ATP-
hydrolysis; it likely plays a part in allosteric regulation of the system, by sensing nucleotide 
binding and coupling hydrolysis with the filament’s overall conformation and binding to 
DNA49. Stabilisation of this helix might promote the active state of the filament, by incorpo-
rating it as part of the protein-protein interface49. The helix is disordered in non-filamentous 
forms of RadA and HsRAD51, implying it is fairly flexible, and that its localisation is de-
pendent on interactions in the filament structure. In support of His352’s contribution to 
filament assembly, the H352A mutant is significantly defected in single-stranded DNA bind-
ing.  
NMR and mutational analysis of human RAD51’s N-terminus, HsRAD51(1-114)61, es-
tablished its role in single- and double-stranded DNA binding, specifically residues 61–69 
that constitute a positively charged surface. The N-termini fold into compact all-helical do-
mains, which form lobes lining the upper part of the filament, and point into its helical 
groove – with amino acids 61–69 located at the top of these lobes (as seen in the NMR struc-
ture fitted into an electron microscopy reconstruction of human RAD51 filament on single-
stranded DNA). 
DNA is believed to be bound in a relatively stretched (often inhomogeneously) and un-
twisted manner within recombinase filaments63. And despite its presence, single-stranded 
DNA itself was not visualised in the aforementioned crystal structure, even though it mimics 
the DNA-bound conformation. This is likely due to the DNA being too poorly ordered to be 
seen, for instance because different protomers could be binding DNA at different stoichi-
ometries49. Study of DNA binding by ScRad51, in presence of ATP and Mg2+, indicated that 
its binds both single- and double-stranded DNA over a wide range of pH at 4 ± 1 nucleotides 
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(or base pairs) per monomer64. An average value of 4 nt per protomer, corresponds to an ex-
tension of ~120 Å per turn of DNA helix – and is hence consistent with the observed 
structure. It remains possible nevertheless, that DNA was not bound in the filament, or was 
digested by trace nuclease contamination. ATPγS was probably hydrolysed during the crys-
tals’ growth, and clear density for only one large ion was seen at the nucleotide-binding site 
– most likely a sulphate (present in the medium) mimicking the binding of phosphate49. 
There is ample space however, for an ATP molecule to be modelled into the phosphate-
binding loop with just minor adjustments to the nearby structure.  
Synthesis of the above results is clearly implicative of an allosteric communication be-
tween the ATPase- and DNA-binding sites to affect nucleoprotein filament structure and 
DNA strand exchange. It should be noted though, that while ATP-binding is necessary for 
the recombination function of Rad51 (as well as RadA and RecA), hydrolysis is required 
only by Dmc155. 
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Figure 6. Crystal structure of an active (ATPγS and ssDNA bound) configuration of the 
ScRad51 filament49, with an N-terminal truncation corresponding to the HsRAD51 N-
terminus. (a) The filament has a pitch of 130 Å, and shows alternating monomer-
monomer interfaces to be slightly different (yellow and green), such that the filament 
possesses pseudo 6-fold but only an exact 3-fold screw symmetry. A sulphate (black 
balls) can be seen mimicking the binding of phosphate in the ATPase site, which is sit-
uated directly at the interface between neighbouring subunits (arrow). N-terminal 
domains line the upper segment of the filament (circled). ATPγS and ssDNA them-
selves are not visualised due to being hydrolysed and disordered respectively. (b) The 
Rad51 filament polymerises via stacking of a β-strand from the linker between the N-
terminal and ATPase domains of one monomer (green), against the central sheet of 
the adjacent monomer (yellow). Interactions between the ATPase domains comprise 
the His352-bearing helix, which is disordered in nonfilamentous forms, but is stabi-
lised thereby. The histidine itself may or may not be involved in ATP hydrolysis. (c) In 
one variant of the intersubunit interface, His352 from one monomer is positioned di-
rectly over the ATPase site of the preceding monomer (left). In the second form, the 
His352 is shifted away from the ATPase site, and occluded therefrom by Phe187 of the 
previous monomer (right). Adapted from Conway et al. (Nat. Struct. Mol. Biol., 2004). 
1.5 The BRCA2 tumour suppressor 
Bacterial cells respond in an exceptionally affirmative fashion to the event of a double-
stranded break in DNA, to the extent where within 30 minutes of its occurrence, RecA con-
stitutes by far the most abundant protein in the cell. This luxury is not afforded to human and 
mammalian cells with their considerably larger genomes, which rely instead on harnessing 
the recombination protein that is present already in their nuclei, and relocalising it to the sites 
of double-stranded break damage where the repair reactions then take place – the so-called 
repair foci.65 
BRCA2 orthologues constitute the primary recombination mediator in higher eukaryotes, 
providing a rapid mechanism for RAD51 loading that has seemingly relegated RAD54 to a 
more minor role therein over the course of evolution66. These orthologues vary greatly in 
size, ranging from the 3,418 a.a. (384.073 kDa) human protein – see Fig. 7, to the 383-
residue Caenorhabditis elegans counterpart called BRC-232. 
Human BRCA2 harbours a succession of eight repeated sequences of ~35 a.a. in length 
termed BRC motifs with variably sized linker regions, interspersed within a ~1100 residue 
roughly middle portion of the protein (a.a. 1009 – 2083) – and confer its ability to interact 
with RAD5167. Their number is highly conserved between mammalian species67, but greatly 
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diverse in non-mammals, e.g. Arabidopsis thaliana Brca2 and C. elegans BRC-2 possess 
four BRC repeats and one such repeat respectively32. 
The ~700 residue DNA-binding domain is located in the C-terminal region of BRCA2, 
i.e. amino acids 2,482 – 3,184, and is comprised of five subdomains. These include an alpha 
helical domain, followed by three oligonucleotide/oligosachharide-binding (OB) folds, with 
an insertion of a ‘tower’ subdomain in the second OB fold. Situated between the helical and 
first OB fold lies a pocket that receives a small highly acidic polypeptide called DSS1 (re-
garding which more later).68 
BRCA2 also harbours an additional 36 a.a. C-terminal RAD51 binding (CTRB) domain 
between residues 3,270 and 3,305 that is unrelated to the BRC repeats69 (see §1.5.1). Unlike 
the latter however, it interacts solely with RAD51 polymers and appears to stabilise nucleo-
protein filaments already established on single-stranded DNA, via preventing their 
dissociation by the BRC repeats through their binding of individual monomers69. Phenotype 
of mice homozygous for a mutation in the CTRB domain is characterised by increased can-
cer incidence, reduce viability, and hypersensitivity to DNA crosslinking agents, but through 
a relatively moderate impairment of homology-directed repair32,69. Therefore, while it makes 
a significant contribution toward the mediator function of BRCA2, it appears to be compara-
tively dispensable vis-à-vis the BRC motifs32. However, evidence shows Ser3291 therein is 
phosphorylated by cyclin-dependent kinases (CDKs) at the G2-M transition that eliminates 
the CTRB domain’s interaction with RAD51, and dephosphorylated upon DNA damage70. It 
has thus been suggested it provides a regulatory ‘switch’ that can either promote or suppress 
RAD51-mediated repair of DNA double-strand breaks, by disfavouring or favouring the dis-
ruption of RAD51-ssDNA filaments by BRC repeats respectively69. DMC1 too can bind this 
domain, albeit with weaker affinity32. It is though only found among vertebrate species69. 
None of the BRC repeats however, appears to have affinity for DMC1. In fact, the main 
DMC1-interacting site has been mapped to a 26 a.a. region (residues 2386–2411) called the 
PhePP motif, which is highly conserved amongst mammalian orthologues.32 
Toward its C-terminus, BRCA2 harbours two nuclear localisation signal (NLS) sequenc-
es, with one flanking either side of the CTRB domain. The first is constituted by 3266-Lys-
Lys-Arg-Arg-3269, and the other by 3313-Lys-Lys-Lys-331570. In fact, the smallest known 
cancer-associated deletion in BRCA2 (that is also the most C-terminal of such mutations), 
substitutes a stop codon for Thr3195 (T3195X), thus ablating the final 7% (224 amino acids) 
of BRCA2 and rendering it cytoplasmic. The Lys3326Ter polymorphism however, elimi-
nates 92 residues from its C-terminus without consequence.71 
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The N-terminal region of BRCA2 binds PALB2, through the former’s amino acids 21 via 
39. This contains a minimal ~10 residue motif (a.a. 26–36) that is structured in the complex 
and includes a short α-helix. PALB2, a 1186 residue protein, interacts with BRCA2 through 
the former’s C-terminal WD40 domain (a.a. ~836–1186), a sequence of repeated motifs 
commonly involved in protein-protein interactions that folds into a circularised β-propeller. 
In this case, it assumes a seven-bladed structure, and BRCA2(21–39) binds into a pocket 
constituted by the tips of the fourth and fifth blades. The interaction buries ~1,100 Å2 of sur-
face area, typical of transient regulatory bindings.72 
 
Figure 7. BRCA2 protein sequence, and major binding partners. The N-terminal region har-
bours the PALB2-binding domain (a.a. 21–39)72. The middle portion (a.a. 1,009–
2,083) contains eight 35 a.a. BRC repeats that interact with RAD515. After is a 
DMC1-binding PhePP motif (a.a. 2,386–2,411)32.  The C-terminal region comprises 
the DNA binding domain (a.a. 2,482 – 3,184)68. This in turn is composed of five sub-
domains, the alpha helical domain (αD), and three oligonucleotide/oligosachharide-
binding folds (OB1, OB2 and OB3); an additional tower (T) domain constitutes an in-
sertion in OB2. A small area between αD and OB1 also binds DSS1. Toward the C-
terminus lies an independent RAD51-binding (CTRB) domain (a.a. 3,270–3,270)69. 
This is closely flanked by a nuclear localisation sequence (NLS) on either side (a.a. 
3,266–3,269 and 3,313–3,315)70. The relative positions, lengths, and spacings of the 
various domains are exact and precisely to scale. 
1.5.1 BRCA2 and cell proliferation 
In an early study73, the Brca2 locus in mice was mutated using embryonic stem cell tech-
nology, in order to delete amino acids 626–1,437. Southern blotting identified clones 
carrying the mutant gene, and the cell lines were injected into blastocysts. Chimaeric mice 
born mostly transmitted the Brca2- allele to their progeny. Heterozygous mice were healthy 
and fertile (and did not show signs of tumourigenesis until at least 8 months of age). Litters 
from Brca2+/- intercross matings did not yield any Brca2-/- offspring, suggesting Brca2 is 
crucial for embryonic development.  
Embryos from varying stages of development were histologically examined to determine 
the time and cause of their lethality. All (16) embryos were normal at 6½ days of develop-
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ment. However, by 7½ days, ~25% of the (45) embryos exhibited a mutant phenotype and 
overall growth arrest. Given they resembled embryos from the previous day, implies the de-
velopmental block occurred after 6½ days of gestation. An inability to derive homozygous 
mutant embryonic stem cell lines, further suggested that the Brca2 gene is requisite for em-
bryonic cells’ survival and proliferation. Since Brca2 null mutant embryos do initiate 
formation of morphological features, it is implicit that the development arrest is not due to a 
differentiation defect but lack of proliferation. This occurs at the time when the embryo un-
dergoes its most rapid phase of cell division.  
Appearance of the mutant phenotype in Brca2-deficient embryos was tallied with the 
gene’s expression via in situ hybridisation. No transcripts are detectable at 6½ days. But at 
7½ days, Brca2 is upregulated and transcribed throughout the embryo. These transcripts are 
also particularly prevalent in tissues with high mitotic indices, and downregulated in post-
division cells. Using a yeast two-hybrid screen, MmRad51 was shown to interact with Brca2 
(in this case a C-terminal region comprising residues 3,138–3,232). The interaction was fur-
ther affirmed in mammalian cells. A minimal 36-residue segment (a.a. 3,196–3,232) was 
found to display a strong association, of which removing 13 amino acids (residues 3,196–
3,232) eliminated the interaction. 72, 95 and 100% identity exists between the 94, 36 and 13 
amino-acid fragments therein and the human homologue respectively, suggestive of their 
functional significance. Expression patterns of Brca2 and MmRad51 were also nearly identi-
cal, and homozygous mutants of the two genes arrest growth at similar stages. This region 
then came to be regarded as the CTRB domain. 
Brca2-/- and control (Brca2+/+ and Brca2+/-) embryos at day 3½ were gauged for γ-
radiation sensitivity. Following administration of 400 Rads, inner cell mass of the latter was 
minimally affected, but completely abolished in the former. Furthermore, while trophoblasts 
in the controls were only marginally reduced, there was a significant decrease amongst 
Brca2-/- embryos. MmRad51 null embryos however, appear more sensitive to γ-irradiation 
(based on the response of trophoblast cells). Such assays indicate that replicative growth ar-
rest and death are in fact a secondary consequence of a defect in DNA damage repair. 
Above conclusions thus also help explain the high penetrance of early onset breast can-
cers amongst human carriers of a BRCA2 mutation. In mammary epithelial cells having lost 
BRCA2 function, RAD51-effectuated double-strand break repair is presumably compro-
mised, which destabilises the genome. Some RAD51 activity continues, but ultimately 
BRCA2’s mediator function is found wanting. Higher severity of MmRad51 compared to 
Brca2 mutant phenotype (though very similar), too is consistent with this scenario. 
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But while MmBrca2 deficiency induces embryonic lethality, BRCA2-deficient breast epi-
thelial cells proliferate and become tumours. One resolution of this apparent paradox is that 
developmental arrest is cell-type specific. Embryonic cells are hypersensitive to unrepaired 
double-strand breaks and hence inviable. Mammary epithelial cells on the other hand can 
survive with an unstable genome (perhaps due to a hormonal response74), but accumulate 
genome alterations that contribute to malignancy. Mouse mutants of tumour suppressor 
genes also differ in the extent to which their phenotypes resemble the human syndromes.  
1.5.2 BRCA2 and genomic stability 
A mouse strain with a targeted mutation in exon 11 of Brca2 was used to probe its role in 
DNA repair, so-designed to model a mutation linked with ovarian cancer75.  This was pre-
dicted to diminish the encoded protein to half its size at amino-acid residue 1492. 
Homozygous mutant cells expressed transcripts from the intact 5’ region of the gene and a 
partial protein was also synthesised. Hereby, the Brca2- allele endowed a stunted develop-
ment phenotype, potentially accordant with an incomplete Brca2 enzyme. Though the Brca2-
/- genotype caused significant growth retardation, such embryos were often viable till birth. 
Some even survived into adulthood, but succumbed to thymic lymphomas. The exceptional 
embryonic survivability of this strain was exploited to establish a Brca2-/- cell line. 
These were then used as a system to test for cellular and genome abnormalities that would 
delineate Brca2’s role in the DNA damage response. Cells in culture exhibited a proliferation 
impediment that worsened with successive passages of the cell cycle. Elevated arrest at the 
G1 and G2/M phases and an impaired ability to enter S phase, was accompanied by an in-
creased expression of p21 and the pro-apoptotic p53 protein. Normal cells too arrest at the 
two checkpoints upon γ-irradiation. Whereas the p53- and p21-dependent G1 checkpoint 
prevents replication of damaged templates, the G2 checkpoint blocks segregation of dam-
aged chromosomes. Which of the apoptotic or cell-cycle arrest responses predominates 
depends on the cell-type, e.g. lymphoid progenitor cells typically initiate rapid apoptosis. 
Such cells were extracted from foetal livers of Brca2-/-, Brca2+/- and Brca2+/+ embryos. Ho-
mozygous mutant cells showed a similar apoptotic response to the controls when exposed to 
γ-radiation, even down to 10 rads. Apoptosis and checkpoint activation were thence intact. 
Thus Brca2’s involvement is indicated to be in DNA repair, independent (or at least distinct) 
from cell cycle control and apoptotic aspects of the damage response.  
Mutant cells also exhibited increased sensitivity to various genotoxins, especially ionizing 
radiation and methyl-methanesulphonate (MMS), which induce DNA double-stranded 
breaks and interstrand crosslinks respectively. This suggested that Brca2’s function is in par-
ticular relevant to the repair of these lesions. 
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Moreover, Brca2-deficient cells displayed an excessive occurrence of spontaneous (unin-
duced) chromosomal aberrations. They included chromatid and chromosome breaks, and 
frequently tri- and quadriradial chromosomes. The latter are reflective of chromatid ex-
changes that take place in mitotic recombination during cell division. Apart from structural 
abnormalities, aberrations in chromosome number (polyploidy) was observed as well. There 
was a significant increase in the number of cells with greater than four times the DNA con-
tent of controls. As such these data are further evidential of Brca2’s specific function in 
DNA double-strand break repair.  
Again, the divergent phenotypes of neoplastic transformation in Brca2-/- mice hereby, and 
proliferative arrest beggars explanation. Reconciliation ensues from a model whereby sec-
ondary mutations (including in proto-oncogenes) that grant evasion from cell cycle 
checkpoints constitute an important precondition for tumourigenesis76. Hence, the very spon-
taneous genetic instability rendered in cells lacking functional Brca2, which is the cause of 
reduced proliferation – might also precipitate these secondary changes77. 
A second study78 sought to clarify the nature of genome aberrations in such Brca2-/- cells. 
The effect of Brca2 truncation on spontaneous gross chromosomal rearrangements was ex-
plored. Integrity of the chromosomes’ structure in Brca2-deficient cells was examined by the 
means of spectral karyotyping. Metaphase spreads derived from Brca2-/- lymphocytes (fol-
lowing 20 passages in culture) showed sundry structural anomalies amongst the 
chromosomes, including multiple translocations between two different (non-homologous) 
chromosomes and even acentric fragments with parts from three – see Fig. 8. These kinds of 
aberrancies usually arise from mutagenic processing of DNA double-strand breaks, whereby 
several broken DNA ends bearing little or no interhomology are indiscriminately ligated to-
gether. All (12) Brca2-/- metaphases surveyed exhibited a similar pattern of aberrant 
chromosomes, which were not observed in controls. Also, their preponderantly random and 
inconsistent nature between mutant cells indicated that the underlying DNA damage took 
place continuously. 
Tumourigenic mutations in humans are frequently accrued as a consequence of gross 
chromosomal rearrangements, comprising translocations (genetic exchange between non-
homologous chromosomes), as well as inversions, large deletions, and partial or complete 
loss of chromosomes. Results hereby indicate that BRCA2 inactivation amplifies the occur-
rence of such rearrangements, triggering the additional genetic changes necessary for 
neoplastic transformation by loss of heterozygosity at functionally important genomic loci. 
This homozygosity then underpins the loss of tumour suppressor genes and/or activation of 
proto-oncogenes that is characteristic of cancer. 
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Brca2 hence suppresses tumour formation by the repair of spontaneous (and induced) 
double-strand breaks, and prevention of gross chromosomal rearrangements and loss of het-
erozygosity. 
 
Figure 8. Spectral karyotyping analysis of chromosomes from Brca2-/- lymphocyte cells after 
20 passages in culture reveals a high frequency of spontaneous random aberrations. A 
representative metaphase spread shows a dislocated chromosome fragment (panel 4), 
myriad translocations between two chromosomes as in t(X;16), t(12;16), t(13;14), and 
t(X;16), rearrangement amongst three chromosomes such as 13, 16 ad 5 (panel 5), 
and potentially even more. Reproduced from Yu et al. (Genes Dev., 2000). 
1.5.3 Colocalisation of BRCA2 and RAD51 
In reaction to DNA double-stranded breaks, the RAD51 protein relocalises within the nu-
cleus into distinct repair foci, which are visualisable by confocal microscopy65. Formation of 
RAD51 foci is dependent upon BRCA2, as well as the RAD51 paralogues, RAD52, RAD54, 
and the HOP2-MND1 complex. They are accompanied also by RPA. Localisation kinetics 
vary between components, indicating that their assembly is a carefully choreographed pro-
cess, involving the sequential recruitment of one protein based upon another65. These 
interactions moderate RAD51’s ability to bind DNA. 
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Given that Rad51 and Brca2 interact in mice, one might expect that the two be found at 
the same sites upon induction of DNA double-strand breaks.  
In an experiment65, an asynchronous culture of HeLa cells was analysed for the presence 
of RAD51 by immunofluorescent staining. After treatment with 10 Gy of ionising radiation 
and being allowed to settle for 3 hours, the number of cells exhibiting RAD51 foci increased 
manifold. Similarly, when irradiated cells (with a recovery period of one hour) were assessed 
for the presence of RAD51 and BRCA2 foci, the two were found to exactly coincide (see 
Fig. 9). 
RAD51 likewise colocalised with RAD54, and RPA65. Accumulation of recombination 
mediator proteins such as BRCA2 supports the notion that these foci represent the sites of 
double-strand break repair by homologous recombination. The latter signals the presence of 
DNA intermediates (in this case undergoing repair). 
Collectively, the above findings signify that BRCA2 directs the activity of RAD51 not 
only at molecular scale, but also at the microscopic (focus formation) level. 
 
Figure 9. BRCA2 (green) and RAD51 (red) foci in HeLa cells were visualised through con-
focal microscopy 1 hour after exposure to 10 Gy of ionising radiation using rabbit 
anti-BRCA2 and mouse anti-RAD51 antibodies and immunofluorescence staining, and 
observed to precisely colocalise (denoted by yellow foci in the merged images). A sim-
ilar pattern was observed with RAD54, and partially so with RPA. Reproduced from 
Tarsounas et al. (Phil. Trans. R. Soc. B, 2004). 
1.5.4 Structure of BRC4 – RAD51 (ATPase domain)  
One of the two major (partial) x-ray crystal structures of BRCA2 determined to date, is 
that of the fourth BRC repeat (BRC4) in complex with the ATPase core domain of RAD5179. 
The structure depicts the BRC repeat binding RAD51 via mimicry of the latter’s polymer-
isation motif49 (see Fig. 10a, b). BRC4 remains in contact with RAD51 over an unbroken 
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stretch of 28 residues (Leu1521 – Glue1548). Nine amino acids (Phe1524 – Val1532) form a 
β-hairpin that stacks up against β-strand 3 (β3) of RAD51, furthering the latter’s central β-
sheet by an additional two short antiparallel strands – and ‘zipping’ the two molecules to-
gether akin to interprotomer contacts in Rad51 filament’s crystal structure (§1.4.3, Fig. 6). 
For illustration, the sequence of human RAD51’s oligomerisation motif, 85-GFTTATE-
91, bears high similarity to the BRC consensus, GFXTASG (where X denotes a generic ami-
no acid). 
Following the hairpin, the BRC motif folds around helix 4 (α4) of RAD51 via a small 
linker (Lys1533 – Ala1535), which carries into an amphipathic α-helix (Lys1536 – 
Val1542). Remainder of the residues at the C-terminal end (Lys1543 – Glu1548) make an 
irregular coil, with parts of a 310-helix traversing helices α4 and α5 of RAD51 (Fig. 10c). 
The RAD51-BRC4 complex buries 2,026 Å2 in surface area, comprising mostly of hy-
drophobic interactions (Fig. 10d, e), but also some polar contacts. Three main hydrophobic 
points of contact keep the BRC motif in close proximity to RAD51, i.e. Phe1524, Ala1527, 
and Leu1545/Phe1546 (further abbreviated henceforth). F1524 lies in the β-sheet contacting 
RAD51, its aromatic ring situated deep within a hydrophobic pocket of the latter (constituted 
by the side chains of M158, I160, A190, A192, L203, and A207). Similarly, A1527’s β-
carbon is placed inside a small pocket in RAD51, formed by the side chains of F166, P168, 
L171, L186, and V189. L1545 and P1546 assume a wedge lodged between the helices α4 
and α5 of RAD51; surrounded by residues L204, Y205 and S208 from the former, and R254, 
L255, G258 and F259 of the latter. Binding between the two molecules is further strength-
ened by hydrophobic contacts between Ile1534 in the linker region of BRC4, and the 
hydrogen-bonded Ser1538, Leu1539 and Val 1542 in the α-helix. 
A few polar interactions also exist (Fig. 10f). Part of the interaction that keeps BRC4 
lined up alongside β3 of RAD51, is maintained by the β-hairpin via a set of three successive 
antiparallel backbone-to-backbone hydrogen bonds, linking the sequence 1525-HTA-1527 of 
the former to 189-VAY-191 of the latter. RAD51’s D187 receives a hydrogen bond from 
S1528 of BRC4 (the third location in the hairpin loop), and also interacts electrostatically 
with K1530 therein. E213 of RAD51 is hydrogen-bonded to BRC4’s S1538, the main-chain 
nitrogen of A1535, and the carbonyl group of K1533 (through a water molecule). The S1538 
is kept poised for interaction by A1535 of BRC4 and RAD51’s V212. Lastly, R250 from 
RAD51 is ionically paired with G1548 towards the C-terminus of BRC4. 
Six out of eight BRC motifs in BRCA2 when expressed in vitro could interact directly 
with recombinant RAD51. While BRC5 and 6 were devoid of binding, BRC3 and 4 were 
particularly efficient. This is explained by interactions involving residues not conserved 
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across BRC repeats, granting enhanced or diminished stability to the binding. For instance, 
L1521 and L1522 of BRC4 form hydrophobic contacts with the side chains of F195 and 
H199 from RAD51, and the backbone carbon of L1522 further accepts a hydrogen bond 
from H199. Also, H1525 forms a quasihydrophobic pocket through packing against the ali-
phatic regions of T1520 and L1531. This lends extra stability to the β-hairpin loop, and 
accounts for BRC4’s higher affinity for RAD51. Disparity amongst the BRC repeats’ affini-
ties for RAD51, has potentially important implications for the latter’s regulation by BRCA2 
(see §1.5.5). 
Curiously, and in apparent contradiction with BRCA2’s function as a recombination me-
diator, RAD51 nucleoprotein filament formation is suppressed when incubated with BRC 
peptides in vitro. Similarly, RAD51 focus formation is suppressed upon overexpression of 
BRC repeats in vivo. It so appears BRCA2 prevents self-association of RAD51 monomers 
into inactive filaments without bound DNA or rings (by sequestering and targeting it to sin-
gle-stranded DNA). BRCA2 could hence constitute as 'cage’, whereupon by interacting with 
RAD51 through multiple BRC motifs, it orders their spatial distribution such that they are 
optimally primed for loading onto DNA.79 
Owing to a propensity for RAD51 to assume various self-assemblies, BRC4 had been co-
valently linked to RAD51 and purified as a fusion protein. 
Amongst carcinogenic BRCA2 mutations, are multiple deleterious point mutations affect-
ing BRC repeats, which the structure helps explain. Presumably, these disrupt some of the 
aforementioned interactions, and weaken RAD51 binding. Thereby, function of the remain-
ing seven repeats seems unable to rescue the phenotype. This could be because the 8 BRC 
repeats work synergistically as a RAD51-binding module, whose overall topology is pivotal 
for its function. Changes that lessen the affinity of any of the repeats for RAD51, could 
hence interfere with BRCA2’s activity by perturbing the spatial distribution of recombinase 
molecules bound within it.79 
For instance, the T1526A mutation weakens BRC4’s affinity for RAD51. Cancer-causing 
mutations affecting equivalent positions in other BRC repeats are also found, e.g. T1011R in 
BRC1, S1221P (BRC2), and T1980I in BRC7. It was evident from the structure that T1526 
receives a hydrogen bond from the backbone nitrogen of K1530, and is important for the 
correct and stable configuration of the β-hairpin loop. It also donates a hydrogen bond to 
S1528’s hydroxyl function, keeping it poised for interaction with D187 of RAD51. Hence, 
by disrupting the above interactions, a mutation in the threonine (or equivalent) would com-
promise the binding between BRC repeats and RAD51.  
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Another common breast cancer-linked mutation alters Gly1529 (fourth residue in the 
hairpin), to arginine. This is likely also to adversely impact its conformation and diminish 
RAD51-binding.  
Notably, both the above mutations occur in the β-hairpin region, the most critical fold for 
BRC motifs’ association with RAD51. 
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Figure 10. Crystal structure of BRC4 in complex with RecA-homology/ATPase domain 
of RAD5179. (a) BRC4 peptide (green) binds RAD51 (magenta helices, blue sheets, 
and yellow N-terminus) by mimicking the β-strand polymerisation motif of the latter 
(c.f. §1.4.3 and Fig. 5b). This entails an interaction of the BRCA2 sequence 1524-
FHTA-1527 with RAD51 through antiparallel β-strand pairing, as seen in a close-up 
of the interface (b). Phe1524 and Ala1527 therein mediate hydrophobic contacts with 
RAD51. (c) A topological description of the complex, in the same colour scheme as 
previously. Detailed view of hydrophobic interactions involving the α-helical region 
(d), and the β-hairpin region (e), in a coil (green BRCA2) upon surface (grey RAD51) 
format. Only interacting side chains are depicted. (e) Polar interactions. RAD51 in 
cartoon representation, and BRC4 as a coil (green). Relevant side chains shown in 
stick mode. Dotted lines denote hydrogen bonds. Implemented in MacPyMOL (and 
Inkscape) using PDB-1N0W. 
1.5.5 Two classes of BRC repeats 
Using a semiquantitative yeast two-hybrid assay, a fragment of BRCA2 containing 
BRC1–4 was found to bind RAD51 with an affinity comparable to a segment comprising all 
BRC repeats80. Similarly, BRC4’s interaction was shown to be 3× stronger than that of 
BRC181. 
Recently, quantification of binding affinity of each BRC motif toward RAD51 and 
RAD51-ssDNA (using GST-tagged BRC repeats and purified RAD51), revealed two evolu-
tionary distinct classes therein67. Repeats 1–4 showed strongest interaction with RAD51 in 
accordance with previous experiments and bound in an approximately 1:1 stoichiometry, 
whereas 1–5 bound very weakly. And while BRC 1–4 blocked ATP hydrolysis by RAD51 
(that causes dissociation of filaments), BRC5–8 did not have this effect. However, the latter 
exhibited high affinity toward RAD51-ssDNA complexes. Furthermore, BRC repeats 1–4 
prevented RAD51-dsDNA complex formation, but 5–8 did not harbour this activity. 
Such data are implicative of a scenario whereby BRCA2 binds to free-form RAD51 
through BRC1–4, with the high-affinity binding mode of this group catalysing the rate-
limiting nucleation step, i.e. by delivering RAD51 to single-stranded DNA, locally suppress-
ing ATPase activity, and preventing futile association with dsDNA. The second group of 
BRC5–8 could then bind RAD51 molecules emerging as filaments from the BRCA2-RAD51 
nucleus on ssDNA, stabilising the RAD51-ssDNA association and guiding nascent filament 
formation. Once the filament begins to extend beyond the footprint of BRCA2, the latter 
would dissociate having facilitated both filament nucleation and growth. 
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Thereby, the two categories of repeats appear to cooperate in a complementary and rein-
forcing (but only partially redundant) manner, in order to maximise the probability of 
presynaptic filament formation. 
1.5.6 Structure of BRCA2DBD – DSS1 – ssDNA  
Another important structure is that of the BRCA2 DNA/DSS1-binding domain (DBD), in 
complex with DSS1 (deleted in split hand/split foot protein 1), and single-stranded DNA.68 
Following BRC repeats in BRCA2, is a ~1000 residue C-terminal region that harbours 
the DNA/DSS1-binding domain, and is its most conserved segment amongst vertebrates 
(68% average identity versus 42% for the whole protein), as well as putative orthologues in 
lower eukaryotes. It is the site of 27% of tumour-derived missense mutations in breast can-
cer82. DSS1 is a 70-residue acidic polypeptide, which is found associated with virtually all 
BRCA2 in human cell lines, and is seemingly important for its stability83. 
The BRCA2 DBD consists of five sub-domains (see Fig. 11a). The first is made of 190 
amino acids and comprises mostly α-helices (helical domain, αD). After are three structural-
ly homologous domains that possess the ~110 residue oligonucleotide/oligosaccharide-
binding (OB) fold, i.e. OB1, OB2, and OB3. In the crystal, these are arranged linearly, 
packed together into an extended 115 Å long structure. The remaining domain exists as a 
130 amino-acid insertion in the OB2 fold, and takes the form of a pair of long antiparallel 
helices (the stem), with a three-helix bundle (3HB) at the end, which harbours a helix-turn-
helix (HTH) motif. This structure, which protrudes away from OB2 by 80 Å, is termed the 
‘tower domain’. 
BRCA2 OB domains have structures very similar to the canonical OB fold84 (Fig. 11b), 
i.e. a five-stranded β-sheet (β1 – β5) coiled in on itself to form a β-barrel, and capped by an 
α-helix (between β3 and β4). OB2 and OB3 harbour pronounced single-stranded DNA-
binding grooves characteristic of such folds. The binding site is formed by one face of the 
barrel, where three loops come together, i.e. L12 (between β1 & β2), L45 (between β4 & β5), 
and L3α (between β3 and the α-helix). The tower domain contributes an additional β-strand 
(Tβ1) to OB2’s groove (pairing with β1), thus increasing its surface area. OB1 has a shallow-
er groove, due in parts to its L12 loop being disordered, and the L45 loop folding away from 
the groove. Furthermore, the former is longer by ~20 amino acids in OB1 than the average 
amongst OB folds. 
OB2 and OB3 are packed in tandem, with their grooves aligned to make a continuous 
channel. The packing buries 1261 Å2 in total surface area, and involves both van der Waals 
interactions and hydrogen bond networks. Residues within this interface are also mutated in 
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cancer, and 4% of tumour-derived missense mutations in BRCA2 DBD map onto amino ac-
ids therein, i.e. Val2829, Arg2893, Glu2921, and Asn3042. This prearrangement of the two 
folds is thus likely to be important for BRCA2’s function. OB1 and OB2 too pack extensive-
ly through van der Waals forces and hydrogen bonds, burying 1271 Å2 in total surface area. 
In contrast to OB2 and OB3 however, they arrange in a pseudo two-fold symmetric (head-to-
head) manner. Their grooves though remain collinear, as with OB2-OB3 packing. The OB1-
OB2 packing is further stabilised by a nine amino-acid stretch of DSS1 that slots like a 
wedge between the two folds. 
The helical domain is composed of a core of four helices (α1, α8, α9, and α10) and two 
consecutive β-hairpins (β1 – β4). A ~50 amino-acid fragment comprising four short helices 
slithers around the core structure, and constitutes an additional layer of structural folds. Heli-
ces α9 and α10 pack with OB1, by means of van der Waals interactions through hydrophobic 
and aromatic residues, as well as side- and main-chain hydrogen bonds. These elements are 
some of the best conserved in the entire BRCA2 DBD. It is also the DSS1-receptor therein 
alongside OB1. 
DSS1 binds to BRCA2 via an N- (a.a. 7 – 25) and C-terminal (a.a. 37 – 63) fragment, 
with the middle segment being disordered. And while these flanking sequences are highly 
conserved, the intervening portion is not. Similarly, majority of the DSS1-binding BRCA2 
residues are highly conserved as well. The N-terminal segment of DSS1 winds about the hel-
ical domain, spans the αD-OB1 interface, and culminates in packing with OB1. The C-
terminal segment packs first with the OB1-OB2 interface, followed by OB1, and then finish-
es at the OB1-αD interface. Two of DSS1’s β-strands, β1 and β2, pack with β6 and β5 of 
OB1, respectively. All in all, the two termini of DSS1, which has a 37% acidic residue con-
tent (and 13% aromatic), follow the path of an extended, meandering groove on the αD and 
OB1 surface, which in turn is rich in basic, aromatic and hydrophobic residues. The DSS1- 
and nucleotide/sugar-binding sites lie roughly on opposite sides of the OB1 fold. Two DSS1-
interacting BRCA2 residues are mutated in cancer, i.e. Ala2564 and Arg2580. 
The tower domain’s stem is comprised of α-helices Tα1 and Tα5. The intervening three-
helix bundle (helices Tα2, Tα3 and Tα4) is supported by the N-terminus of Tα5, which is in-
corporated into the 3HB’s hydrophobic core. Between 3HB and Tα1 is a disordered segment 
of 12 amino acids. The tower harbours four of the seven most mutated residues in BRCA2 
DBD, i.e. Ala2872 and Ile2865 that mediate Tα1- Tα5 interactions, and Glu2777 and 
Lys1871 which are solvent exposed on the stem. This in conjunction with the conservation 
of residues at the tower’s base and 3HB, is implicative of the domain’s role in BRCA2’s tu-
mour suppressor function.  
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Using native gel electrophoretic mobility shift assay and end-labelled DNA probes, the 
BRCA2DBD-DSS1 complex was found to have affinity toward oligo(dT), oligo(dC), and 
single-stranded DNA of mixed sequence – but not double-stranded DNA. However, an iso-
lated helical domain–OB1–DSS1 complex bound single-stranded DNA comparatively 
weakly (with an estimated affinity 1/100th that of the entire domain).68 
Structure of BRCA2DBD-DSS1 in further complex with oligo(dT)9 single-stranded 
DNA, was solved separately from the former and with an internal deletion in the tower do-
main68 (Fig. 11c). The latter yielded better diffracting crystals than otherwise, whilst 
maintaining an identical core structure. Complete density could be seen for only five of the 
nine nucleotides. Single-stranded DNA bound in a uniform configuration in the OB2-OB3 
channel, with the bases’ edges bound at the top of the channel, and the phosphodiester back-
bone forming a ridge along its surface. As seen in other single-stranded DNA-binding 
proteins, BRCA2 OB-ssDNA contacts entail stacking interactions between bases and aro-
matic residues, hydrogen bonds amongst bases’ edges and polar residues lining the top and 
sides of the channel, and phosphates interacting with polar residues or main-chain amide 
groups. Thereby, OB2 made the most significant contacts, and therein three residues in-
volved in DNA binding (but without structural roles) are found mutated in cancer, i.e. 
Lys2754, Gln2945, and Ser2907 – underlining the importance of single-stranded DNA bind-
ing to BRCA2 function. The phosphate group of a sixth nucleotide was visible, interacting 
with the main-chain amide of Ala3007 from OB3’s L12 loop, but the base was presumably 
disordered. Remainder of the OB3 groove was unavailable for DNA binding due to being 
involved in crystal packing. 
Tumour-derived missense mutations in the BRCA2 DBD are scattered across the five 
domains82, with 25.0% residing in the helical domain, 25.4% in OB1, 8.6% each in OB2 and 
OB3, and 32.4% in the tower domain – suggesting they are all important to BRCA2’s tu-
mour suppressor activity. These encompass residues with structural roles, DNA- or DSS1-
binding functions, as well as ones on the tower’s surface. 
Role of the specific helix-turn-helix motif within the three-helix bundle at the tower’s end 
is not clear, though in other proteins it mostly binds double-stranded DNA. It might thence 
enable BRCA2 to bind at the single- and double-stranded DNA junction upon end-resection. 
The BRCA2 orthologue in Ustilago maydis (corn smut, a fungus), Brh2, does preferentially 
bind such ssDNA-dsDNA junctions85. However, BRCA2 itself has been found to exhibit no 
especial preference for these junctions over mere single-stranded DNA. Though the adoption 
of secondary structure by the long stretches of ssDNA generated during resection could 
mimic dsDNA. 
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The abovementioned structures were derived from crystals of a 736 amino-acid mouse 
BRCA2 DBD bound to DSS1, which diffracted to 3.1 Å; those further bound to oligo(dT)9 
ssDNA fragments, and then ones with a deletion of the tower therein that both diffracted till 
3.5 Å. However, further crystals of an 816-residue rat BRCA2 DBD bound with DSS1 were 
also obtained, and diffracted to 3.4 Å. 
 
Figure 11. Crystal structure of BRCA2 DNA/DSS1-binding domain68. (a) Tertiary level 
view of the mouse BRCA2DBD–DSS1 structure, showing the helical domain (purple), 
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followed by the three successive oligonucleotide/oligosaccharide-binding folds OB1, 
OB2 and OB3 (orange, blue and teal respectively), and the tower (T) domain insertion 
in OB2 (also blue). A three-helix bundle (3HB) can be seen atop the tower. The struc-
ture is depicted from C- to N-terminus (left-right), in order for DNA and DSS1-
binding surfaces to face the viewer. DSS1 (lime green) is seen bound between the heli-
cal and OB1 domains. Disordered regions are missing. (b) A generic OB-fold 
structure based on its smallest variant, the B subunit of verotoxin-1 (VT1B)84. Five β-
strands (ribbon arrows), fold into a closed β-sheet (i.e. β-barrel), capped by an α-
helix (cylinder). Three variable loops (L12, L3α, and L45), of the five in total linking the 
structural segments, contribute residues for the oligomer-binding site. (c) The 
BRCA2DBDΔTower–DSS1–oligo(dT)9 structure68 (monochrome), with ssDNA (red 
sticks) and DSS1 (gold) for emphasis. Only five of the nine nucleotides are ordered 
and discernable. Bases bind along the side and top of the OB2-OB3 channel. For a 
greater discussion of this see §4.2 and Fig. 15. Created in MacPyMOL using PDB- 
1MIU, -1BOV, and -1MJE. 
1.6 In vitro full-length BRCA2  
Mechanistic (including structural) studies of human BRCA2 have been hindered by the 
challenges of purifying a single polypeptide of its size (i.e. 3,418 a.a.). Its biochemical and 
molecular functions were thus inferred by using fragments of the molecule, or small fungal 
and worm orthologues (Brh2 and BRC-2 respectively), which each comprise a single BRC 
motif and are known to stimulate ssDNA binding by RAD51, and/or its promotion of DNA-
DNA interactions during homologous recombination. 
Moreover, its insufficient solubility and propensity to degrade when expressed in the la-
boratory (being eight to ten times more massive than the average protein), has further 
hampered its isolation86. Also, it tends to occur in complexes with other proteins, and is often 
unstable on its own. 
Following a decade and a half endeavour, derivation of pure extracts of the full-length 
human BRCA2 protein was reported concurrently by the Kowalczykowski*, Heyer†, and 
                                                      
* Stephen C Kowalczykowski, Department of Microbiology and Molecular Genetics, 
University of California Davis, USA. 
† Wolf-Dietrich Heyer, Department of Microbiology and Molecular Genetics, University 
of California Davis, USA. 
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West‡ groups. This is believed to constitute the largest singular protein to have been purified 
to homogeneity. 
The Kowalczykowski laboratory employed two maltose-binding protein (MBP) tags at 
the N-terminus of hBRCA2, which helps its solubility and folding, and stabilises the protein 
that was then purified from cultured human epithelial kidney cells86. The Heyer group puri-
fied the protein from yeast, having affixed a glutathione S-transferase (GST) tag to its N-, 
and a Flag epitope and polyhistidine (His10) tag at its C-terminus, respectively87. This policy 
allowed the group to verify the integrity of the purified product by detecting for the presence 
of both tags. West and team purified BRCA2 from human epithelial cancer (HeLa) cells, 
having inserted the gene as part of a bacterial construct66 – see §2.1.1 for details. 
The first study86 showed it bound human RAD51 and DMC1, yeast Rad51, but not E. 
Coli RecA in vitro. However, there was also no significant interaction with human RPA, E. 
Coli SSB, or human RAD52. The amount of RAD51 molecules bound by each copy of 
BRCA2 scaled linearly with the former’s concentration (indicative of strong interaction in 
the nM domain), till about 4.5 ± 0.9 RAD51s per BRCA2 were bound. Following on, weaker 
binding (in the µM range) was manifest. At maximal saturation, ~6 RAD51 proteins were 
bound to every BRCA2. BRCA2 strongly preferred binding to either single-stranded, or 
double-stranded DNA with an ss- tail, over dsDNA. It also prevented and favoured RAD51’s 
association with ds- and ssDNA respectively. When exposed to both single- and double-
stranded DNA, strand exchange activity of RAD51 is reduced to background levels; however 
after prior incubation with BRCA2, this inhibition was diminished in a concentration-
dependent manner. Though its magnitude was less, stimulation by BRCA2 was maintained 
in the presence of RPA. Prior incubation of ssDNA with RPA acutely suppressed DNA 
strand exchange by RAD51 in an absence of BRCA2, which was then promoted by up to 20-
fold upon addition of the latter. An effect was evident at substoichiometric ratios as low as 
100-fold. Therefore, despite not possessing explicit RPA binding activity, it seemed that in-
teractions of BRCA2 with RAD51 and DNA were sufficient to allow RAD51 access to 
RPA-coated ssDNA, for RPA to then be displaced as filament nucleation and growth ensued. 
Furthermore, BRCA2 stabilised the RAD51 nucleoprotein filament via inhibition of its ssD-
NA-dependent ATP hydrolysis activity in a concentration-dependent manner to levels 
observed in absence of DNA, since ATPase activity inactivates and turns over the RAD51 
protein. 
                                                      
‡ Stephen C West, Cancer Research UK London Research Institute, Clare Halls Laborato-
ries, South Mimms, UK. 
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The second study87 also confirmed purified human BRCA2 bound RAD51, and indicated 
a stoichiometry of 6 ± 1 molecules of RAD51 for each copy of BRCA2. Though dependent 
on accuracy of measurement of the latter’s concentration, it was nonetheless fairly consistent 
with the values derived by Kowalczykowski group. Single molecule studies had suggested a 
nucleation of as little as 2 or 3 RAD51 monomers was adequate for priming filament growth 
(though other estimates of 4 or 5 are higher), but in either case BRCA2 seemed to bind 
enough RAD51 protomers to promote filament extension. Minimal RAD51 binding to sin-
gle-stranded DNA occurred in presence of saturating amounts of RPA, but this was 
stimulated seven-fold on addition of BRCA2. A stimulation was observed at substoichio-
metric concentrations of 1 BRCA2 to 33 RAD51 molecules. The effect was highest in 
presence of ATP and Ca2+, which stabilises the active ATP-bound form of RAD51 on ssD-
NA. BRCA2 exhibited no significant differences in binding to either an ssDNA circle, or a 
gapped DNA substrate comprising five 5’ and four 3’ junctions. RAD51’s binding to ssD-
NA, i.e. in presence of BRCA2, was enhanced five-fold by DSS1 than without. 
Here it could be noted that BRCA2’s saturation at having bound 6 RAD51 molecules, is 
consistent with Pellegrini et al.’s observation of only six of the eight BRC repeats being ca-
pable of direct interaction with RAD5179 (§1.5.4). 
Lastly, the study by West laboratory66 found BRCA2 bound single-stranded DNA in a 
concentration-dependent manner, but did not form stable complexes with dsDNA – demon-
strating that it was an ssDNA-binding protein as suggested by structural and biochemical 
analyses of the BRCA2 DNA-binding domain by Pavletich group. Furthermore, its electron 
microscopy visualisation by rotary metal shadowcasting revealed putative rod-shaped ‘di-
mers’, but also ball-shaped ‘monomers’. These displayed dimensions with the tungsten 
coating of 15 ± 2 nm, and 270 ± 30 nm × 16 ± 2 nm, respectively. Their respective masses 
were inferred by comparison with ferritin to be 337 kDa and 860 kDa, i.e. consistent with 
BRCA2 monomers and dimers. Examination of protein molecules bound to tailed DNAs (3.5 
kb linear duplexes with 54-nt 3’ ssDNA tails at one end), showed 91% were situated at an 
end of the DNA substrate, none were bound to both ends, and only 9% were associated with 
the internal dsDNA region. In assessing whether BRCA2 modulated the relative ss- and 
dsDNA binding affinities of RAD51, presence of low quantities of the former was found to 
vastly increase latter’s binding to ssDNA. Likewise, BRCA2 reduced RAD51’s binding to 
dsDNA, illustrative of the provision of differential targeting necessary for homologous re-
combination. The DNA-binding assays were performed in low-salt conditions, whereby 
BRCA2 binds ssDNA, while RAD51 binds ss- and dsDNA equally; and comprised ATP and 
Mg2+ to the facilitate formation of active nucleoprotein filaments. Added analysis did not 
show evidence of a BRCA2-RAD51-ssDNA ternary complex per se, suggesting BRCA2 
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acted as a molecular chaperone that facilitated RAD51’s loading onto ssDNA, and then dis-
sociated from the two. BRCA2 was also found to promote RAD51-effected DNA strand 
exchange by virtue its abovementioned properties. Its dimerisation would be consistent with 
the observed dimeric forms of Brh288, and the crystallographic dimer of BRCA2 DBD seen 
its X-ray study68. 
While these experiments corroborated ideas regarding BRCA2’s function, i.e. especially 
that it helped nucleate RAD51 filament growth, and refined understanding of the mechanism 
by which this is coordinated. Perhaps more importantly, the purifications provided an avenue 
for structural studies amongst others of full-length BRCA2. Though it is remarkable this ex-
tent of biochemical experiments could be performed with the microgram quantities derived, 
the still extremely low yields preclude it from high-resolution structural analyses. 
1.6.1 Overview of thesis 
A couple of prodigious efforts at the genetic, cellular, and latterly biochemical levels 
(several of which are reviewed hereby), have unravelled some valuable insights into the 
functions of this very important protein, whose malfunction clearly continues to blight many 
human lives. 
However, understanding of the explicit mechanistic bases for its action remains incom-
plete, and structural characterisation of full-length BRCA2 is now conspicuous by its 
absence. Many fundamental questions can still be posed, for instance with regards to the or-
ganisation of various structured/folded domains within BRCA2; its manner of interaction 
with RAD51 and the number of protomers that are typically bound; whether it interacts with 
RAD51 monomers or polymeric assemblies such as rings and filaments; the manner of its 
interaction with single-stranded DNA and facilitation of RAD51’s loading thereupon; its oli-
gomerisation state; whether it initiates filament nucleation at a single or multiple sites on 
ssDNA; and if filament growth proceeds from BRCA2 bidirectionally, or its polarity if oth-
erwise. The list is by no means exhaustive, as this and more should become clarified. 
Hereby, we provide structure- as well biochemically-based mechanistic insights into full-
length BRCA2’s interaction with RAD51 and DNA, and its facilitation of recombinase load-
ing and nucleoprotein filament formation; and thus delineate some of the precise functions of 
BRCA2 in homology-directed repair by RAD51 that have remained ill-defined in the overall 
scheme. 
We sought to visualise BRCA2’s mechanism via single-particle negative stain electron 
microscopy. The low abundances of particles in the preparations precluded them from cryo-
EM. We solved the structure of full-length human BRCA2 on its own and in complex with 
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human RAD51, and identified BRC repeats and the C-terminus in the former and RAD51 in 
the latter by antibody labelling. We also analysed the BRCA2-ssDNA complex and BRCA2-
RAD51-ssDNA pseudo-complex by 2D electron microscopy.  
Also, we quantify the affinity of BRCA2 toward various lengths of single-stranded DNA, 
and establish the minimum stretch requisite for effective DNA-binding. We probe BRCA2’s 
effect on both the length of RAD51 nucleoprotein filaments, and the frequency of nucleation 
events. Furthermore, we ascertain whether BRCA2 would bind at multiple sites along an 
ssDNA molecule; and determine the polarity that RAD51 filaments emanate from BRCA2, 
and subsequently grow. 
Significantly, we discover that human BRCA2 might most commonly occur as dimers, 
and discuss the implications and mechanistic advantages that are conferred by such an ar-
rangement in light of and with regards to the many of the above. 
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2 Methods 
2.1 Protein expression and purification 
2.1.1 BRCA2  
The human BRCA2 protein used here was first purified as such in the laboratory of Prof 
Stephen C West, Cancer Research UK London Research Institute (Clare Hall laboratories), 
South Mimms, UK. Purification was later also carried out by Dr Eric H Kong of the Zhang 
group, Macromolecular Structure and Function Laboratory, Imperial College London, South 
Kensington, UK. 
A bacterial artificial chromosome (BAC) was constructed in which the human BRCA2 
gene complete with upstream and downstream regulatory elements was FLAP tagged at ei-
ther the N- or C‐terminus. The FLAP tag is composed of enhanced green fluorescent protein 
(EGFP), and S- and Flag-affinity tags separated by PreScission- and TEV-protease sites. 
Stable HeLa cell lines expressing the gene were selected and the protein purified by Flag- 
and GFP-affinity purification. GFP and S tags were removed by TEV cleavage, leaving only 
a small 1.3 kDa Flag tag. Some PALB2 was found to co-purify with N-terminally tagged 
BRCA2, whereas little to none was associated with the C-terminally tagged protein.66 
In our preparations, HsBRCA2 was obtained by slight modifications to the above meth-
odology. C-terminally GFP-Flag tagged BRCA2 was purified from 20 litres of HeLa cells 
containing a BAC-BRCA2FLAP vector. Following cell collection and lysis via a homogeniser, 
BRCA2 was purified with Anti-Flag M2 affinity gel (Sigma Aldrich) and GFP-Trap_A aga-
rose beads (Chromotek). Order of the affinity steps was reversed in some derivations without 
apparent differences. The final protein (200 µl at 2.5 µg/ml), was saved as small aliquots at -
80 °C. For initial electron microscopy analyses, the purified protein was further subject to a 
gel-filtration step through Superose 6 10/300 GL (GE Healthcare), to provide a more mono-
disperse population. 
As BRCA2 was expressed from its own promoter at levels similar to the endogenous pro-
tein, the sample was very dilute (precluding it from high-resolution cryo-electron 
microscopy studies), but of good quality/purity and reasonably homogeneous – see Fig. 15a. 
2.1.2 BRCA2-RAD51  
To constitute the BRCA2–RAD51 complex, BRCA2 was partially purified with GFP-
Trap agarose and incubated with excess human RAD51, i.e. 0.5 μM for 30 minutes at 4 °C. 
The BRCA2-RAD51 complex was purified away from the remaining RAD51 by binding to 
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M2-Flag agarose, washed extensively and eluted with 3x (triple-) Flag peptide (Sigma Al-
drich). 
HsRAD51 had been purified as per its first reported purification, again by the West group 
(CRUK LRI, Clare Hall laboratories, South Mimms, UK). Human RAD51 could thence 
simply and quickly be purified following overproduction in E. Coli.89 Dialysis of cell-free 
extracts against buffer comprising low concentrations of spermidine, results in selective pre-
cipitation of HsRAD51 as microcrystallites (observable by light microscopy). These crystals 
could then easily be redissolved in phosphate buffer, and the protein purified to homogeneity 
by hydroxylapatite, affi-gel heparin and Q-sepharose chromatography.90 
2.2 DNAs 
ssDNA binding affinity of BRCA2 with increasing lengths of the former was assessed in 
the West laboratory. Oligos of 20, 30, 33, 37, 40, 50, 66, 74 and 100 nucleotides were em-
ployed. Those ranging between 20- and 70-nt, all constituted 5’ derivatives of the following 
74-mer (written 5’–3’): 
GCGCTACCAGTGATCACCAATGGATTGCTAGGACATCTTTGCCCACCTGCTACCC
CGGGTTCGAAATCGATAAG. 
The 100-mer was (5’–3’):  
GGGCGAATTGGGCCCGACGTCGCATGCTCCTCTAGACTCGAGGAATTCGGTACC
CCGGGTTCGAAATCGATAAGCTTACAGTCTCCATTTAAAGGACAAG. 
We created two gapped DNAs (gDNAs), for purposes of characterizing the BRCA2-
ssDNA complex by 2D electron microscopy. The intention being for BRCA2 to bind in the 
intervening single-stranded DNA sequence, while the flanking duplex arms helped delineate 
the path of DNA-binding across its surface. This is because while the ssDNA, which besides 
would be occluded by BRCA2, is difficult to visualise under negative-stain, the dsDNA 
would not and is possible to be observed. The ssDNA gap sizes were designed for BRCA2 to 
bind into comfortably in light of results from the previous experiment. 
gDNA1 had two 50-nucleotide oligos annealed to the 5’ and 3’ ends of a 200-mer, result-
ing in an ssDNA gap of 100-nt. gDNA2 was related but the complimentary oligos were 65 
nucleotides in length, giving a 70-nt ssDNA interval. The 200-mer had the following se-
quence (5’–3’):  
GAGTTTTATCGCTTCCATGACGCAGAAGTTAACACTTTCGGATATTTCTGATGAG
TCGAAAAATTATCTTGATAAAGCAGGAATTACTACTGCTTGTTTACGAATTAAAT
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CGAAGTGGACTGCTGGCGGAAAATGAGAAAATTCGACCTATCCTTGCGCAGCTC
GAGAAGCTCTTACTTTGCGACCTTTCGCCATCAACT. 
To study RAD51 filament nucleation events on single-stranded DNA mediated by 
BRCA2 under electron microscopy, linear viral φX174 ssDNA was used (West lab). This 
was prepared by annealing a 22-nucleotide oligo, 5′-
TAAAACTCTGCAGGTTGGATACGCCAATC-3’, to φX174 ssDNA, and subsequent 
treatment with PstI restriction enzyme. The linearized ssDNA was then gel purified. 
The gDNAs were constructed by Dr Eric Ho Kong of the Zhang laboratory, Imperial Col-
lege London, UK. 
2.2.1 DNA gold-labelling 
To deduce the direction of RAD51 filament growth from BRCA2 on single-stranded 
DNA, ssDNA molecules gold-labelled at either their 5’- or 3’-terminus were constructed 
(West group). A 5’-biotinylated ssDNA substrate was generated via PCR amplification with 
a single primer (5′-biotin-TAAAACTCTGCAGGTTGGATACGCCAATC-3’), and φX174 
RFI (replication form 1) dsDNA as template. The polymerase chain reaction product, 5’-
biotinylated linear single-stranded DNA, was gel purified and labelled at the 5’-end with 5 
nm gold particles coupled to streptavidin. 
2.3 Protein-DNA complexes 
2.3.1 BRCA2-ssDNA 
Electromobility shift assays (EMSAs) were carried out to determine the minimum length 
of single-stranded DNA that BRCA2 could effectively/stably bind (West laboratory). 
BRCA2-ssDNA binding reactions (10 µl), contained ssDNA oligonucleotides (1 nM) that 
were 32P-labelled at their 5’-end, together with BRCA2 (1 nM) in binding buffer (20 mM 
HEPES, 2 mM ATP, 2 mM MgCl2, 1 mM dithiothreitol, and a pH of 7.5). The process was 
analogous for 3’-gold labelled ssDNA. 
After 10 minutes at 20 °C, the protein-DNA complexes were fixed with 0.25% glutaral-
dehyde, and incubated at 20 °C for 15 minutes. They were then analysed by electrophoresis 
through 1% agarose gels run for 2 hours in TAE buffer at 4 V cm-1, dried on to filter paper, 
and visualised by autoradiography. 
In order to prepare the BRCA2-gDNA complexes for electron microscopic visualisation, 
we incubated purified BRCA2 with 100 nM of gapped DNA for 30 minutes at 37 ºC in a low 
salt buffer (50 mM HEPES pH 7.5, 10% glycerol, 50 mM NaCl, 0.01% Triton X-100, 1 mM 
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EDTA, 1 mM dithiothreitol). Binding of BRCA2 to the gapped DNAs was affirmed by EM-
SA.  
The latter experiments were performed by Dr Eric Kong, MSF lab, Imperial College, 
London, UK. 
2.3.2 BRCA2-RAD51-ssDNA 
RAD51-ssDNA complexes were prepared by incubating 150 nM RAD51 with 0.2 nM 
linear φX174 single-stranded DNA, in binding buffer at room temperature (as an internal 
control, again in the West lab). 
To form BRCA2-RAD51-ssDNA complexes, 0.1 nM BRCA2 was incubated with 150 
nM RAD51 for 1 minute in binding buffer at room temperature, prior to the addition of 0.2 
nM ssDNA and further incubation for 3 minutes. 
To probe the effect of BRCA2 on the frequency of RAD51 filament formation, 40 nM 
RAD51, with and without 0.2 nM BRCA2 (the latter as a control), was incubated for 1 mi-
nute in binding buffer at room temperature, before an addition of 0.2 nM ssDNA, following 
which the incubation was carried on for a further 1 minute. 
To determine the polarity of RAD51 nucleoprotein filament formation from BRCA2 (as 
in §2.2.1), 0.2 nM BRCA2 and 150 nM RAD51 were premixed in binding buffer, sans dithi-
othreitol. After 1 minute, 5’- or 3’-gold labelled ssDNA was added, and the incubation 
continued for another 1 minute.    
These preparations were then applied to pre-treated (glow-discharged) electron microsco-
py grids, and negatively-stained for analysis. 
2.3.2.1 Protein gold-labelling 
In order to ascertain the identity of BRCA2 in visualisations of filaments emanating 
therefrom, immunoaffinity gold-labelling of BRCA2 was performed by means of an anti-
body toward Flag (F3165 anti-Flag M2 mouse monoclonal, Sigma Aldrich), conjugated to 
20 nm gold particles with an InnovaCoat nano-gold conjugation kit (Innova Biosciences). 
0.2 nM BRCA2 was incubated with 0.1 μg/ml of antibody-conjugated gold nanoparticles for 
15 minutes in binding buffer (without dithiothreitol). Afterwards, 150 nM RAD51 was add-
ed, followed in 1 minute by 0.2 nM ssDNA, and the incubation resumed for another 1 
minute. 
First, BRCA2 (0.2 nM) was incubated with 0.1 μg/ml antibody-conjugated gold particles 
for 15 min at room temperature in binding buffer without dithiothreitol. RAD51 (150 nM) 
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was then added for a further 1 min; this was followed by the addition of 0.2 nM ssDNA, and 
incubation was continued for a further 1 min. 
2.4 Antibody labelling 
We employed antibody labelling in order to identify the locations of various domains or 
regions within our electron microscopy reconstructions of BRCA2 and the BRCA2-RAD51 
complex. 
For BRCA2, we used an antibody against the Flag tag at the C-terminus (anti-Flag M2-
peroxidase produced in mouse, Sigma Aldrich), and another specific for a region between 
BRC5 and BRC6 (OP95 anti-BRCA2 Ab-1 mouse monoclonal, Merck Millipore). 
For the BRCA2-RAD51 complex, we utilised an anti-RAD51 antibody (14B4 ab213 pro-
duced in mouse, Abcam). 
Complexes with antibodies were prepared by incubation with 10–30 nM of antibody for 
30 minutes at 4 ºC. In both cases, binding efficiencies of the antibodies towards BRCA2 and 
BRCA2-RAD51 were gauged by immunoprecipitation, prior to EM analysis. 5 µg of anti-
body was incubated with 2 ml of BRCA2 lysate, or 10 ng of purified BRCA2-RAD51 
complex, for 2 hours in 2 ml IP buffer at 4 ºC accompanied by constant mixing. 50 µl of 
Dynabeads Protein G (Life Technologies) was then added, and the mixture incubated for 
another 2 hours to capture antibody-bound protein, or complex. Beads were washed five 
times with 1 ml IP buffer, resuspended in SDS PAGE gel loading buffer, and analysed by 
SDS PAGE. Captured antibody complexes were then detected by Western blotting. 
The complexes were constituted and purified by Dr Eric Kong of the Macromolecular 
Structure and Function Laboratory, Imperial College London, UK. 
2.5 Negative-stain electron microscopy 
2.5.1 Specimen preparation 
For purposes of electron microscopy reconstruction of BRCA2, 2 μl of protein solution 
was applied to a TAAB 300-mesh continuous carbon grid, which had been glow-discharged 
for approximately 60 seconds and left for another ~60 s. Excess sample was blotted, and the 
grid stained with 2% w/v uranyl acetate solution for yet another ~60 seconds. Finally, excess 
stain was removed by blotting with filter paper, and the grid allowed to air dry. The grid it-
self was a 3 mm-wide circular copper mesh, precoated with a thin layer of continuous 
graphite film. 
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For BRCA2-RAD51, the procedure was similar in outline. Although thereby a copper 
Quantifoil R2/2 holey carbon grid was employed, which was coated in-house with a thin lay-
er of continuous carbon film. This practice sometimes has the advantage of allowing easier 
judgement of well-stained locales on the grid, from the shading of carbon-covered holes. Al-
so, it allows one to be more wilful with regards to the thickness or otherwise of carbon 
coating, which is often found to be inconsistent among commercially available ready-coated 
grids. The glow-discharged grid in this case, had the complex adsorbed for 2 minutes at 
room temperature, washed twice with water, and then stained as previously. 
The coating process entailed graphite covered mica sheets whereby the carbon was 
stripped off the mica by floating it on water, and then lowered onto grids underneath by suc-
tioning the water. Coated sheets were kindly supplied by Dr Fabienne Beuron, Electron 
Microscopy Facility, The Institute of Cancer Research, London, UK. 
Similar methodology again to the two above was utilised for our gapped-DNA and anti-
body complexes. 
When analysing RAD51-ssDNA and BRCA2-RAD51-ssDNA complexes (West group), 
the samples were applied 2 minutes after glow discharge and negatively stained as before. 
When analysing RAD51 filament nucleation on ssDNA in the presence and absence of 
BRCA2, the samples were administered after 1 minute (prior to staining). 
The glow-discharge treatment confers an overall charge to the carbon, and increases the 
ad- sorption of the particles to the grid potentially by several orders of magnitude91. The stain 
solution pervades the space in between the particles, possibly permeating any cavities and/or 
crevices present within the protein molecules themselves. Heavy metal atoms such as those 
of uranium in this case, are exceptionally electron-rich and as a consequence scatter any in-
cident electrons very strongly, i.e. as opposed to focusing the electrons – that results in the 
background appearing dark with the particles in white (hence the name). 
2.5.2 Data acquisition 
The prepared grids were loaded into a Philips CM200 series FEG (field emission gun) 
transmission electron microscope (TEM), equipped with a TVIPS TemCam-F415 4,096 × 
4,096 pixel charged-coupled device (CCD) camera, at the Centre for Biomolecular Electron 
Microscopy (CBEM), Imperial College London. This was the case for BRCA2, the BRCA2-
RAD51 complex, and the antibody complexes. 
For BRCA2-gDNA complexes, higher contrast was desired to enable the DNA to be 
seen; hence these data were collected on an FEI Tecnai F20 TEM equipped with a Falcon II 
4k × 4k direct electron detector (FEI), again at CBEM Imperial. 
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In both cases, the microscopes were operated at their maximum operating voltages of 200 
kV, and 16-bit images were acquired at 50,000× magnification. Given the pixel densities of 
their respective detectors, this resulted in sampling intervals of 1.76 and 2.05 Å pixel-1 for 
the CM200 and F20 TEMs respectively. Images at the former and latter were collected with 
electron dosages of around 40 and 20 e– Å2 respectively; exposure had been compensated at 
the F20 because of much greater sensitivity of its detector. Objective astigmatism was typi-
cally corrected at higher magnifications still (100,000 or 150,000×). 
BRCA2, BRCA2-RAD51, and the antibody complexes were visualised at nominal under-
foci ranging from ~ 1 or 1.5 μm to 3 μm. BRCA2-gDNA images were acquired at defoci of 
~ – 4 μm, again due to the requirement for higher contrast. 
Collection of tilt-series and -pair data for the purposes of validating the BRCA2 and 
BRCA2-RAD51 3D reconstructions is set out in §2.5.4.10. 
The other electron microscopic analyses were carried out by the West laboratory, using 
an FEI Tecnai G2 Spirit T12 twin transmission TEM comprising a Gatan Orius 3,000 × 
4,000 pixel CCD camera. These observations were generally performed at a magnification of 
67,000×. 
2.5.3 Data preprocessing 
2.5.3.1 Coarsening 
For the purposes of image processing, raw micrographs or ‘boxed’-out particles from 
therein were ‘coarsened’ by a factor of 2, essentially coalescing adjacent pixels. This causes 
file dimensions, and sizes divided by 22; and pixel sizes multiplied by 2, to 3.52 and 4.10 Å 
pixel-1 for the CM200 and F20 respectively. This allows faster subsequent processing times. 
It is also not sacrificial in the information sense, as given the various artefacts introduced by 
negative staining (addressed later), the image data is far removed from having any ‘real’ sig-
nal to such resolution scales. 
It so happens as a consequence of the Nyquist sampling theorem92 (a fundamental result 
in digital information theory) that the theoretically achievable resolution from data sampled 
at 3.52 Å pixel-1 (a ‘spatial’ sampling frequency of v = !!.!"  Å  ), is limited to 2 × 3.52 Å = 7.04 
Å (the Nyquist frequency of fNyquist= !!v = !!.!"  Å) – again much under the bounds of negative 
stain electron microscopy. 
The coarsening process was performed in IMAGIC93 (Image Science Software), with the 
aid of specifically written scripts to automate the process for multiple micrographs or parti-
cles. 
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2.5.3.2 Particle selection 
Individual particles were picked manually in EMAN294 (e2boxer), into ‘box’ dimensions 
of 128 × 128 (post-coarsening). For antibody and gDNA complexes, 162 × 162 boxes were 
used in order to accommodate the two. 
The above yielded a dataset of 8,773 particle images for BRCA2, and 6,877 for BRCA2-
RAD51. 
Care was exercised at avoiding obvious aggregates and potential degradation products. 
The latter usually exhibited significantly small sizes, as well as inconsistent dimensions and 
shapes amongst each other. 
Neither the micrographs, nor the picked particles were CTF-corrected prior to processing. 
2.5.3.3 Filtering, masking and normalisation 
These raw images contain undesired data in addition to useful information about the par-
ticles. This comprises low frequency artefacts over long scales (such as background density 
ramps and stain gradients), and high frequency noise over short scales that could both harm 
the accuracy of image alignment and angular assignment procedures, which rely on cross-
correlation functions. High frequency elements, although noisy, also harbour the fine details 
one hopes to mine from the dataset. Therefore, while it might be necessary to suppress such 
spatial frequencies for the purposes of determining low-resolution preliminary models and 
during the initial stages of refinement, they could later be reintroduced for achieving maxi-
mal resolutions. 
The band-pass filter normally applied is the product of a narrow Gaussian high-pass filter 
to cut away the disturbing low spatial frequencies, and a wide Gaussian low-pass filter to cut 
away the high frequencies. The former is associated with the low frequency cut-off that 
gradually cuts away spatial frequencies lower than this value, and the latter with the high 
frequency cut-off that does the same for frequencies greater than its value. Band-pass param-
eters are chosen to maintain the outer envelope of the particle (a low frequency cut-off based 
on the size of the molecule), and to remove high frequency noise beyond the expected reso-
lution (high frequency cut-off). 
The values appointed corresponded to 270 Å for the former (a number that should be 
greater than the biggest dimension of the particle), and 10 Å for the latter. These were ex-
pressed in terms of their corresponding spatial frequencies as a fraction of the Nyquist 
frequency, which equated to 
! !"#  Å  ! !.!"  Å   = 0.026  and ! !"  Å  ! !.!"  Å   = 0.704 respectively. The latter’s 
value was changed to 1, corresponding to the Nyquist limit of 7.04 Å, during the final stages 
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of refinement. For the purposes of antibody and gapped DNA complexes, a low pass filter 
(high frequency cut-off) corresponding to 60 Å was employed, in order to enhance the con-
trast therein by emphasising the overall features and suppressing fine details. 
Following filtering, a soft-edged circular mask of fractional radius 0.9 and a drop-off of 4 
pixels, was applied to the particle images. The former is expressed as a fraction of the inner 
radius of the box, and the latter as the half-width at half-maximum of the roll-off that fol-
lows.  
Gaussian (viz. gradual) filters are applied in Fourier space to avoid an introduction of 
‘ripples’ in the real space image, which would be the effect of a sharp-edged filter. Likewise, 
‘soft’ masks are applied to real images to avoid creating ripples in Fourier space. This is im-
portant, as many single particle electron microscopy algorithms involve forward or reverse 
Fourier transforms, and subsequently often correlation calculations. 
For individual images, the range of density values (represented by grey levels) may be in-
consequential, as display programs often scale these numbers for representation. But should 
one be performing cross-correlations for the alignment of particles images to a set of refer-
ences, and some happen to contain exceptionally large numerical values, they would yield 
higher peaks and falsely appear to provide the best match. Moreover, the value of the Fourier 
transform at the origin is equal to the mean value of the image; hence a high mean value 
would generate a big central peak in the Fourier transform that is unrelated to the structural 
information. 
Hence, the particle images were normalised to an average density of 0, with an arbitrarily 
selected standard deviation of 10. 
In 16-bit greyscale images, each pixel can assume 216 (i.e. 65,536) different grey values 
that indicate its brightness level. 
All the above procedures were carried out simultaneously (in immediate succession) in 
IMAGIC-V. 
2.5.4 Image processing (IMAGIC V) 
Single molecules in solution are not held in fixed orientations and hence have six degrees 
of freedom, three translational (𝑋,𝑌,𝑍), and three rotational corresponding to the ‘Euler’ 
angles (𝛼,𝛽, 𝛾) – see Fig. 12. The image collected in an electron microscope is a projection 
along the Z-direction (by matter of definition), and thus eliminates the out-of-plane transla-
tion parameter Z. This leaves five parameters to be determined for every particle image, the 
two in-plane translational degrees of freedom (𝑋,𝑌), the in-plane rotational degree of free-
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dom (𝛼), and the two out-of-plane rotational degrees of freedom (𝛽, 𝛾). The in-plane de-
grees of freedom (𝑋,𝑌,𝛼) are removed by various forms of alignment. 
It is the out-of-plane rotations of individual molecules (𝛽, 𝛾) that are the key to three-
dimensional information, and must be identified in order to carry out a 3D reconstruction. 
The processing of single particle images is thus aimed at determining these parameters for 
each of the individual particles in the dataset(s). 
 
Figure 12. The six degrees of freedom of single molecules in solution, three transla-
tional (𝑋,𝑌,𝑍), and three rotational (𝛼,𝛽, 𝛾). An image collected in a microscope is a 
projection along the Z-axis, which leaves five parameters to be determined. Alignment 
of the particles removes the in-plane degrees of freedom (𝑋,𝑌,𝛼). This leaves only the 
out-of-lane rotational degrees of freedom (𝛽, 𝛾) to be determined for each of the indi-
vidual particles, in order to perform a 3D reconstruction. 
2.5.4.1 Reference-free alignment (centring)  
Alignment of low-contrast images with respect to a set of well-defined references images 
tends to bias the dataset towards the properties of the references, purely by selecting for 
similarities with the template contained within random noise variabilities in the particle im-
ages. Therefore, ‘reference-free’ alignments are to be used to obtain the first inventory of the 
various typical molecular views present within the dataset (most especially when no prior 
structural information is available with regards to the sample at hand), and in its most simple 
iteration can involve simply the translational ‘centring’ of the molecular images. Since only 
a translational alignment is performed, the rotational orientation of all the molecules remains 
random. 
Multivariate data analysis methodologies are then used to find similar images, in similar 
rotations, which come to constitute ‘classes’. The resulting class averages are then compared 
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to find similar averages with different in-plane rotational orientations. Such systematically 
present views constitute good, unbiased reference images with which to commence multi-
reference alignment procedures. 
In our case, the pretreated particle images of BRCA2 and the BRCA2-RAD51 complex 
were centred by ‘mass’, which places the centre of image mass (i.e. intensities) at the centre 
of the image frame. Only density values within a circle of radius 0.9 as a fraction of the inner 
radius of the images, and above a density threshold of 0.0 were utilised for mass calculation. 
The former corresponds to the masking radius of the raw particles, and contributes toward 
some saving of processing time (especially for a few of the latter, more computationally in-
tensive procedures). 
2.5.4.2 Multivariate statistical analysis (MSA) 
Multivariate statistical analysis (MSA)95–97, singular value decomposition (SVD), or prin-
cipal component analysis (PCA), are methods employed for multivariate data analysis. 
Despite subtle mathematical differences, what these methods have in common regarding ap-
plication to large image datasets, is that they are all based on the decomposition of the total 
interimage variance into mutually orthogonal components in hyperspace – eigenvectors (or 
eigenimages), which are ordered according to decreasing magnitude. This decomposition is 
specific to the dataset being analysed. 
In essence, MSA looks for differences in features among the various particles, which it 
extracts out as ‘references’. The first eigenimage one obtains is an average of all the aligned 
particles, the second image represents the strongest set of differences that exist among the set 
of particles ignoring that average, and the third image any differences that are left after tak-
ing those two differences out etc. The object is to isolate the strongest set of varying features 
from amongst the particles, which can be utilised as a mechanism for eliminating noise (as 
not much noise is seen appearing in these images, i.e. what one mostly observes is the real 
variations that occur due to changes in the particles). This process hence constitutes an effi-
cient noise reduction method, and then instead of classifying the particles directly, one 
classifies them after they have been ‘filtered’ as per this scheme. Having run this procedure, 
one can then perform k-means clustering (in MSA subspace), and derive a set of class aver-
ages for one’s particle data – see §2.5.4.3.  
The biggest advantage of the MSA technique is that it enables any particle in an entire da-
taset comprising many thousands of individual particles to be represented as a linear 
combination, with different weights or eigenvalues, of the eigenimages of the set98. This ef-
fects a massive a compression of the information in the dataset, correspondingly reducing the 
computing time required for the processing of the images, and facilitating their interpreta-
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tion. An additional advantage of this methodology is that the eigenimages of the centred data 
allow one to have an objective indication of the symmetry properties of the constituent parti-
cles (since it would constitute one of the main features of symmetric molecules)98. 
One is then able to calculate the ‘distance’ between the images based on the eigenvalues 
ascribed to them98 (see Fig. 13a). In practice, an entire dataset could usually be described by 
the early eigenimages, with the higher eigenimages pertaining mostly to the noise compo-
nents of the data. 
The pre-treated and centred particles from the BRCA2 and BRCA2-RAD51 datasets were 
subjected to MSA, employing initially 30 eigenimages, and later the maximum allowed 69. 
Only pixels within a circle of radius 0.9 as a fraction of the inner radius of the input images 
were defined to be active during the process. 
2.5.4.3 Hierarchical ascendant classification (HAC) 
After MSA has culminated, one can calculate the distance between each image in a da-
taset and every other image. This is as in order to build class averages, one needs to be able 
to group similar particles together into classes.  
Originally, each image is a ‘class’ by itself, but then the ‘nearest’ classes can be coalesced 
two at a time, until at the end all the images become a member of one large class encompass-
ing the entire dataset. This process is called ‘hierarchical ascendant classification’ 
(HAC)99,100 – see Fig. 13b. At each level of the classification, two classes are merged in a 
way that intra-class variance is minimised and inter-class variance maximised. This is done 
as per the Ward criterion101, which describes the intra-class variance added upon the merger 
of two classes i and i’, and is given by: 
𝐴𝑑𝑑𝑒𝑑  𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒!,!! =    (𝑤! ∙ 𝑤!!)!(𝑤! + 𝑤!!) ∙ 𝑑!,!!! ;  
where d is the distance between the two classes as determined by MSA, and wi and w! ' are 
the ‘weights’ respectively. At any given point in the procedure, the program attempts to 
merge pairs of classes together, which at that level of the classification will be associated 
with minimal added variance. 
Finally, the partition obtained with HAC is post-processed, by allowing members of all 
classes to ‘migrate’ to any class more conducive in terms of minimising the intra-class vari-
ance98. 
In order to obtain a set number of classes from the above process, one can ‘cut’ the ‘tree’ 
of this history of mergers at the appropriate level. The images contained in classes under this 
level could then be summed into single class averages. 
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For the BRCA2 dataset, the number of classes in the beginning was chosen so as to corre-
spond to an average of ~20 particles per class, to elucidate the overall form of the molecule. 
Later, an increased number of classes were used, corresponding eventually to less than an 
average of 10 particles per class, in order to extract the smaller details by making the classes 
more representative of their constituent particles, though at some expense of the contrast in 
individual class averages. The latter however is more than compensated by the increased ac-
curacy of alignment, classification, and angular assignment with progressive cycles of 
refinement, and the overall increased number of class averages representing a greater number 
of views with higher integrity. This remained the scenario until a final refinement step via 
projection matching was carried out. 
For the BRCA2–RAD51 complex, the number of classes corresponded to an average of 
~23 particles per class, and this continued to be the case until the final two cycles of refine-
ment by projection matching. Due to slightly more heterogeneity in the dataset, this proved 
desirable in order to derive a ‘consensus’ reconstruction. 
 
Figure 13. Multivariate statistical analysis (MSA) and hierarchical ascendant classifi-
cation (HAC). MSA allows the calculation of ‘distance’ between individual particle 
images in multidimensional hyperspace (a), based on the eigenvalues describing each 
image. (b) HAC tree based on the similarity between individual particles. One can ob-
tain the desired number of classes by trimming the tree at a specific level. Adapted 
from Dan Bose, PhD thesis, Imperial College London, 2005. 
2.5.4.4 Class averaging 
An electron microscopy dataset, even under negative stain, is comprised of a large num-
ber of relatively low contrast, low signal-to-noise ratio (SNR) images of individual particles, 
where the latter is defined as: 𝑆𝑁𝑅 = !"#$"%&'  !"  !"#$%&!"#$"%&'  !"  !"#$% ∙98 
a b 
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They hence prove problematic to judge or process, without prior application of some 
form of averaging procedure, to substantially enhance the SNR of the data. One is able to 
achieve this via the alignment and averaging of a number of similar molecular images to-
gether. The signal scales linearly with the number of images averaged; under the idealised 
assumption that all the images averaged are identical, i.e. apart from the noise that differs 
from image to image. Noise on the other hand scales as the square root of the number of im-
ages, and thus the SNR also scales as such. These class averages may then be used as 
references for a new multi-reference alignment followed by MSA-based classification round. 
After a number of iterations, ‘good’ class averages, with increased SNRs can usually be ob-
tained. The high SNR values thus derived are of great importance to the accurate assignment 
of Euler angles to these images98. 
All images that had been assigned to the same class in the classification process were av-
eraged together to generate class averages. 
One has the option to exclude a certain fraction of the worst members from each class (by 
the measure of intra-class variance), at either the HAC or averaging stage. Neither was 
availed, as it yielded little practical benefit in our case. 
2.5.4.5 Multi-reference alignment (MRA) 
Following an initial reference-free alignment of the dataset, one begins to employ multi-
reference alignments (MRA). These entail an alignment of the dataset to a number of indi-
vidual reference images. Initially, they would be class averages resulting from the centring of 
particles. 
On having obtained this set of class averages, one considers as varied a subset of these as 
possible (in terms of molecular views represented), as a template for a round of reference-
based alignment. Such references should also as far as possible, constitute the strongest set 
of class averages (high SNRs), while also exhibiting the most detail. 
The classifications’ accuracy was checked via extraction of particles within selected clas-
ses, followed by visual assessment of their consistency with the respective class averages. 
This was done first in IMAGIC, and then later using ‘classeditor’, a convenient program 
written by Dr Timothy Grant (Grigorieff Lab, Janelia Farm Research Campus, Howard 
Hughes Medical Institute, Ashburn, Virginia, USA). 
Upon alignment, the MSA process is run again, and a new set of class averages generated 
by classification and averaging, from which one makes a selection as previously, for yet an-
other round of alignment and so forth. After having iterated this procedure a few times, class 
averages representative of various distinct views of the molecule should begin to emerge. 
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And following several iterations, one is supposed to have obtained a fairly varied set of class 
averages with more homogeneous components. These can then constitute the basis for Euler 
angle assignment and three-dimensional reconstruction. 
The above process was repeated multiple times. In the case of BRCA2, starting with a 
preliminary selection of 5 class averages, which was broadened with every passing round, 
eventually 66 stable averages were carried forward for the purposes of creating an initial 3D 
reconstruction, after 5 such cycles of two-dimensional refinement.  
Similarly, for BRCA2-RAD51, beginning with an initial 10 class averages (a number that 
was increased with progressive cycles), finally 80 stable averages were taken forward in or-
der to generate a preliminary 3D reconstruction (following 4 rounds of 2D refinement). 
However, in either case only a small subset of these class averages was used to construct 
the very first 3D, which was then widened in preparation for constructing the initial ‘refer-
ence’ 3D for alignment. 
 Once such an initial 3D is obtained, 2D reprojections of 3D models from successive re-
finements are subsequently used as alignment references, in order to resolve additional 
projections of the structure. Hereby, uniformly distributed projections within the asymmetric 
triangle, spaced at 10° and accounted for any symmetry at the given stage, were utilised 
throughout up until the round(s) of projection matching. 
Extended 3D objects yield very varied projections in terms of intensity. Hence, it is nec-
essary to normalise the references, as otherwise alignment shall be biased towards references 
with the greatest contrast. 
All such references were therefore normalised to an average density of 0, and an arbitrary 
variance of 100, i.e. the same parameters as for the pre-treated images. 
2.5.4.5.1 Brute-force alignment 
All the reference-based alignments described hereby were performed using the brute-
force, ‘timalign’ program optimised for noisy datasets (written by Dr Timothy Grant, Janelia 
Research Campus, HHMI, USA). 
This algorithm performs a full translational alignment at every rotation of the particle 
along first a user specified ‘coarse’ sampling (set to be 10°), and then every 1°. In case of the 
BRCA2-RAD51 complex, a value of 4° was used for the former at the projection matching 
rounds. 
The program searches for the highest cross-correlation peak over all the coarse rotations, 
and finally refines the rotational and translational parameters about the highest scoring rota-
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tion. This is performed against each reference image (for every particle image), and the alto-
gether best solution taken to be the optimum alignment. The biggest downside of such an 
approach is its CPU intensive nature. It is however most effective for sub-ideal samples. 
By contrast, a ‘typical’ MRA scheme would involve a sequential, translational followed 
by rotational alignment (or vice versa). As a result, should the first of these be wrong, the 
latter might then also be incorrect. This can yield erroneous alignments, most especially for 
noisier datasets. 
The program also always allows the original, pre-treated images to be used as the input, 
i.e. as opposed to the previously aligned images, and so has the advantage of avoiding inter-
polation errors between successive alignments. Furthermore, it does not mandatorily impose 
a restriction on the translation of particles, e.g. as a function of mask radius and box width. 
In our cases, the fairly liberal default threshold of 20% the box inner radius was specified 
(corresponding to a maximum displacement of ~13 pixels or 45 Å along any direction), even 
more so because one’s best care had been taken in centring the particles during picking 
stage.  
An unrestricted yet informed prescription of such a maximum shift for the purposes of 
alignment, can offer substantial saving of CPU-time whilst still maintaining maximal accu-
racy. 
2.5.4.6 Euler angle assignment 
Class averages resulting from alignment and classification procedures represent two-
dimensional projections of the 3D structure along discrete directions. Having derived a de-
cent assortment of these, a three-dimension structure can then be obtained if the orientational 
relationships between such images are known. 
Two of the ways these may be deduced, are angular reconstitution by common lines102–104, 
and projection matching105. 
2.5.4.6.1 Angular reconstitution (AR) 
The angular reconstitution (AR) method allows one to a posteriori determine the relative 
orientations of the 2D projections of a 3D structure. This is based on the ‘common lines pro-
jection theorem’, which states that two different 2D projections of the same 3D object, 
would always posses a one-dimensional (1D) line projection in common. 
From angles between pairs of common line projections, the relative Euler-angle orienta-
tions of these projections can be calculation. The figuring of angular orientations for at least 
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three projections (class averages) is needed for solving the orientation problem for an asym-
metric molecule. 
The process begins with the generation of line projections at 1° intervals from the two in-
put class averages, or a class average and reference, which generates ‘stacks’ of individual 
line projections over 360° called ‘sinograms’. A line-by-line correlation is then run between 
the two sinograms, which produces a maximum at the position corresponding to the common 
line projection. The angles of these lines thus provide the relative orientation of the two pro-
jections. By adding a third projection, and finding its relative orientation with respect to the 
first two, an ‘asymmetric triangle’ covering the unit sphere can be constructed. The angles of 
further projections are found via brute-force correlations of these projections’ sinograms 
with all other sinograms. 
Correlation functions and coefficients have an intrinsic downside in that they are both 
multiplicative (or ‘squared’) operations, which cause the more powerful components of the 
data, i.e. the low spatial frequencies in any EM dataset, to become overinflated relative to the 
weaker components – the high frequencies harbouring smaller details that one is often inter-
ested in. By dividing the Fourier components by square roots of their amplitudes, these 
unfavourable effects can be modulated, resulting in better correlations based on fine features 
of the particle. This constitutes the basis for an ‘amplitude square root’ (ASQ) filter106, which 
can be applied to sinograms, particularly during the later phases of refinement, when one 
wants to focus on the (weak) high resolution data components, and boost these to statistically 
significant levels. The advantage conferred by this practice in negative stain electron micros-
copy might however be insignificant. 
The class averages were assigned angular reconstitution Euler angles as described above. 
In case of anchor-set based angle assignments, reference projections had been created at 30° 
intervals, and then at 10° during the advanced stages of refinement of the BRCA2 structure; 
and 10° throughout for the BRCA2–RAD51 reconstruction. 2° angular increments in ‘search' 
were utilised, but reduced at the end to 1° in the case of BRCA2; though maintained at 2º for 
BRCA2–RAD51. ASQ-filtering was also employed during later stages of the former. Again, 
the two-fold increased sampling thereby causes a four-fold gain in processing time, but like-
ly leads to no improvement. 
However, it does make sense to use finer angular increments for search than those used to 
create the anchor-sets, as the process entails interpolation unlike projection matching. 
All anchor-set references were normalised to an average density 0, and an arbitrary vari-
ance of 100. 
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2.5.4.6.2 Projection matching 
In MSA/angular reconstitution based reconstruction methodologies, projection matching 
is often used as a complimentary technique to angular reconstitution, in order to refine the 
angular assignment and alignment of the structure. Thereby, uniformly spaced references are 
reprojected from the 3D reconstruction as elsewhere, and used to align the dataset – with all 
the particles aligning to a particular reference being averaged and assigned the Euler angles 
of that reference. As a consequence, the resulting structure is very biased toward the input 
3D model, and there are few opportunities for alternative projections to diverge. However, 
this methodology can be very effective at the final refinement steps once a reliable recon-
struction has been derived via other means. 
Projection matching was used for the alignment and classification of particles, at the last 
stage of refinement of BRCA2’s structure, and for the last two stages of BRCA2–RAD51. In 
case of the former, references had been generated at 6° intervals in an asymmetric triangle 
arrangement, taking account of any symmetry. In the latter, first a 10° separation was used, 
and then 6°. 
All projection-matching references were normalised to an average density of 0, and an 
arbitrary variance of 100. 
2.5.4.7 Three-dimensional reconstruction 
Following from angular assignment, one obtains a set of class averages with assigned Eu-
ler angles. In principle, these 2D class averages are then ‘back projected’ along the assigned 
angles, creating a sum of densities at their intersection that reconstructs the 3D volume of the 
molecule. 
However, there is a limiting complication in the above’s implementation. 2D projections 
of a 3D object in real space, correspond to radial 2D slices in the 3D Fourier transform of the 
object. In the analytic case, projection operations through a 3D object extend from –ve to 
+ve infinity, resulting in infinitely thin central sections (i.e. mathematical planes) in its Fou-
rier transform. Naturally, biological macromolecules posses defined maximum extents, and 
projection operations thus need only extend over this distance ‘D’. Due to reciprocity of Fou-
rier space, central sections arising thereby have a discrete width (!!). Unlike the analytic case, 
these ‘slabs’ will therefore overlap over more than a mathematical line. Owing to their dia-
metric arrangement, this effect is more pronounced closer toward the origin in Fourier space 
(i.e. low spatial frequencies). Consequentially, should one be performing a 3D reconstruction 
by simply inserting stacks into Fourier space by back-projection of Euler-angle assigned 
class averages, the former shall overlap close to the centre of the 3D Fourier transform and 
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overweight the low frequency components, causing a burring of the map. The scale of this 
effect is then determined by the extent of the overlap. To counteract the problem, ‘exact fil-
ter’ algorithms can be applied, which at their most basic level constitute a high-pass filter in 
order to suppress the low frequencies; but are calculated separately for each input class aver-
age, and account for various factors, such as the dimensions, symmetry, and uneven 
distribution of views of the particle. The latter’s effects are ‘absorbable’ therein.98,107 
In the case of BRCA2, a selection of three from the set of 66 stable class averages men-
tioned in §2.5.4.5 thought to represent roughly orthogonal views, were manually designated 
mutually perpendicular Euler angles and used to construct a tentative 3D model via exact-
filtered back projection. Anchor references were created from this map and used to sequen-
tially assign Euler angles to a number of other class averages in the set deemed valid 
representations of views of the particle, and compatible with the preceding subset, by com-
parison with reprojections (see later), and subsequently added to the subset of averages 
constituting the 3D volume. 
For BRCA2-RAD51, beginning with a subset 10 of the 81 stable averages from 2D re-
finement used to generate the tentative 3D model, this was added to as before until a 
preliminary reconstruction composed of 26 was derived. Due to the bigger size, and clearer 
and more distinctive projections of these molecules, assigning angles to a larger number of 
these start-up averages proved more convenient. 
MRA references were then created from these initial 3D reconstructions, and used to 
align the respective particle datasets. The newly aligned particles were run through MSA, 
HAC and averaging to generate a new set of class averages. These were assigned Euler an-
gles according to anchor-set references from the initial 3D model, and used to construct a 
new model. This process was repeated till no further change could be observed in the recon-
structions. 
 Thereby, once the dimeric nature of the reconstructions became apparent, the as-of-then 
unsymmetrised volumes were rotated for the top view to have Euler angles (0, 0, 0), i.e. fac-
ing down the Z-axis – about which they were then symmetrised. These models constituted 
the bases for the succeeding refinements, and C2 symmetry was retained therefrom. The re-
finement processes were continued until no further improvement could be deciphered within 
the reconstructions, following which projection matching was utilised to finalise the struc-
tures.  
Quality of a reconstruction can be assessed by comparison of its constituent class averag-
es with the reprojections from the 3D volume along the same Euler angle directions. At each 
stage averages with poor corresponding reprojections were thence excluded and the remain-
 - 64 - 
der used to build revised reconstructions. Class averages considered unfit for incorporation 
into the 3D maps, owing to for example, bad or poorly resolved features, low contrasts, or 
heterogeneous members, were excluded in the first instance. During the last couple of rounds 
of refinement, a quantitative but arbitrary criterion, i.e. a maximum of 40% error between 
average and reprojection, was utilised as a threshold for meriting inclusion into the recon-
struction. By these stages, the reconstructions had improved greatly and so necessitated 
reduced user supervision and management. 
The relative size of the object inside the 3D volume influences the shape of the exact fil-
ter. If the molecule is small compared with box dimensions, then it follows that the thickness 
of central slices in Fourier space is relatively large; and that these intersecting slabs influence 
each other over a wider frequency range. An object size as fraction of image size of 0.6 was 
specified throughout for the purposes of both reconstructions. This value was based on 
measurements of class averages, and earlier on observations of the length of BRCA2 ‘di-
mers’ in metal shadowing electron microscopy studies66, which found it to be 270 ± 30 Å so 
that: 
!"#$!%!  !"#$%&'(  !"#$!"#$  !"#!  !"#$%! =    !"#  Å!"#$%&'(  ×  !"#  !"#$!     !"  !"#$%& = !"#  Å!.!"  Å  ×  !"# = !"#  Å!"#  Å = 0.6. 
Any point-group symmetry being utilised was also specified when performing reconstruc-
tions (and angular reconstitution), because if true this creates an advantageous redundancy in 
the data, which besides facilitating faster convergence of the refinements and enabling higher 
resolutions to be obtained, makes the overall procedure more resistant to deviations from the 
correct scenario. 
Prior to generating either anchor-set or alignment references, the 3D volume in question 
was band-pass filtered between parameters corresponding to 10 and 270 Å for BRCA2; and 
the 3σ resolution and 270 Å for BRCA2–RAD51. The reconstructions were centred by mass 
within a spherical radius of 0.9, followed by 0.7 (i.e. as a fraction of the box size) – by the 
same rationale, and in the same manner as the pre-treated particles. The references were then 
normalised to an average density of 0, and an arbitrary variance of 100. 
2.5.4.7.1 Euler angle refinement 
After every round of MRA, MSA, classification and Euler angle assignment by angular 
reconstitution, some class averages would not get designated correct angles, which would 
lead to erroneous reprojections. Following intermediate phases of refinement of BRCA2’s 
structure, and from the beginning of BRCA2–RAD51’s, class averages with prefect reprojec-
tions were extracted and used to build reference models. Anchor set projections from these 
were used to refine the earlier Euler-angle assignments. From these refined angular designa-
 - 65 - 
tions to the same set of class averages, new, refined 3D maps were created. One again, aver-
ages with good correspondences, of which there would now be a greater number, were 
extracted and the process repeated as before, until the Euler angles had stabilised, and no 
further class averages could be incorporated into the reconstructions. Such iterative refine-
ments of angular assignments and 3D reconstructions within stages, thus constitute mini-
refinements in a larger scheme of iterative alignment-based refinements. 
Prior to the creation of any such anchor set references, the 3Ds were filtered and centred 
as above; and the reference images normalised as usual to an average density of 0, and an 
arbitrary variance of 100. 
2.5.4.7.2 3D masking 
If desired, the reconstructed 3D image can be zeroed outside a sphere of certain specified 
radius, in order to mask any noise densities beyond this perimeter. The cut-off would not 
have a sharp edge, but rather a steep linear roll-off. For BRCA2, initially no mask was em-
ployed, followed by a ‘soft’ spherical mask of radius 0.9, and then 0.7 as a fraction of the 
box width. In the case of BRCA2–RAD51, one of fractional radius 0.7 was utilised through-
out.  
Later, one may impose a ‘fitted’ mask on the 3D. This generates a 3D mask delineating 
the 3D object in the 3D volume. One proceeds first via a low-pass filtering of the concerned 
3D volume. The filtered volume is then binarised, such that all grey values above a certain 
threshold are set to 1 (white), and the ones below to 0 (black). To find the threshold for bi-
narisation, a density (i.e. grey value) survey of the filtered volume may be run, and the 2σ 
value used as a threshold criterion. Sharp edges of the mask are then removed by averaging 
over the 3D environment of each input voxel. One’s original 3D volume is multiplied by this 
mask to create a binary masked 3D. The basic idea is that when ‘inside’ the object, one has a 
higher local variance level than ‘outside’ the object. 
A low-pass parameter of 0.1 (corresponding to 70.4 Å), a density threshold of 2σ, and a 
3D convolution volume with a linear dimension of 5 pixels, were used to create ‘soft’ binary 
masks for both reconstructions. 
However, the masks were found to slightly cut into the protein densities along the sides of 
the molecules. To solve this, masks were ‘dilated’, whereby the original masks are isotropi-
cally ‘extended’ by a certain distance, to create a ‘looser’ fitted mask. In both our cases, the 
masks were dilated by 2 pixels, i.e. ~ 9 Å. 
Binary masking was only performed for the purposes of either projection matching or 
creating the final reconstructions therefrom. In the case of BRCA2, it was employed for gen-
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erating the finalised structure, after the terminal round of refinement by projection matching. 
For BRCA2–RAD51, it was utilised for generating alignment references for the penultimate 
and ultimate rounds of refinement via projection matching, as well as creating the conclud-
ing reconstruction. 
Such masks can also be projected along the directions of input class averages of 3D re-
constructions, and used to binary mask the former, after their re-binarisation and 
smoothening in 2D. This practice is roughly equivalent to solvent flattening in X-ray crystal-
lography. In our cases, the projected 2D masks were binarised using the same 2σ value as 
used to binarise the 3D masks, and softened by convoluting over an area of linear size 5 pix-
els. They were then used to reconstruct the 3D volumes with no masking, a soft spherical 
mask of fractional radius 0.7, or binary masking yet again – for the purposes of resolution 
estimation. 
2.5.4.7.3 3D map visualisation 
Density thresholds corresponding to predicted molecular weights of the structures, which 
were then experimentally confirmed via scanning transmission electron microscopy, were 
calculated using a sub-routine in IMAGIC assuming a specific protein density of 0.844 Da 
Å-3 (see next). The maps were rendered in UCSF Chimera108, for voxels with density values 
greater than this threshold. 
It should be noted however, that at the resolutions concerned, protein folds get ‘smoothed 
out’ such that only tertiary and quaternary features can be resolved. This causes an over- and 
underestimate for the values of volume and surface area respectively, for a set size and mass, 
than would be the case otherwise. To account for this issue, in actuality ‘corrected’ thresh-
olds were calculated using 1.2× the supposed molecular mass as a guideline. 
If available, the above procedures were carried out on binary masked maps, to be able to 
avoid the contribution of ‘mass’ by the surrounding noise affecting the accuracy of the above 
estimations. 
Fitting of the Rad51 crystal structure49 into the BRCA2–RAD51 map was too performed 
in Chimera. The former was first interactively docked into the latter, using anti-BRC and 
anti-RAD51 labelling results of BRCA2 and BRCA2-RAD51 as the guide. The fit was then 
auto-refined therein by use of correlation coefficient as the criterion to be maximised. 
2.5.4.8 Scanning transmission electron microscopy (STEM) 
Scanning transmission electron microscopy (STEM) of our preparations of the BRCA2 
protein and the BRCA2-RAD51 complex, were carried out at the STEM facility, 
Brookhaven National Laboratory, Upton, New York, USA; and the data analysed by Dr Eric 
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Kong, Zhang group, Macromolecular Structure and Function Laboratory, Imperial College, 
London, UK – in order perform molecular mass measurements of the samples as a substitute 
for mass spectrometry. 
The principle of mass measurement by STEM is based on the incoherent nature of large-
angle elastic scattering off atomic nuclei. The signal observed thereby is a sum of the scatter-
ing from all the atoms irradiated by the beam, regardless of their mutual bearings or bonding 
states. Scattering off atoms with different atomic numbers is very nearly proportional their 
respective atomic weights, and so the signal from the detector is highly proportional to the 
local mass traversed by the beam. 
Areas of the grid with clean background, and adequate numbers of specimen, as well as 
tobacco mosaic virus (TMV) particles being used as an internal control and for calibration, 
are selected for mass analysis. Background is computed in clear areas of the image, and the 
signal minus background integrated over each particle and multiplied by a calibration factor, 
to yield a mass value. 
We employed this technique mainly to ascertain the oligomeric state of our molecules. 
We fitted two independent Gaussians corresponding to BRCA2 and BRCA2–RAD51, and 
their cumulative curve to the distribution of masses, and determined the statistics therefrom. 
2.5.4.9 Resolution 
In electron microscopy, signal cannot directly be distinguished from noise, i.e. the exten-
sion of Fourier rings to a certain value does not imply that information is interpretable at that 
resolution; hence the indirect measure of Fourier shell correlation (FSC) is usually utilised in 
its stead, the 3D equivalents of rings in 2D Fourier space being ‘shells’107. 
FSC is calculated by splitting the set of class averages constituting a 3D volume into two 
random halves, and calculating the correlation across the full range of spatial frequencies 
between the two consequent reconstructions. A typical curve shall exhibit high correlations 
over the low frequency components, which then decay away steeply toward the high fre-
quencies. 
Correlations between reconstructions derived from two halves of the dataset, are known 
to be spuriously affected by having the same mask imposed on both, either spherical or bina-
ry – especially if the two have step function drop-offs. However, equally the surrounding 
‘solvent’ region does not comprise one’s particle, but rather extra-molecular noise. The latter 
is significant because its masking therefore does not impact upon inside noise variations, and 
influence information contained in the object itself. Since our reconstructions did not employ 
‘hard’ masks, the latter effect most probably compensates for the former. 
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Nevertheless, as both the half-sets of class averages were still ultimately derived from da-
ta aligned to the same set of references, the resulting FSC is thus regarded as ‘semi-
independent’. Truly independent FSC calculations necessitate generating two separate recon-
structions from data divided into two halves at the outset, the so-called ‘gold-standard’109. 
The latter is then justifiably accompanied by the use of more lax resolution criteria such as 
0.143. However, this practice is not usually considered worthwhile for negatively stained 
electron microscopic reconstructions. 
The global resolution of a reconstruction is estimated by the intersection of its FSC curve, 
with curves defining set resolution criteria, such as 0.5, 0.143, 3σ and ½-bit110. The former 
has a constant value of 0.5 over all spatial frequencies, corresponding to the point where the 
frequency-dependent signal-to-noise ratio of the map, 𝑆𝑁𝑅!"# 𝑣  equals 1111, as in: 
𝑆𝑁𝑅!"# 𝑣 = 𝐹𝑆𝐶(𝑣)1 − 𝐹𝑆𝐶(𝑣),   
so that when FSC(v) = 0.5: 
𝑆𝑁𝑅!"# 𝑣 = 0.51 − 0.5 = 0.50.5 = 1; 
where v denotes spatial frequency (resolution), and FSC(v) is the resolution dependent FSC. 
This criterion is the strictest and most commonly employed, but is known to be overly con-
servative, e.g. for gold-standard reconstructions but also for less symmetric particles, where 
useable information is present beyond this threshold110. The 0.143 criterion is based on the 
estimated correlation between a map calculated from the full dataset (by averaging the two 
half-maps), and a ‘perfect’ reference containing no noise; and aims to make FSC comparable 
with the crystallographic figure-of-merit (FOM)111. When the two halves of the data are 
combined to produce the best estimate of the structure, the SNR of the full average is in-
creased by a factor of √2 relative to the half-reconstructions. This results in a scaled FSC 
(FSC’) as follows: 
𝐹𝑆𝐶! = 2𝐹𝑆𝐶1 + 𝐹𝑆𝐶 ; 
FSC being the ‘old’ FSC111. Therefore, if FSC = 0.5, FSC’ = 0.67; but if FSC’ = 0.5, FSC = 
0.33. Comparing this merged reconstruction with noise reduced by √2, against a perfect ref-
erence where noise equal zero, results in a correlation (Cref) given by: 
𝐶!"# = 2𝐹𝑆𝐶1 + 𝐹𝑆𝐶 ;!  
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where FSC is again the old FSC111. It can also be shown that Cref is equal to the cosine of the 
average phase error, and equivalent to FOM (a common measure of map interpretability in x-
ray crystallography). Thereby, if Cref  = 0.5, FSC = 0.143. In analogy to crystallography, a 
FOM of 0.5 is commonly used to mean that the map is interpretable, as in that a molecular 
structure can be built. Other criteria measure the point at which the FSC crosses the level that 
would be expected of pure Gaussian (i.e. random) noise110,111. The latter is given by 1/√N, 
where N is the number of voxels in a given resolution shell. A value of two or three times 
this figure is then commonly utilised, making up the 2σ and 3σ criterions respectively. These 
criteria are therefore true ‘curves’, and attempt to denote the point at which the signal in a 
reconstruction lies significantly above the noise floor, but are not in common use at present. 
The ½-bit criterion is also a variable-value curve, and has too been argued to be a useful in-
dicator110. It constitutes one of a family of the so-called ‘information-based’ threshold 
criteria, and expresses the spatial frequency at which the reconstruction harbours sufficient 
data to enable direct structural interpretation at that level. In likeness with the 0.143 criterion, 
this too is tailored to yield resolution values comparable to those in x-ray crystallography; 
but similar to the 3σ criterion is presently in rare usage. 
Naturally, various parts of a reconstruction do not all conform to the same resolution. 
However, assigning a single resolution value to the map where the FSC descends under a 
certain threshold, provides a convenient means of tracking one’s progress over the course of 
refinement. 
Following from intermediate stages of the BRCA2 reconstruction, and the beginning of 
BRCA2–RAD51’s, resolution was charted using FSC and the various threshold criteria. Any 
point-group symmetry utilised for the reconstructions was specified, which in order to ac-
count for its influence, multiplies the Nσ and ½-bit threshold curves by the square root of the 
number of asymmetric units for this cyclic symmetry; as then the number of independent 
voxels in Fourier space 3D shells is thus lower by the degree of symmetry, necessitating its 
division with this number110. A threshold of 3 was specified for the sigma curve throughout. 
The size of the molecule within the 3D reconstruction volume also affects the expected FSC 
levels. Thereby, the smaller the former is inside the latter, the larger is the corresponding 
‘convolution’ sphere in Fourier space whereby the complex structure factors are highly cor-
related. A ‘filling degree’ of 0.6 was hence specified always. 
2.5.4.10 Structural validation 
The overall correctness of the two structures was established by a variation of the tilt-pair 
and tilt-series validation methods, as described by Scheres112 (Nat Struct Mol Biol, 2011). 
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The particle sets used in this analysis each constituted a tilt series ranging between nomi-
nal tilts of 0º and 40º, in steps of 5º. Each particle was independently assigned Euler angles 
using the respective model’s projections. The particle with a nominal tilt of 0º was then used 
as a reference to calculate all the other relative tilt transformations in pairs, as described be-
low. 
The ‘standard’ spherical polar coordinate system (Fig. 14, left) is defined by the ‘azi-
muthal’ angle θ in the x–y plane from the x-axis, the ‘polar’ or ‘zenith’ angle ϕ from the 
positive z-axis (so that ϕ = 90° – 𝛿, where 𝛿      is the ‘latitude’), and the distance or radius r 
from the origin to a point, i.e.: 𝑟, 𝜃,𝜙 ,𝑤ℎ𝑒𝑟𝑒  0 ≤ 𝜃 ≤ 360°, 𝑎𝑛𝑑  0 ≤ 𝜙 ≤ 180°. 
In the IMAGIC convention (Fig. 14, right), the azimuth θ is defined as γ, and the zenith ϕ 
defined to be β, such that by the above order: 𝑟, 𝛾,𝛽 ,𝑤ℎ𝑒𝑟𝑒  −90 ≤ 𝛾 ≤ 90°, 𝑎𝑛𝑑  −180 ≤ 𝛽 ≤ 180°. 
But for the special case of C2 symmetry: 0 ≤ 𝛽 ≤ 180°. 
As per the above equivalencies between standard and IMAGIC angles, and the known rela-
tionships of Cartesian to spherical coordinates, one can then write: 𝑥 = 𝑟 cos 𝜃 sin𝜙 = 𝑟 cos 𝛾 sin𝛽 ,  𝑦 = 𝑟 sin 𝜃 sin𝜙 = 𝑟 sin 𝛾 sin𝛽 , 𝑎𝑛𝑑  𝑧 = 𝑟 cos𝜙 = 𝑟 cos𝛽. 
Considering vectors 𝑣! and 𝑣! for two equidistant points on the sphere P1 and P2 respective-
ly, one has: 𝑣! = 𝑟, 𝜃!,𝜙! = 𝑟, 𝛾!,𝛽! , 𝑎𝑛𝑑  𝑣! = 𝑟, 𝜃!,𝜙! = 𝑟, 𝛾!,𝛽! . 
Writing these in terms of Cartesian coordinates: 𝑣! = 𝑟 cos 𝛾! sin𝛽! 𝑥 + 𝑟 sin 𝛾! sin𝛽! 𝑦 + 𝑟 cos𝛽! 𝑧, 𝑎𝑛𝑑  𝑣! = 𝑟 cos 𝛾! sin𝛽! 𝑥 + 𝑟 sin 𝛾! sin𝛽! 𝑦 + 𝑟 cos𝛽! 𝑧. 
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One can then reckon the scalar (dot) product of the two vectors, as a product of their magni-
tudes 𝑣!  and 𝑣! , and the cosine of the angle τ between them. This would be the angle they 
subtend at the centre of the sphere, and hence the ‘tilt angle’ between a pair of Euler angles. 
Explicitly, 𝑣! ∙ 𝑣! = 𝑣! 𝑣! cos 𝜏 = 𝑟! cos 𝜏 , ∵ 𝑣! = 𝑣! = 𝑟. 
By expansion, one therefore has: 𝑣! ∙ 𝑣! = 𝑟! cos 𝛾! sin𝛽! cos 𝛾! sin𝛽! + sin 𝛾! sin𝛽! sin 𝛾! sin𝛽! + cos𝛽! cos𝛽! . 
Factorising, = 𝑟! sin𝛽! sin𝛽! cos 𝛾! cos 𝛾! + sin 𝛾! sin 𝛾! + cos𝛽! cos𝛽! . 
Using the trigonometric identity whereby cos (A) cos (B) + sin (A) sin (B) ≡ cos (A – B), one 
gets: = 𝑟! sin𝛽! sin𝛽! cos 𝛾! − 𝛾! + cos𝛽! cos𝛽! . 
Equating, 𝑟! sin𝛽! sin𝛽! cos 𝛾! − 𝛾! + cos𝛽! cos𝛽! = 𝑟! cos 𝜏 ,  sin𝛽! sin𝛽! cos 𝛾! − 𝛾! + cos𝛽! cos𝛽! = cos 𝜏. 
Therefore, the tilt angle τ between two views with Euler angles (β1, γ1) and (β2, γ2) is ex-
pressed as: 𝜏 = cos!! sin𝛽! sin𝛽! cos 𝛾! − 𝛾! + cos𝛽! cos𝛽! . 
The reconstructions were validated by comparing the expected versus the measured tilt of 
each of the (nine) pairs in the series, calculated as per the formula derived above. Angles 
were converted from the IMAGIC (α, β, γ), to the SPIDER/FREALIGN convention (ψ, θ, 
φ)113,114, for the purposes of determining out-of-plane errors in the tilts in TILTDIFF111 as 
follows: 𝜓 = 𝛼 + 90°,  𝜃 = 𝛽, 𝑎𝑛𝑑  𝜙 = 270° − 𝛾. 
A value of 360° was added to and subtracted from, negative and positive angles respectively, 
so as to all conform to the range 0° ≤ ψ, θ, φ ≤ 360°. 
Whilst it is possible to obtain perfectly valid electron microscopy reconstructions from 
untilted negatively stained particles, tilted views often tend not to appear as expected for a 
particular angle of tilt, due to the effects of stain, especially that surrounding the molecules. 
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The phenomenon of ‘flattening’ of the particles perpendicular to the carbon support film is 
also often quoted115, and believed to be a consequence of the heavy-metal staining. Some 
sources espouse the severity of this effect to be as much as 50%, or even up to 70%. 
Furthermore, in the specific case of BRCA2, the reconstruction does not possess especial-
ly distinct projections over a relatively wide range of angles, further compounding the 
procedure’s difficulty. 
We also analysed –20°/+20° and 0°/+20° tilt-pairs for both datasets. Euler angles were 
assigned for either tilt in the tilt-pairs by projection matching in SPIDER (and the correct 
assignments visually adjudged by comparison with model projections). Tilt transformations 
were computed via their substitution into the aforementioned formula. As the more familiar 
IMAGIC alignment references were employed, conversion of the angles from SPIDER for-
mat was not necessitated. References had been projected from binary masked final 
reconstructions, accounting for C2 symmetry, and normalised. Since the nearest view can be 
across the other half of the Euler sphere, the angles were translated using the symmetry rela-
tionship for an object with two-fold rotational symmetry, so as to always correspond to the 
shortest angle between them. For such an object in IMAGIC, every projection at (β, γ), has 
an equivalent projection at (β, γ – 180°) for positive γ; and (β, 180° + γ) for negative γ. 
While the results were confirmatory, i.e. the mean tilt values lay close to the applied tilts; 
the associated percentage errors were large (more so for the smaller-angle 0°/+20° tilt-pairs) 
– see §3.2.6. However, amongst the distribution of tilt-angle values for each, there were 
somewhat tight clusters with lesser errors. 
The tilt-pair series methodology as in the negative stain electron microscopy study of 
human telomerase (also a dimer)112, proved to be much more successful in our case, than the 
usual approach of analysing a set of tilt-pairs with the same angle. This is conceivably be-
cause while certain individual particles can be free of staining artefacts, enabling their 
analyses as a series of tilt pairs; in a collection of tilt-pairs, several such pairs might be af-
fected by the skewing effects of negative stain. 
Even though the grids were adjusted for eucentric height in the electron microscope at 
high magnifications, owing to an inherent ‘wobble’ in the stage/grid-holder, the overall de-
foci of images would alter upon application of tilts, i.e. move closer to focus with increasing 
angles. Therefore, the defoci were manually compensated in the TEM to be the same as the 
untilted images to a good approximation. 
All these data were collected at the FEI Tecnai F20 TEM, at the Centre for Biomolecular 
Electron Microscopy, Imperial College London, UK. And since its detector yields a lesser 
pixel size for the same magnification, consequently causing the particles to appear smaller; 
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the 3D models (derived from CM200 data) were scaled by the requisite factor (i.e. 3.52 Å 
pixel-1 / 4.10 Å pixel-1 ≈ 0.86 or 86%), and the volumes padded to have the same box side as 
the particles (hereby 162 pixels) by addition of empty voxels. References were then created 
from these models as per usual.  
 
 
 
 
 
Figure 14. Comparison of the standard and IMAGIC spherical coordinate systems. The 
zenith ϕ in the former corresponds to β in the latter, and azimuth θ is equivalent to γ. 
However, whilst in the standard convention the azimuth covers a full rotation (0° ≤ θ 
≤ 360°), and zenith covers half (0° ≤ ϕ ≤ 180°); in IMAGIC the zenith encompasses 
360° (–180° ≤ β ≤ 180°), and azimuth 180º (–90° ≤ γ ≤ 90°). Although in the case of 
C2 molecules, the former too is then obviously restricted to 180° (0° ≤ β ≤ 180°). 
IMAGIC incorporates another angle α representing the inplane orientation of the par-
ticles for a fixed β and γ, and ranging the full rotation. Radius r denotes distance from 
the centre, but is made redundant for most angular calculations. In SPI-
DER/FREALIGN formats, the angles then relate to IMAGIC’s as follows: ψ ≡ α, θ ≡ 
β, and φ ≡ γ, i.e. the same as standard113,114 (see text for details, §2.5.4.10). 
2.5.4.10.1 Handedness 
Beyond accurately determining orientations for structural validation, elucidating the 
handedness of a reconstruction in negative stain can be more intractable. 
Standard IMAGIC 
(𝑟, 𝜃,𝜙);   𝑤ℎ𝑒𝑟𝑒  0° ≤ 𝜃 ≤ 360°  0° ≤ 𝜙 ≤ 180°    
(𝑟, 𝛾,𝛽);   𝑤ℎ𝑒𝑟𝑒  −90° ≤ 𝛾 ≤ 90°  −180° ≤ 𝛽 ≤ 180°    
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We proceeded by first determining the approximate tilt axis of our images. This could be 
deduced by comparing untilted and tilted micrographs, and observing the direction in which 
the field of view would get ‘compressed’ in the latter. In our case this was horizontal, imply-
ing a tilt axis that was roughly vertical. We then compared the defocus on the left and right 
halves of the micrographs; for tilted micrographs the former would be less underfocused than 
the latter, and hence up and down respectively. This was confirmed by displacing an under-
focused, untilted image up- and downwards in the TEM and observing the change in 
defocus. There was no difference between the top and bottom halves. 
Having determined the tilt direction, we compared the surface views from both un-
mirrored and mirrored models that gave rise to the (equivalent) projections as seen in the tilt-
series (and -pair) validations. The object being to identify the mirror whose tilt direction was 
commensurate with that of the micrograph.116 
The results thereby were statistically inconclusive, with slightly better than even splits for 
the hands depicted in Fig. 19 from the pairs/series analysed (see §3.2.6 for numbers on the 
latter). The task was made more difficult by the fact that the BRCA2 reconstruction harbours 
pseudo-mirror symmetry within its dimeric structure. Further ambiguity is added at the reso-
lutions concerned, as the mirrors can tend to look similar. 
Hence, we predicated as to the handedness of the structures, by selecting the mirror of the 
BRCA2-RAD51 reconstruction that was most compatible with the fitting of Rad51’s crystal 
structure49. Following therefrom, we then based the handedness of the BRCA2 reconstruc-
tion on the mirror that corresponded best with the aforementioned handedness of the 
BRCA2-RAD51 structure, again on the premise of fitting (see §3.2.8). 
2.5.4.11 Antibody complexes 
Owing to the large mass of HsBRCA2, and challenges in deriving the requisite amounts 
of protein, we were not able to employ internal labelling and nanogold particles, to be able to 
identify specific regions within the reconstructions. 
We therefore utilised monoclonal antibodies, their distinctive overall Y-shapes being vis-
ible in negative-stain electron microscopy; and often also the constitutive globular lobes, 
when viewed uncomplexed on their own (see Fig. 22a). 
Guided by this shape, we selected individual antibody-bound particles. The antibodies 
were then masked-out from the particles, by making soft hand-drawn binary masks around 
the particles. This was to avoid angular misassignment of the particles, due to the attached 
antibody densities. 
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The particles had been low-pass filtered to 60 Å (and a high pass of 270 Å), to facilitate 
their Euler angle assignment, i.e. through enhancement in SNR afforded by suppression of 
noisy high frequencies, thus assisting angular designations based on overall shape. 
A series of closely spaced dots were placed around the perimeter of the particles, and 
used to create initial sharp-edged masks. These were then smoothed by a low-pass parameter 
of 0.1 (~ 70 Å), and multiplied with the original particle images, to yield antibody-bound 
particles with soft binary masks. 
The particles were assigned Euler angles by matching against projections from the re-
spective 3D models. Reconstructions were rotated in UCSF Chimera via the command line, 
to exactly correspond to each of these views in turn. In every instance, a cylinder was placed 
perpendicularly into the screen, touching the surface where the antibody appeared to make 
contact with the particle in its projection image. This helped localise the antibody’s position 
in two-dimensions at each step (as should be the case, since each particle is a 2D projection 
image). After repetition with multiply oriented antibody-bound particles, one obtained a sub-
stantial overlap of these cylinders, indicating the antibody’s location in three-dimensions. 
Cylinders of diameter 20 pixels had been employed to account for error in individual plac-
ings. For a visual illustration, see §3.2.7 and Figs. 22b-d. 
We deployed this technique, in our case because of an inability to derive class averages, 
owing to the sparsity of antibody-bound particles. Thence, while each separate assignment 
has an associated uncertainty (encapsulated in the cylindrical width), and only defines the 
position of the antibody in two-dimensions; a series of such assignments reduces this error, 
and pinpoints its location in three-dimensions. 
The methodology was utilised for each of the three antibody complexes, i.e. anti-BRC 
and (C-terminal) -Flag antibodies against BRCA2, and the anti-RAD51 antibody against 
BRCA2–RAD51, in order to identify these domains within the respective reconstructions. In 
the latter, as there were multiple targets for the antibody, particles with several antibodies 
bound were frequently observed. 
For BRCA2–Ab1 (anti-BRC) complex, an initial selection of 86 particles was made. Of 
these, the eight very best in terms of clarity were incorporated into the analysis in Fig. 22c. 
For the BRCA2–anti-CFlag complex, a total of 65 antibody bound particles were selected. 
These were first separated into nominally ‘good’ (22), ‘average’ (23) and ‘bad’ (20) parti-
cles. Similarly to BRCA2-Ab1, eight of the most clear were then utilised for analysis in Fig. 
22b. For BRCA2–RAD51–anti-RAD51, three good and 43 average particles were prelimi-
narily identified. From amongst these, two of the former and eight of the latter were finally 
employed in the analysis (Fig. 22d). 
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The reconstructions had been low-pass filtered to 60 Å for creating reference projections, 
and 10 Å for generating surface views.  
2.5.4.12 gDNA complexes 
To outline the trajectory of DNA across BRCA2, i.e. in its complex with single-stranded 
DNA, we exploited its binding to gapped DNA substrates, as and for the reasons described in 
§2.2. 
Particles of BRCA2-gDNA complexes, showing clear DNA density flanking a central 
protein density, were selected for analysis. Since binary masks were not necessitated hereby, 
a soft circular mask of inner radius fraction 0.9, and an 8-pixel drop off was used. The imag-
es were band-pass filtered between parameters of 60 and 300 Å, former to aid visibility of 
the DNA strands, and the latter to account for added length due to DNA. 
Euler angles were designated using matching model projections of the BRCA2 recon-
struction. The corresponding surface views were oriented in Chimera as previously, and 
DNA traced thereon as per its track in the particle projections (see §3.2.10 and Fig. 24b). 
A total of 77 eligible BRCA2-gDNA particles were boxed. These comprised 48 from the 
100 nt, and 29 from the 70 nt gapped DNA complexes; of which the 29 most clear-cut cases 
were used in the analysis, including 15 from the former, and 14 from the latter dataset re-
spectively. 
As BRCA2-gDNA data were collected at the F20 TEM, the BRCA2 3D reconstruction 
was appropriately scaled and padded like before prior to generation of angular assignment 
references and surface views; and low-pass filtered to 60 Å for purposes of the former, and 
10 Å of the latter. 
2.5.4.13 BRCA2–RAD51+ssDNA 
We sought also to delineate the trajectory of nucleated RAD51-ssDNA filaments from 
BRCA2 and analyse where on its surface they emerged. 
Hereby, the complexes were boxed into size 180 × 180 squares to better accommodate the 
filament, though this needed not be the full filament. 
Similarly to gDNA complexes, the central particles were matched to the best-fit BRCA2 
model projections, albeit the projections were then rotated to match the particles (and not 
vice versa), so as to correspond to their original orientations in the micrograph. Surface 
views corresponding to the rotated projections were rendered in IMAGIC at the threshold 
discussed in §2.5.4.7.3. 
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Initially, approximate points were placed on the projections and surface views, where it 
was thought the filaments were most likely originating. Thick lines denoting RAD51-ssDNA 
filaments were then traced onto the surface views, based on matching projections with the 
dot markers, and original particles with issuing filaments (for subsequent interpretation) – 
see §3.2.11.2.1 & Fig. 28. 
This (tentative) analysis was performed using seven micrographs of the type in Fig. 27c 
derived from the West laboratory, and a sum total of a mere four particles that had the 
‘clearest’ appearance. 
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3 Results 
3.1 Purification 
Human BRCA2 protein was purified, and the human BRCA2–RAD51 complex constitut-
ed and purified, as described in §2.1.1 and §2.1.2 respectively. The samples were soluble, 
and their analysis by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) and silver staining, revealed the preparations to be of good quality (see Fig. 15a). 
Since PALB2 had previously been found to be associated with affinity purified N-
terminally tagged BRCA2, but not with the C-terminally tagged protein,66 the latter was em-
ployed throughout in our single-particle electron microscopy and other analyses. Thereby, 
the residual compositional heterogeneity visible in the SDS gel is due mainly to non-specific 
degradation of the large BRCA2 protein, as confirmed through mass spectrometry by the 
West laboratory. This is compatible too with the presence of smaller particles with self-
inconsistent sizes and shapes observed under negative-stain EM (Fig. 16, left).  
Above affirmations are valuable as affinity steps were performed in low salt buffers that 
would favour BRCA2’s association with its partner proteins, and potentially skew various 
subsequent results such as those of DNA binding via contribution of their own respective 
activities. 
As before, BRCA2 was found to stimulate RAD51–ssDNA nucleoprotein filament for-
mation, as determined by gel-shift assays (Fig. 15b). In its sole presence, only ssDNA was 
detectable. The BRCA2–ssDNA complex was moderately apparent in BRCA2’s presence 
(sans RAD51), as opposed to RAD51–ssDNA that was relatively weakly visible in RAD51’s 
(sans BRCA2). However, BRCA2–ssDNA and RAD51–ssDNA complexes were strongly 
obvious in the sum presence of BRCA2 and RAD51, and unbound ssDNA notably absent. It 
should be noted that a ternary BRCA2–RAD51–ssDNA is thought not to exist per se66, with 
BRCA2 dissociating from RAD51 and ssDNA on loading former upon the latter and facili-
tating initial filament growth, hence the absence of a third ‘super-shifted’ band. 
The binding of BRCA2 to gapped DNA substrates, i.e. as opposed to single-stranded 
DNA, was also established through electromobility shift assays (EMSAs) – see Fig. 15c. 
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Figure 15. Purification of BRCA2 and BRCA2–RAD51, and binding to single-stranded 
DNA. (a) SDS-PAGE showing purified proteins used in electron microscopy analyses. 
(b) BRCA2 promotes RAD51–ssDNA complex formation as seen by gel shift assays. 
(c) BRCA2 binds gapped DNA, as determined by gel-shift assays. 
3.2 Negative stain electron microscopy 
3.2.1 Micrographs and particles  
As BRCA2 was expressed from its endogenous promoter at in vivo levels (500 ng from 
20 L of cells), negative stain electron micrographs of our preparations were generally quite 
scant in terms of particles (see Fig. 16 - left), which precluded them from analysis by cryo-
electron microscopy that necessitates significantly higher concentrations of samples to be 
practical.  
The micrographs also showed visible aggregation, and wisps of smaller particles that ex-
hibited no mutually consistent size or shape, facilitating their ready exclusion as degradation 
products (i.e. as opposed to valid and intact subpopulations). 
The 8,873 and 6,877 particle projections respectively of BRCA2 and the BRCA2–
RAD51 complex so-picked (Fig. 16 - right), exhibited a respective ‘long’ and ‘short’ dimen-
sion of ~ 120 Å and 250 Å in the former case, which were then larger in the latter case 
especially as to the short dimension (by ~ 40 Å). 
Interestingly, we observed a propensity for ‘dimeric’ shapes, broadly similar to previous 
rotary shadowing electron microscopy visualisations of BRCA266. The observation then that 
the sizes of BRCA2–RAD51 particles was consistent with these, suggested that at the very 
least RAD51 binding did not dissociate the BRCA2 ‘dimers’. 
Either of the particles was rather elongated, with those of BRCA2–RAD51 being ‘wider’ 
in the other two dimensions. This lent a ‘dumbbell’ or ‘kidney-bean’ appearance to BRCA2 
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(Fig. 16a - right), whereas a more ‘heart-‘ or ‘V-shaped’ appearance to BRCA2–RAD51 
(Fig. 16b - right). 
With regard to antibody labelling, complexes were constituted using low concentrations 
of antibodies (i.e. 10–30 nM, with ~5 nM BRCA2), in order not to saturate the micrographs’ 
background with antibody particles – see §2.4. As a result, only a fraction of the observed 
particles had visibly bound antibodies (~5%), and in turn the number of particles where both 
‘monomers’ had antibody attached was exceedingly low. The situation was slightly different 
in case of BRCA2–RAD51 particles as each particle presumably had multiple sites to which 
(anti-RAD51) antibodies could bind. 
In any case, having a singular antibody bound per particle, enabled easier adjudgement of 
the antibody’s point of binding on the particle’s projection, by eliminating confusion arising 
from several attached antibodies. 
Likewise for BRCA2-gDNA complexes, we detected approximately one particle with 
DNA bound per scanning every two frames, further compounded hereby by the inevitable 
difficulty in identifying and unambiguously tracing naked DNA under negative stain condi-
tions, especially in complex with proteins. 
Incidentally, DNA is better observed (with higher contrast), in cryo- rather than negative 
stain EM, due to lack of interference by heavy metal ions or ‘masking’ by uranyl acetate 
nano crystallites. 
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Figure 16. Example transmission electron microscopy captures of negatively stained 
BRCA2 (a) and BRCA2–RAD51 (b) samples, and selections of particles therefrom. 
Whilst some heterogeneity in terms of aggregates and degradation products can be 
seen, the presence of a homogenous species therein is evident. With BRCA2 a prepon-
derance of dimeric shapes is observed (a, right), which then remains consistent with 
BRCA2–RAD51 (b, right), except that the latter appear ‘fatter’. 
3.2.2 MSA and classification 
As can be seen in the predominant five eigenvectors of the centred dataset of 8,773 
BRCA2, and 6,877 BRCA2–RAD51 particle images (Fig. 17a, b); a stark 2-fold component 
is obvious in the second and third eigenimages of the former, and the second, third, and 
fourth such images of the latter that is suggestive of a dimeric species. 
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It is worth reiterating here that the first eigenvector represents the sum of a collection of 
particle images, which in the above cases had only been subject to ‘centring’ (i.e. reference-
free alignment), and thus appears as a ‘disc’ since the particles’ rotational orientations had 
remained arbitrary. Its diameter however can be used as measure of the particle’s size, and is 
visibly larger for BRCA2–RAD51 than for BRCA2. The observation that a two-fold rota-
tional symmetry was apparent in the very next few eigenimages, was indicative of the 
specimens’ oligomerisation state being that of a dimer. Nonetheless, symmetrical eigen-
images can be incidental and/or spurious, and hence their implication was treated with 
caution and not presumed. 
Following initial reference-based alignment, the first eigenvector appears increasingly 
characteristic of the particle’s shape (including in this case exhibiting two-fold symmetry) as 
opposed to merely its size, as the particles get rotationally as well as translationally aligned. 
A two-fold symmetry in the molecules, was also apparent in the MSA and HAC derived 
class averages, i.e. prior to either commencing 3D-based MRA, or imposition of C2 sym-
metry on the structures.  
It should noted that two-dimensional projections of a three-dimensional object with 2-fold 
cyclic symmetry, do not possess two-fold symmetry in themselves, unless either along or 
perpendicular to the symmetry axis of the 3D object, in which case they will display 2-fold 
rotational symmetry and mirror symmetry respectively. Though one could detect clear two-
fold symmetry in class averages along such angles; it is usually also intuitively apparent 
from ‘intermediate’ views if the projections are derived from a three-dimensional molecule 
with C2 symmetry. 
As rounds of MRA, MSA, and HAC based classification progressed, class averages de-
picted visible improvement in terms of SNR, the variety of views depicted, intra-class 
variance, (i.e. becoming gradually more faithful), and observable detail – that are indicative 
as to an improvement along the refinement process. 
Viewing individual particles constituting the class averages, one could see that by the fi-
nal rounds of MRA followed by MSA and HAC (or projection matching) based 
classification; particles comprising most individual classes were quite homogeneous and re-
sembling of the averages (see Fig. 17c, d), reflective of more accurate alignments and 
convergence of the refinement procedures – especially given the low SNRs of most particles 
images and artefacts of negative stain. 
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Figure 17. Multivariate statistical analysis and classification. The five predominant 
eigenvectors of the centred dataset of 8,773 BRCA2 (a), and 6,877 BRCA2–RAD51 
particles (b). Images 2 and 3 in the former, and 2, 3 and 4 in the latter show clear 2-
fold symmetry, suggestive of such a component within the particles themselves (i.e. 
dimers). These in fact constitute the first non-trivial vectors of the data, as the very 
first eigenimage denotes the total average of the particle images (and hence looks cir-
cular). Image 5 in either case might be indicative of the sub-optimal centring of a 
subset of particles. The latter is then larger for BRCA2–RAD51 than BRCA2 reflective 
of its bigger size. From toward the ending stages of BRCA2 (c) and BRCA2–RAD51 
(d) refinements, a selection of 10 class averages (top) and 5 individual particles from 
each (below), reveals the former to be representative of the latter (i.e. not a spurious 
summation of noise and/or inaccurately aligned/classified particles). 
3.2.3 Angular assignment and particle alignment 
As rounds of MRA and MSA/HAC-based classification followed by averaging pro-
gressed, anchor-set based Euler angle designations of the class averages improved alongside, 
i.e. the percentage error in individual angular assignments decreased, whilst the spread of 
‘views’ widened, and the averages’ α angles settled close to 0° – a good signifier as to the in-
plane parameters being eliminated through repeated alignments. All such developments con-
stituted indicators as to an improvement along the refinement process. 
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Toward the end, angular reconstitution Euler angle designations of the class averages 
were accurate and precise enough so as not to necessitate significant adjustment and fine-
tuning via miniature refinements (as in §2.5.4.7.1), yielding increasingly little change or im-
provement. Their extent was therefore reduced during these stages. 
At the end of this phase for BRCA2, the average angular reconstitution error of the set of 
1000 class averages that were created was 21.31%, and 18.55% for the 80% best. The angles 
were very well distributed over the Euler sphere by the expectations of negative stain elec-
tron microscopy (see Fig. 18a), with only a handful of devoid views – principally a cluster 
situated close to (90°, 0°), and to lesser extent (135°, 0°) and (45°, 0°), i.e. the ‘head-on’ side 
view, and 45° tilts from the equator toward the north and south ‘poles’. These represented 
387 of the above averages that were used to generate the reconstruction, which was then car-
ried over to the final projection matching step. 
The spread was even more uniform for BRCA2–RAD51 (Fig. 18b), with no notably ab-
sent views. Hereby, they represented 211 of the 294 class averages used to create the 
reconstruction that was taken forward to the first of the projection matching steps. 
Adoption of ‘preferential orientations’ by fixated molecules can be a concern in negative 
stain EM117, especially for elongated molecules such as the ones here. The presumption being 
that these particles would ‘roll’ along their long axes, and for instance prefer not to ‘stand’ 
on their ends. This situation is clearly avoided in cryo-EM, whereby particles are flash fro-
zen in random orientations. And indeed a vastly uneven distribution of orientations can cause 
artifacting in the structure, as a result of poor sampling. However, it should be considered 
that gravity has negligible influence at molecular scales, which would facilitate such a state 
of affairs. Rather, the distribution of charge over the molecule and the grid’s carbon support 
should wield by far the greatest effect. Therefore, it would not seem reasonable to expect 
particular views on purely geometric bases. 
At the projection matching stages, there were no references to which any particle failed to 
align; i.e. for all 578 angular orientations at 6° separations over (half) the Euler sphere in 
case of BRCA2, and 214 followed by 578 at 10° and 6° separations respectively in the case 
of BRCA2–RAD51. However, naturally some of the resulting classes were more ‘populated’ 
than others. 
Because of this, projection matching derived class averages shall evidently be evenly 
spaced in angle, as the unequal distribution of particles within the classes shant be reflected. 
As a result, angular maps so obtained are perhaps less meaningful than those using angular 
reconstitution, as the latter works by interpolation and consequently does not ‘force’ particles 
into predefined Euler angles. 
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Nonetheless, the failure of no one particle to not get assigned to a particular reference out 
of up to 578, was indicative of a good spread of views amongst the particle datasets. 
a 
 
b 
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Figure 18. Distribution of Euler angles of the 387 and 211 class averages of BRCA2 (a) 
and BRCA2–RAD51 (b) respectively, which constituted the last 3D reconstructions 
derived via MSA-based classification, averaging and anchor-set based angular as-
signment. Due to C2 symmetry only half the Euler sphere is relevant and is shown. A 
fairly even spread of views is apparent in either case, with only comparatively scarce 
coverage in a few areas for BRCA2; whilst no regions like such are obvious in the 
case of BRCA2–RAD51. It should be minded that as a price paid for 2D projection of 
the Euler (hemi)sphere, the scaling is non-linear and much more compressed toward 
the periphery than the middle, which exaggerates the angular spacings closer thereto. 
3.2.4 Structures of BRCA2 and BRCA2–RAD51 
As 3D refinements advanced, the reconstructions exhibited improvement in a number of 
respects. The agreement between class averages and their corresponding reprojections be-
came more exact, and hence the correlation error between the two decreased; whilst the 
observable detail amongst them increased. A greater percentage of averages as well as num-
ber of particles could be incorporated in the structures, drawing on a bigger proportion of the 
image datasets, i.e. either by visual adjudication, or a criterion such as an upper bound on the 
3D error between class average and reprojection for meriting inclusion. 
Despite the additional inputs, there was an accompanying reduction in the average corre-
lation error in the 3D reconstructions, all of which could be considered signifiers of a 
globally convergent refinement in entropy space. 
For BRCA2, 387 of the 1000 class averages were included in the last 3D reconstruction 
derived by MSA/HAC-based classification and averaging, and assignment of Euler angles by 
angular reconstitution. This model possessed an overall 3D error of 35.69%, i.e. the mean 
correlation error between the individual averages and their reprojections, and was carried 
over to the projection matching stage.  
The concluding structure obtained after projection matching (with binary masked class 
averages), incorporated 568 out of the 578 averages, i.e. the vast majority of the particle da-
taset, and possessed an average correlation error in the map of 18.22%. All of these class 
averages displayed excellent, i.e. close to perfect, correspondence with their respective 
reprojections (see Fig. 19a, ii). 
The reconstruction itself shows an elongated molecule, with maximum dimensions of ~ 
250 Å (length) × 135 Å (width) × 120 Å (height) – see Fig. 19a, i. This comprises main den-
sities that form smooth arcs at the far sides of the molecule, and antiparallel elongated 
densities along the side rims that connect the two halves and cage a central space, as seen 
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from the concave face (i.e. top view). This lends the molecule a distinctive overall ‘jelly 
bean’ appearance, which is apparent in the side view and tilts thereof, i.e. with a groove in 
the middle, but also a relatively flat base. When observed from the bottom view, one sees 
densities from the adjacent halves enclosing a central rectangularly shaped ‘channel’. The 
two halves corresponding to monomers themselves resemble ‘scoops’ and pack together in a 
‘yin-and-yang’ arrangement to constitute the dimer. 
The binary masked structure, at the density rendering threshold that yields 1.2× the cor-
rect mass (for the reasons in §2.5.4.7.3), provides a volume of 1,090 nm3, and a surface area 
of 1,430 nm2. Whilst this probably more or less compensates for the former, the latter likely 
remains a marked underestimate due to the absence of secondary structure elements at the 
resolutions concerned. 
In the case of BRCA2–RAD51, ultimately 211 out of 294 class averages were included in 
the reconstruction derived via MSA, HAC and averaging, and anchor-set based angular as-
signment. This 3D had a mean correlation error between the averages and their reprojections 
of 24.22%, and was carried forward to the next (projection matching) step. 
The ending structure, obtained after two rounds of projection matching, incorporated 553 
of the 578 class averages; and contained a 21.28% average error in the map, again using bi-
nary masked class averages, and comprising the vast majority of the dataset. And as before, 
the averages showed outstanding, close-to-exact agreement with their corresponding repro-
jections (Fig. b, ii). 
Once again, the structure revealed a prolonged shape (Fig. 19b, i), i.e. with two halves 
connected by extended densities along the outer rims of the central cavity; albeit being 
slightly longer by ~15 Å (i.e. 265 Å), noticeably wider by 30 Å (165 Å), and substantially 
taller by 45 Å (again 165 Å) than BRCA2. Apparent in the side view, was the appearance of 
extra density along the sides of the central cage, which contributed to the added width, and 
the disappearance of a clear middle groove. Also evident was a steeply sloping underside, 
which culminated in a pointed ‘tip’ at its base, i.e. as opposed to being flat as previously. 
These gave the reconstruction a more inverted triangular appearance. And in the top view, 
this now resembled a parallelogram. Furthermore, the central ‘channel’ could no longer be 
found in the bottom view. 
The binary masked map, rendered at a contour level that as before provided 1.2× the ex-
pected molecular mass (as also derived by STEM measurements), yielded a volume and 
surface area of 1,560 nm3 and 1,800 nm2 respectively. And likewise, whilst the former is 
probably approximately accurate, the latter is most likely a considerable underestimate. 
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Due to the overall change in shape in comparing the two reconstructions, and thus an ap-
parent tertiary reorganisation in going from BRCA2 protein to the BRCA2–RAD51 
complex; it is not manifestly obvious which density in the latter corresponds to RAD51, as 
one could not then simply perform a difference map for this purpose. To assist with this, and 
the fitting of BRCA2 into the BRCA2–RAD51 structure, we employed our anti-BRC and 
anti-RAD51 labelling results (as detailed in §3.2.7 and §3.2.8). 
It must also be stated that the BRCA2 and BRCA–RAD51 reconstructions were carried 
out entirely independently, without using projections of the former as references for either 
alignment or angular assignment of the latter’s particles, in order to prevent the well docu-
mented phenomenon of model bias118–120 (as mentioned in §2.5.4.1 and §2.5.4.6.2). 
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Figure 19. 3D reconstructions of BRCA2 (a) and the BRCA2–RAD51 complex (b). (a i) 
The BRCA2 structure shows a dimer with significant densities on the far ends of an 
elongated molecule. The region of less mass in the middle comprises two prolonged 
antiparallel densities along the sides of the molecule that connect the two presumedly 
monomeric halves of the structure. This constitutes a central groove in the structure 
that gives the molecule its roughly characteristic kidney-bean shape, albeit with a flat 
base at the bottom comprising a cavity, formed by two distinct regions of density 
packed in a rectangular arrangement. The monomers themselves pack in a head-to-
tail conformation to constitute the dimer. (ii) A representative selection of 20 of the 
C 
R 
S 
C 
R 
S 
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568 (binary masked) class averages (C) contributing to the reconstruction, displaying 
excellent agreement with their corresponding reprojections (R) from the (spherically 
masked) structure. This theme was maintained throughout the full set of averages and 
reprojections. The respective surface views (S) from the binary masked structure are 
also shown. (b, i) The BRCA2–RAD51 complex has a more distinctive overall triangu-
lar appearance, without a channel at the bottom or a clear V-shaped groove in the 
middle (c.f. BRCA2). Whilst the former is indicative of conformational change, the lat-
ter indicates RAD51 binding, as its place is now assumed by extra density along the 
side rims of the structure. (ii) 20 illustrative class averages out of the 553 constituting 
this reconstruction and their respective reprojections, once again displaying excellent 
correspondence – as throughout the entire set. As before, surfaces are also shown. In 
either case, the class averages (C) are hardly distinguishable from the reprojections 
(R). 
3.2.5 Resolution 
FSC calculations differ based on the kind of mask imposed on the half reconstructions121, 
and the filling degree of the structure inside the volume. For instance, binary masked recon-
structions shall produce the highest correlation values, whilst unmasked maps the least. 
Various programs will also differ in the way they take into account of the structure’s filling 
degree, while some might not do so at all. Furthermore, all else being the same, FSC values 
still differ – presumably owing to the slightly different correlation algorithms amongst the 
programs. 
Values of resolution will then of course vary depending on the threshold criterion em-
ployed. For 3σ and ½-bit curves, their calculation in turn depends on the specified imposed 
symmetry of the reconstructions. Symmetry averaging creates correlations that these criteria 
compensate for, which fixed value criterions obviously do not. 
Scaled FSC (i.e. FSC’, see §2.5.4.9) may also be used, which accounts for the higher 
SNR in the combined reconstructions. Its use is most often found in ‘gold-standard’ FSC 
calculations, whereby its rationale is very well established. 
For the sake of consistency, in our case all Fourier shell correlations were performed us-
ing spherically soft masked half-reconstructions (of radius 0.7× the box width) in IMAGIC, 
intended as a compromise between the potentially optimistic and pessimistic FSC values 
provided by binary and unmasked models respectively. The molecules’ filling degree of 0.6, 
and C2 symmetry (in applicable stages) were also specified. For assessment of resolution, a 
blanket criterion of the fixed 0.5 threshold was applied (though other curves were retained 
for reference purposes). This was intended to yield conservative values, in light of the semi-
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independent FSCs utilised, whereby the half-reconstructions are already biased toward the 
previous 3D model (having been obtained from class averages derived from particles aligned 
to a common template). These data were then rendered using an Excel macro created by Dr 
Timothy Grant§. 
 The resolution as determined by Fourier shell correlation using the 0.5 criterion, then 
gave rise to a value of 18.4 Å for BRCA2 and 19.5 Å for BRCA2–RAD51 (see Fig. 20). At 
~19 Å, these are close to the physical limits of negative stain electron microscopy, whereby 
the size of uranyl acetate crystallites tends to impose a lower bound of ~18 Å on these sam-
ples115, and thus far less limited by either the size of the datasets or quality of the 
preparations. 
 
 
 
Figure 20. FSC coefficient and resolution criteria plots for the finalised BRCA2 and 
BRCA2–RAD51 reconstructions. FSCs are calculated from spherically masked half 
reconstructions, albeit from binary masked class averages. The 0.5, ½ bit, 0.143 and 
3σ threshold curves are overlaid. From their intersections with the FSC curves one 
obtains resolution values of 18.4, 15.2, 13.5 and 12 Å for BRCA2, and 19.5, 16.0, 14.2 
and 13 Å for BRCA2–RAD51 respectively. Higher resolutions (lower values) toward 
the +ve x-axis. 
                                                      
§ Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA. 
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3.2.6 Structural validation 
Due to the difficulties of tilt-pair analysis in negative stain electron microscopy, we 
adopted the modified ‘tilt-pair series’ approach as our primary means of validation of the 
reconstructions, as explained in §2.5.4.10. 
Thereby, the observation that the measured tilts lay as close as an average ~2° of the ex-
pected tilts in the best cases for both, verified the overall correctness of the structures (Fig. 
21a, i). The values were then (2.4 ± 1.4)° for BRCA2, and (1.6 ± 1.4)° for BRCA2–RAD51 
– see Fig. 21a, ii. 
Tilt-angle determinations were more accurate in the case of BRCA2–RAD51 complex in 
general, presumably facilitated by its larger size and more distinctive shape. 
Three and two such series for BRCA2 and the BRCA2-RAD51 complex respectively 
were analysed. 
We had also carried out conventional tilt-pair analysis on both samples (Figs. 21b & c). 
We selected particles from each tilt set (untilted and tilted) that were in agreement with pro-
jections from the corresponding model along the same angles as they (to check for correct 
angular assignment), and independently calculated the tilt angle for each of the pairs of pro-
jections using the formula derived in §2.5.4.10. 
For 0°/+20° tilt pairs, in the case of BRCA2 (Fig. 21b, i); of the 45 pairs selected a clus-
ter of 32 exhibited a mean tilt of (25.6 ± 19.8)°, from which a further subset of 26 then 
displayed a tilt of (18.6 ± 14.6)°. On the other hand, the full set of 45 pairs gave an average 
tilt of (40.9 ± 30)°, skewed greatly by a number of large outliers. For BRCA2–RAD51 (Fig. 
21b, ii); of the 30 selected pairs, 26 produced a mean angular difference of (25.7 ± 16.7)°, 
with a smaller subgroup of 22 yielding (21.2 ± 13.9)°, and a yet smaller one of 20 giving 
(18.9 ± 12.4)°. The complete set of 30 provided an average tilt angle of (30.6 ± 20.0)°, again 
influenced highly by a few big outliers. A consistent theme of more accurate (but not more 
precise) measurements, from a larger proportion of the selection, was observed in the case of 
BRCA2–RAD51 complex compared with BRCA2 alone. 
For –20°/+20° datasets, in the case of BRCA2 (Fig. c, i); 43 tilt pairs were selected, of 
which a 35 strong subset that excluded outliers produced a measurement of (34.5 ± 22.1)°. A 
still tighter cluster of 22 yielded (37.3 ± 15.3)°. The set of 43, i.e. incorporating anomalous 
tilt values, gave an overall value of (43.4 ± 31.6)°. In the case of BRCA2–RAD51 complex 
(Fig. c, ii); again 43 pairs were selected, which altogether produced a measurement of (32.7 
± 26.3)°, while a subset therein of 23 gave a value (36.9 ± 16.5)°. Improved determinations 
for BRCA2–RAD51 were thus again obvious hereby. 
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The outliers in each case consisted mostly of upper extreme outliers, i.e. tilt values >90°, 
but present also were lower far outliers, such as values of 0°. 
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The linked image cannot be displayed.  The file may have been moved, renamed, or 
deleted. Verify that the link points to the correct file and location.
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Figure 21. Tilt series (a), and tilt pair (b, c) analysis. (a, i) Particles from 0–40° tilt 
series with 5° steps, of BRCA2 (top) and BRCA2–RAD51 (bottom), and matching 
reprojections with measured angles indicated. (a, ii) Table indicating the applied ver-
sus measured tilts for each of the tilted particles, of BRCA2 (left) and BRCA2–RAD51 
(right). The difference for each pair is indicated, as well as their mean/standard de-
viation calculations. Measurements are stated to one decimal place. (b, i) Selected 0–
20° tilt pairs of BRCA2, and matching reprojections with Euler angles shown. Calcu-
lated tilt angles are denoted. These examples have measured tilts close to 20°. As can 
be seen (c.f. matching reprojections), a 20° tilt of the BRCA2 structure can entail very 
little change in its projection (§2.5.4.10). (b, ii) Same for BRCA2–RAD51. These ex-
amples too have measured tilts of ~20°, and as seen here, a 20° tilt of the BRCA2–
RAD51 structure tends to yield slightly more distinct projections. In either case refer-
ences are rotated to match the particles. (c, i) Selection of 0–40° BRCA2 tilt-pairs, 
matching reprojections with angles, and calculated tilts. (c, ii) Same for BRCA2–
RAD51. In these cases particles are rotated to match the references. Various filterings 
and maskings are depicted. 
3.2.7 Structural domains 
In order to identify various domains within the structures, we had utilised antibody label-
ling (as in §2.4). Specifically, we used an antibody against the C-terminal Flag tag of 
BRCA2, and another between BRC5 and BRC6 (Fig. 22a). Furthermore, we employed an 
antibody against RAD51 in the BRCA2–RAD51 complex. We did not find other good 
(monoclonal) antibody candidates against BRCA2 as tested through immunoprecipitation 
experiments. 
Thereby, we then focused on particles with a single bound antibody, to reduce ambiguity 
in positional assignment of the antibody’s binding site in the particle’s projection. However, 
this was helpful as well for angular assignment of the particles themselves, as a crowd of 
antibodies would often render a particle’s boundary somewhat ambiguous and hence unfa-
vourable to accurate masking. Nonetheless, as they were all too many, we did analyse 
several cases of particles bound to multiple antibodies for BRCA2–RAD51. 
Euler angles were assigned to particles with attached antibodies, as per the respective 3D 
map’s projections. Using these angular designations and the locations of the antibodies, we 
then derived their (three-dimensional) positions on the respective structures via (a manner 
of) triangulations – as discussed in §2.5.4.11 (see Figs. 22b-d). 
From these we saw that BRCA2’s C-terminus was situated on the top surface towards the 
far ends of the dimer (Fig. 22b). Similarly, we found the anti-BRC antibody was located on 
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b, ii 
the side rim of the structure, but toward the main monomer density (Fig. 22c), i.e. indicating 
that BRC repeats lay along these elongated densities. The latter would also suggest the extra 
density responsible for RAD51 was that observed on the outer rim of the BRCA2–RAD51 
reconstruction (between the two globular monomeric halves). To test this, we labelled the 
BRCA2–RAD51 complex with an anti-RAD51 antibody. 
We did indeed then find these to be positioned along the side rims of the BRCA2–
RAD51 structure (Fig. 22d). However, they proved harder to localise to specific points, pre-
sumably due to the multiple antibody targets within this complex, which meant they could 
label the several cognate RAD51 monomers in any permutation. Regardless, the results indi-
cated that RAD51 molecules were bound about the central cage region (on either side), 
toward the top of the structure. 
a 
 
 
b, i 
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Figure 22. Antibody complexes and identification of structural regions. (a)  Field of 
antibodies (left), and selected antibody particles (right). The globular oval domains 
are most often times visible, but appear markedly flexible relative to each other. (b, i) 
A selection of three BRCA2-CFlag particles bound to anti-Flag antibody (left, circled 
blue), matching projections from the reconstruction (middle), and their corresponding 
surface views (right). Where the antibody meets the particle’s projection, a cylinder 
(also blue) is inserted at right angles into the surface. (b, ii) The result upon many 
repetitions creates an overlap of cylinders where the antibody is located (top), which 
is then highlighted (below). (c, i, ii) The similar process for BRCA2 labelled with anti-
BRC5/6 antibody (magenta), and BRCA2–RAD51 bound to anti-RAD51 antibody (d, i, 
ii, gold). Coloured areas then indicate the regions as identified for BRCA2 and 
BRCA2–RAD51, i.e. the BRCA2 C-terminus (blue), BRC5/6 (magenta), and RAD51 
(yellow/gold). 
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3.2.8 Fitting, conformational change in BRCA2 on RAD51 binding, and handedness 
The localisation of both BRC repeats and RAD51 along the outer rims of the BRCA2 and 
BRCA2–RAD51 reconstructions respectively, provided inter-consistent evidence as to each 
other’s locations within the two structures (§3.2.7 and Figs. 22c & d). 
Since RAD51 bound at the top of the BRCA2 dimer, the altered shape at the bottom of 
the BRCA2–RAD51 reconstruction is thus presumably owing to BRCA2, suggesting the 
occurrence of an induced reconfiguration of the BRCA2 molecule upon binding to RAD51. 
The underside slope of the BRCA2–RAD51 complex, indicates there having been a tilt of 
the BRCA2 monomers toward the vertical axis (i.e. in relation to the dimer plane) – see Fig. 
23a. In BRCA2, the bottom channel is constituted by two L-shaped densities, which we posit 
are each contributed by a BRCA2 monomer. The closure of this channel in the complex then 
seems to be brought about by a reorganisation of the L-densities, so as to become more 
closely associated in an intercalated arrangement (Fig. 23b).  
We implemented the above changes in Chimera, via segmentation of the BRCA2 recon-
struction into two presumedly monomeric halves, and their independent fitting into the 
BRCA2–RAD51 density. This resulted in an increase in correlation coefficient between 
BRCA2–RAD51 and the BRCA2 models from 0.64 to 0.78. Although some uncertainties 
remained as to the exact boundary between the two BRCA2 monomers, it was largely appar-
ent the conformational change had predominantly entailed a rotational and tilting motion on 
part of the monomers in order to accommodate the steep slope along the sides of the com-
plex and its pointed tip.  
Modelling this rearrangement spared the antiparallel side densities along the top of 
BRCA2–RAD51’s structure, i.e. those connecting its main polar densities, which had been 
identified previously as belonging to RAD51 via antibody labelling (cf. §3.2.7 and Fig. 22d). 
The two extra density regions could then each accommodate approximately four RAD51 
monomers arranged in a filament-like fashion (Fig. 23c)49. For its potential significance and 
implications, see discussion in §4.2. 
Hereby, we also adjudicated as to the likely handedness of the BRCA2 reconstruction, by 
splitting the two mirrors into their monomeric halves and gauging how well they could be 
modelled into the BRCA2–RAD51 structure, whose handedness we had in turn adjudged on 
the basis of fitting of the Rad51 filament crystal structure49. We found the opposite BRCA2 
mirror to the one hereby described failed to provide a sensible fit. 
The above steps were performed by Prof Xiaodong Zhang, MSF Laboratory, Faculty of 
Medicine, Imperial College London, South Kensington, UK. 
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Figure 23. BRCA2’s binding to RAD51. (a) Interlay of BRCA2 dimer (cyan and yellow) 
and BRCA2–RAD51 (pink mesh) structures, highlights occurrence of conformational 
change. (b) Rearrangement of BRCA2 dimer inside the BRCA2–RAD51 complex in-
volving a rotation and tilt of BRCA2 monomers. (c) This leaves extra density in the 
BRCA2–RAD51 structure that accommodates two oppositely directed sets of ~4–5 
RAD51 monomers in a filament-like manner (orange ribbon). Handedness was as-
cribed to BRCA2 on the basis of its fitting into BRCA2–RAD51, whose determination 
was in turn based on the fit of RAD51 therein. 
3.2.9 STEM mass measurements 
To affirm BRCA2 remained a dimer upon RAD51 binding, we performed molecular mass 
measurements of the BRCA2–RAD51 complex by means of scanning transmission electron 
microscopy – as in §2.5.4.8. 
A histogram of individual mass values (see Fig. 24), binned at 50 kDa intervals, and 
ranging from 0 to 1600 kDa; revealed two subpopulations at ~800 kDa and ~1200 kDa re-
spectively, i.e. consistent with a BRCA2 dimer, as well as a dimeric complex. With regards 
to the former, we believe the process of repeated washings during STEM specimen prepara-
tion partly dissociated the complex. 
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By fitting two separate Gaussians functions to the histogram (i.e. one for each peak), as 
well as a double Gaussian distribution (the sum of the two); we derived molecular mass 
measurements of 760 ± 220 kDa for BRCA2, and 1240 ± 110 kDa for BRCA2–RAD51. 
These data are therefore congruent with a BRCA2–RAD51 complex in which a set of ~4–
5 RAD51 copies is bound per BRCA2 (§1.6), i.e. in a 2-fold arrangement as discussed 
above. 
 
 
 
Figure 24. Histogram of mass determinations and statistical analysis. An independent 
Gaussian curve is fitted corresponding to either subpopulation, such that their cumu-
late provides the optimum fit for the entire bimodal distribution (viz. double Gaussian 
dissociation). The two peaks were measured to be centred at 760 ± 220 kDa (BRCA2) 
and 1240 ± 110 kDa (BRCA2–RAD51). This is commensurate with a BRCA2 dimer, 
and the binding of each monomer to ~4–5 RAD51s in the BRCA2–RAD51 complex. 
The number of particles able to be analysed was rather low, which perhaps contribut-
ed to the relatively large measurement errors (but that could also have been owing to 
heterogeneity). This implementation was performed in OriginPro 9.1 (OriginLab, 
Northampton, Massachusetts, USA). 
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3.2.10 BRCA2–ssDNA 
Alongside recombinase binding, the most important property of BRCA2 as a recombina-
tion mediator, is binding to single-stranded DNA, i.e. as opposed to double-stranded DNA. 
This preference is critical, as RAD51 itself binds ss- and duplex DNA with similar affinities; 
and is therefore dependent on BRCA2 for loading onto its rightful substrate.66 
To characterise BRCA2’s ssDNA binding, the minimum required length of single-
stranded DNA for binding to BRCA2, was probed in the West laboratory. Using 32P-
labbelled oligonucleotides of defined lengths (i.e. 20–100 nt) and electromobility shift assays 
– see Fig. 25a, it was discovered that at least ~50 nucleotides were requisite for the for-
mation of a stable BRCA2–DNA binding, although longer oligos of >66 nt were needed for 
maximal binding. Minimal to no binding was seen with ssDNAs shorter than 40 nucleotides. 
In comparison, previous analysis of the BRCA2 DNA-binding domain alone68 (§1.5.6 and 
see later in §4.1); found it bound 12–20 nt of ssDNA weakly, with stronger binding occur-
ring at 36 nucleotides. Our assays are therefore consistent with the notion whereby stable 
association of single-stranded DNA to BRCA2 necessitates the former’s synergistic binding 
to both monomers of the latter. 
In our group, we visualised BRCA2–gDNA complexes under negative stain electron mi-
croscopy and analysed these through 2D image processing (Fig. 25b), in order to elucidate 
the course of single-stranded DNA bound across the BRCA2 dimer, i.e. as detailed in §2.2 
and §2.5.4.11. 
We discover the relative positions of flanking dsDNA arms about BRCA2 molecules 
bound to the intervening single-stranded DNA, were consistent with a scenario whereby 
ssDNA bound along the long-axis of the dimer at its top surface; which in turn is compatible 
with the positioning of the C-terminus on BRCA2 as determined by antibody labelling 
(§3.2.7), i.e. since it is close to the DBD (being <7% of the sequence length away). 
 
 
a 
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Figure 25. ssDNA binding of BRCA2. (a) BRCA2’s binding to 5’ 32P-labelled ssDNAs of 
lengths 20–100 nt as assessed by EMSA. BRCA2 exhibits nominal binding to ≤ 40 nt, 
stable binding with 50 and 66 nt, but strongest binding only at ≥ 74 nt, suggesting 
their simultaneous binding to either BRCA2 monomer. (b) A selection of five BRCA2 
particles bound to gapped DNA substrates (left column), matching projections from 
the structure (middle), and corresponding surface views (right). dsDNA arms are 
highlighted in the particle images (orange dots), and in accordance with matching 
projections, traced onto the surface views (orange lines) for interpretation. These then 
demonstrate that ssDNA binds along the long axis of the BRCA2 dimer at its top sur-
face. 
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3.2.11 BRCA2–RAD51–ssDNA dynamics (West laboratory**) 
3.2.11.1 Filament frequency and length 
We sought to visualise the precise effect of BRCA2 on RAD51–ssDNA filaments via 
negative stain electron microscopy (Fig. 26a, b). 
On investigating initial nucleation events, there were found to be ~4× nucleoprotein fila-
ments in the presence of BRCA2 than without, having quantified 149 and 204 randomly 
collected frames of the former and latter respectively (giving P < 0.0001 by a two-tailed t-
test) – see Fig. 26d. 
However, relatively short filaments (40–100 nm) were observed either with or in the ab-
sence of BRCA2, and measurement of 332 of the former and 314 of the latter, revealed no 
appreciable difference in length between the two, i.e. either as an average, or using 20 nm 
bins from 0–120 nm followed by a singular > 120 nm bin (Fig. 26c). 
 
Figure 26. Nucleation of RAD51–ssDNA filaments by BRCA2. Difference in the number 
of nucleation events in absence (a) versus the presence of BRCA2 (b) as seen by nega-
tive stain electron microscopy. Right hand columns show enlargements of 
nucleoprotein filaments. Quantifying lengths, and difference in the number of such fil-
                                                      
** Except §3.2.11.2.1. 
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aments per frame, revealed no appreciable change in the former (c), but a 4-fold sig-
nificant increase in the latter (d). Blue and red bars denote RAD51–ssDNA filaments 
with and without BRCA2 respectively. Scale bar (black) indicates 100 nm. 
3.2.11.2 Filamentisation polarity 
As discussed earlier (§1.6 and §3.1), the BRCA2–RAD51–ssDNA ‘supercomplex’ is 
transient, and does not occur stably66. 
Nonetheless, remarkable findings were made in visualising BRCA2–RAD51–ssDNA 
samples under negative stain EM, i.e. the observance of RAD51–ssDNA filaments with 
BRCA2 clearly situated at one end (Fig. 27c). The latter were confirmed to indeed be 
BRCA2 particles using a monoclonal anti-Flag antibody coupled to 20 nm gold particles 
(Fig. 27d). However, at longer reaction time points such terminal BRCA2 particles were de-
tected only infrequently, indicating its dissociation once nucleoprotein filament formation 
had been established, as per the theorised model. This was a striking demonstration of a hith-
erto unknown mono-directional growth of these filaments from BRCA2. To determine the 
polarity of filament growth itself, ssDNA molecules were gold-labelled at either their 5’ or 
3’ termini. Electron microscopy analysis revealed that RAD51 filaments invariably extended 
toward the 5’ gold-labelled end – see Fig. 27e. By contrast, using ssDNA with 3’ gold label, 
similar complexes oriented in the other direction (i.e. 5’–3’), failed to be observed. 
 Our obvious interpretation of these results was hence that BRCA2 promoted unipolar 
RAD51–ssDNA filament growth out of nucleation foci in a 3’–5’ direction, consistently with 
the likewise polarity of DNA strand exchange (relative to the bound ssDNA) that takes place 
later. 
For a description of how the above is in agreement with our structural data, especially 
that concerning BRCA2 and BRCA2–RAD51’s seemingly dimeric nature, see discussion in 
§4.2 and §4.3. 
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Figure 27. Polarity of RAD51–ssDNA filament growth. EM visualisation of RAD51–
ssDNA filaments (a) and BRCA2–ssDNA complexes (b), followed by a BRCA2–
RAD51 complex + ssDNA mixture (c) – all after short incubation times. In the latter, 
one clearly sees RAD51 filament emanating from easily distinguishable BRCA2 parti-
cles. To establish the reality of this situation, BRCA2 (d) and the 5’ ssDNA end (e) 
were in turn immunogold labelled, to enable their localisation within these structures. 
In the former case, gold particles (dark spots) are found on the globular entities cap-
ping the end of the filaments, whilst in the latter case they are situated at the far end of 
the filament from these bodies. This indicates the latter to be BRCA2, and that RAD51 
filaments issue therefrom along ssDNA toward its 5’ terminus, while BRCA2 caps the 
3’ end. 
 - 108 - 
3.2.11.2.1 Image analysis of nucleation events (Zhang group) 
By finding matching model projections and corresponding surface views for the BRCA2 
particles hereby observed capping recently nucleated RAD51–ssDNA filaments, we had 
sought to visualise the points of exit and outline paths of such filaments out of BRCA2 
(§2.5.4.13). 
Thereby, we invariably found these filaments to emerge from one side, and one end of 
BRCA2 dimers, suggesting that productive nucleation ensued from one (and only one) 
RAD51-laden monomer, i.e. that in the correct polarity for RAD51 filament growth on 
bound ssDNA – see Fig. 28. 
The sampled particles were too few for analysis to be rigorous (§2.5.4.13), but it nonethe-
less provided an interesting qualitative assessment. One should note that neither the BRCA2 
nor the BRCA2–RAD51 structures are necessarily accurate representations of the capping 
BRCA2 particles. Presumably, the BRCA2–RAD51 dimer would have offloaded half its 
cognate copies of RAD51, with the concerned BRCA2 monomer then also dissociating from 
the ssDNA – but crucially not the other monomer, which also remains bound to ssDNA. 
Therefore, these might adopt a conformation rather different to that seen in either struc-
ture. Naturally, this makes their analysis difficult, until such a time that BRCA2 can be 
purified at the gross quantities necessary to permit analysis of its and its complexes’ various 
states. 
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Figure 28. 2D processing of BRCA2–RAD51–ssDNA ‘complexes’. BRCA2 particles 
with RAD51–ssDNA filaments emanating therefrom, matching reprojections of the 
former, and corresponding surface views (left–right). Red markers indicate best 
guesses of the points of emergence of filaments on the reprojections and surfaces of 
BRCA2. The outward course of filaments in particle images is modelled onto the sur-
face views. These appear to emerge from one side, and one monomer of the BRCA2 
dimer, reflecting its proposed function.  
3.2.11.3 Multinucleation 
Intriguingly, multiple observations of linearly aligned BRCA2 particles and short RAD51 
filaments were made (see Fig. 29), presumably along the same ssDNA molecule. These sug-
gested that BRCA2 molecules, and by inference BRCA2–RAD51 complexes, bind along 
multiple sites on single-stranded DNA and seed multiple nucleation events. 
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Altogether, the data indicate that BRCA2 facilitates the interaction of RAD51 with ssD-
NA, by creating their critical mass thereon at repair foci, from which filaments then self-
polymerise in a 3’–5’ direction. In accordance with earlier work122, nucleoprotein filament 
assembly itself seems to entail a formation of multiple nucleation clusters followed by sub-
sequent ‘gap-filling, as opposed to continuing elongation from a single or small number of 
such sites.  The growth of these short nascent filaments into one extended filament capable 
of efficient homologous pairing and strand exchange, may require the action of other recom-
bination factors, perhaps in particular RAD52 but also RAD51 paralogues, RAD54, and 
PALB2. 
 
 
 
Figure 29. Observation of multiple RAD51 filament nucleations along ssDNA. Micro-
graph shows various BRCA2–RAD51–ssDNA nuclei in a linear array, presumed to be 
along a single ssDNA molecule. Though this cannot be said definitively, i.e. as the 
ssDNA itself does not get visualised, it is nonetheless likely as DNA was at an ex-
tremely low concentration, and such images were observed throughout the sample 
grid. 
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4 Discussion 
Our research offers new insights as to the role of BRCA2 in driving RAD51 nucleopro-
tein filament assembly on ssDNA during homology-directed repair, which constitutes the 
core enzymatic function of this protein123. The dysfunction of this very process in individuals 
with BRCA2 mutations, leads it to be one of a small group of the most notorious cancer-
related genes3.  
Hereby, we put forward the first structure of full-length BRCA2 protein, on its own and 
bound to its cognate recombinase RAD51. Crucially, we find that BRCA2 occurs, and is ac-
tive as a dimer. Amongst others (see §1.6), we show it binds to two sets of ~4–5 RAD51 
molecules in opposing polarities; that single-stranded DNA binds at the top surface of the 
dimer along its long axis; BRCA2 increases the frequency (4-fold), but not the length, of 
nascent RAD51 nucleoprotein filaments; and that it instigates monodirectional 3’–5’ fila-
ment growth from each nucleation site. 
To encapsulate our results in prior context, detailed below are the salient aspects of our 
proposed model of the mechanism of action of the BRCA2 breast cancer tumour suppressor, 
in view of the structural information. 
4.1 BRCA2 DNA-binding domain and RPA 
Presynaptic filament formation, strand exchange and pairing are all highly dependent up-
on RPA. It is believed this is because of RPA minimising secondary structure in single-
stranded DNA. This would facilitate recruitment/binding of recombination mediators and 
auxiliary factors, loading of RAD51 onto single-stranded DNA, and assembly of more con-
tinuous RAD51-ssDNA nucleoprotein filaments. Though RPA is needed for RAD51-
affected recombination in vitro, its stimulatory effect is minimal if granted access to single-
stranded DNA prior to RAD51. Presumably, this is owing to RPA competing with RAD51 
for the ssDNA substrate, given the former has ~100 times the affinity for single-stranded 
DNA than the latter. It is hence thought accessory factors including recombination mediators 
like BRCA2 help remove RPA from ssDNA.68 
In the study by Pavletich and colleagues of the structure of BRCA2DBD-DSS1, its ability 
to facilitate RPA-dependent recombination activity of RAD51 was too tested.68 As might be 
expected, reaction efficiency was lower when RAD51 and RPA were added simultaneously 
to ssDNA, than if RPA was added after RAD51. However, when BRCA2-DSS1 was added 
concurrently with RAD51 and RPA, catalysis of the reaction was observed as a function of 
the former’s amount. A sub-stoichiometric concentration 1/15th that of RAD51’s sufficed to 
 - 112 - 
stimulate the reaction 2.4-fold. The stimulation plateaued at 4.5-fold upon reaching 16/15ths 
the RAD51 concentration. BRCA2DBD-DSS1 also facilitated the reaction when RPA was 
added after RAD51/ssDNA, though the amount of stimulation achieved was less by 1.9-fold. 
There are manifold parallels between the BRCA2 DNA-binding domain and RPA (see 
Fig. 30). Amongst all proteins carrying OB folds, BRCA2’s are most similar to those in 
RPA, as measured by 3D homology search and visual inspection of several such proteins. 
RPA, a heterotrimeric protein, possesses two OB folds with high affinity for single-stranded 
DNA (DBD-A and -B), and two others with weaker affinity ~1/100th that of the former 
(DBD-C and -D), but which contribute to its overall binding to ssDNA. This is highly remi-
niscent of BRCA2, whereby an isolated αD-OB1 domain also has circa 100 times less 
avidity for single-stranded relative to the full DBD.68 
Structural homology is closest between the BRCA2 OB2 and RPA DBD-A domains68,124, 
the two being superimposable within 1.4 Å r.m.s.d. for 89 out of the 109 alpha-carbons. The 
second closest homology is that between BRCA2’s OB3 and RPA’s DBD-B domains, with 
an r.m.s.d. of 1.5 Å for 84 Cα atoms. These deviations are actually lower than even those 
amongst the RPA OB folds. Although OB1 of BRCA2 is more structurally divergent, its 
closest homologue is also an OB fold of RPA’s, i.e. DBD-D, of 1.9 Å r.m.s.d. for 65 Cα’s. 
 The arrangement of OB folds is also similar to those seen in the RPA-ssDNA crystal 
structure124, which shows the DBD-A and -B domains bound to oligo(dC)8. And as with 
BRCA2, RPA displays minimal affinity for oligo(dA) and oligo(dG), supposedly due to their 
high propensity for forming secondary structures68. Contacts between OB folds and single-
stranded DNA also follow the same paradigm in RPA and BRCA2 DBD. 
Furthermore, Pavletich and colleagues’ data showed that the BRCA2DBD-DSS1 com-
plex can produce two different complexes with single-stranded DNA, i.e. a strongly avid 
complex requiring the tower and involving 32- to 36-nucleotide oligo(dT), and a weaker 
complex only formed at higher concentrations entailing as few as 8 to 12  nt, and apparently 
unaffected by deletion of the tower. Remarkably, such two binding modes have also been 
demonstrated for RPA. One employs only the DBD-A and -B OB folds (as seen in the crys-
tal structure), has low affinity but high cooperativity, and has a DNA-binding footprint of 8 
nucleotides, i.e. 8-nt mode. The other mode engages all DBD domains (A/B/C/D), has high 
affinity but low cooperativity, and involves a binding site of ~30 nucleotides, i.e. 30-nt mode 
(as shown by deletion, mutagenesis, and crosslinking experiments). By analogy, it thus ap-
pears that the binding of OB2-OB3 domain to single-stranded DNA observed in the crystal 
structure of BRCA2DBDΔTower-DSS1-oligo(dT)9, represents the weak complex and mimics 
the 8-nucleotide binding mode of RPA. The strong complex could therefore form by utilising 
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the remaining DNA-binding domains of BRCA2, especially since the αD-OB1 region does 
possess some additional DNA-binding activity.68 
Provided the linker between αD-OB1 and OB2-OB3 folds, and in light of our reconstruc-
tions and the above explained identicalities between BRCA2 DBD and RPA, we believe the 
former could adopt a more compact, ‘horseshoe’-shaped overall quaternary structure like the 
latter in the context of full-length BRCA2 (Fig. 31). 
In support of the above hypothesis, heterologous fusion polypeptides comprising a single 
(BRC3 or BRC4), or multiple BRC repeats of human BRCA2, fused to the large hRPA sub-
unit, which harbours the DBD-A and -B domains – were found to significantly complement 
Brca2-deficient mammalian (hamster) cells. They suppressed spontaneous chromosomal ab-
errations, and promoted Rad51 focus formation and cell survival upon exposure to DNA 
damaging agents. It remains remarkable that as little as 2% of BRCA2 by sequence, com-
bined with RPA70 could at least partly recapitulate its function. But perhaps not surprisingly, 
some of these constructs could be considered analogues of BRCA2 in certain organisms. For 
instance, the BRC3-RPA peptide (the smallest produced) is equivalent to the single BRC 
repeat orthologues found in U. maydis (Brh2) and C. elegans (BRC-2), or those containing 
truncated DNA-binding domains (such as the latter, which lacks the tower).125 
In view of the complexity of the human genome, the RAD51 recombinase may have 
evolved to rely on BRCA2 for its localisation to sites of processed DNA double-strand 
breaks, or specific structures therein. Its lack of preference for single- over double-stranded 
DNA might hence reflect this fact.68 
 
Figure 30. Comparison of BRCA2DBDΔTower-DSS1-ssDNA68 (a) and RPA-ssDNA124 (b) 
crystal structures. The two are highly similar with regards to both structure and func-
tion, with differences only in gross quaternary organisation. Given this, and the 
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flexible linker between the αD-OB1 and OB2-OB3 domains of BRCA2DBD, leads us 
to propose that it might adopt the compact fold of RPA within the 3,418 amino-acid 
full-length BRCA2. Homologous domains are like-coloured, i.e. OB1 and DBD-D (or-
ange), OB2 and DBD-A (blue), and OB3 and DBD-B (teal). DSSI (lime green) and 
ssDNA in stick-mode (red) are depicted. 
4.2 Dimerisation and its significance 
Our data show that BRCA2 exists principally in dimeric form, and these do not dissociate 
on forming complexes with either RAD51 or ssDNA. BRCA2 then appears to bind four to 
five RAD51 monomers per each subunit, which matches or exceeds the minimal nucleation 
length needed to set off filament extension via self-polymerisation (§1.6). 
Each BRC repeat can mimic, with varying efficiencies, RAD51 interprotomer contacts 
requisite for filament and ring assemblies (§1.5.4); which suggests the notion that recom-
binase molecules are aligned by BRCA2 (§1.5.5), in a filamentous or pseudo-filamentous 
manner, in preparation for loading unto ssDNA as such. 
Due to the intrinsic two-fold symmetry imposed by the dimer, such that the monomers are 
organised in a head-to-tail conformation, the two sets of RAD51 molecules bound to the 
BRCA2 dimer would thus be oriented in opposite directions. Upon imposition of a defined 
polarity through ssDNA-binding, one set of these molecules will then be poised correctly for 
interaction with DNA (Fig. 31ii) – as RAD51 filaments grow preferentially in the 3’–5’ di-
rection (see §4.3). Despite invoking only half the bound substrate, this arrangement offers a 
mechanistic advantage, since regardless of the orientation of ssDNA binding, a dimer shall 
always present one set of recombinase molecules in the right direction for productive nascent 
filament formation. 
The potentially decreased diffusion rate of a dimeric versus monomeric species in the 
dense nuclear interior should also be of little consequence, as in the light of even a purely 
passive scenario, an added two times bulk would only slow the diffusivity by a factor of ∛2 
≈ 1.26. And given that nucleoplasmic BRCA2’s diffusion rate was demonstrated to be in the 
millisecond timeframe126 whilst DNA damage signalling and repair processes take place over 
minutes or even hours, a doubled molecular weight is unlikely to hamper the repair’s effi-
ciency – especially provided the substantial reaction benefits afforded by a dimer. 
Even though our data clearly show that human BRCA2 forms dimers in vitro (alongside 
reported evidence for dimerisation of U. Maydis orthologue Brh288), one cannot exclude the 
possibility that it might also assume a different form, e.g. in vivo, upon interaction with part-
ners such as PALB2 and/or (indirectly) BRCA1, or DNA damage or cell cycle mediated 
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post-translational modifications that may trigger a dimer to monomer transition. A similar 
mechanism has been proposed for Brh2, whereby a switch to its monomeric state occurs up-
on DSS1 binding88. In avian DT40 cells, a transition from slower-diffusing species of 
BRCA2 (i.e. large macromolecular assemblies), to ones capable of faster diffusion (smaller 
complexes), has been observed upon induction of DNA breakage126. Such transitions have 
also been proposed as regulatory mechanisms for a couple of DNA damage signallers, e.g. 
ATM and ATR (ataxia telangiectasia and Rad3-related) proteins127.  
Nonetheless, in contrast to ATM or ATR, BRCA2 dimers are active, i.e. in their case at 
RAD51 and ssDNA binding and seeding presynaptic filament formation. Whether BRCA2 
monomers too are similarly or at all active as such, remains to be seen and cannot unambig-
uously be prognosticated toward (though monomeric BRCA2 could conceivably always bind 
ssDNA in the proper orientation that allows RAD51 loading, and thus not be futile during 
half the instances – a problem that is automatically solved by the dimer). 
 
 
Figure 31. Mechanism of action of BRCA2. (i) Crystal structure of RPA in its 30 nt 
ssDNA binding mode124 (as in Fig. 21), showing a compact U-shaped quaternary ar-
rangement of its DNA binding domains/OB folds. As discussed in §4.1, the 704 a.a. 
BRCA2 DBD could adopt a similar configuration inside the 3,418 a.a. full-length 
BRCA2. Two symmetry related RPA molecules with separately coloured domains (1, 
2, 3, 4), are then colour-coded onto the BRCA2–RAD51 structure in place of the 
BRCA2 DBDs (ii). When binding to ssDNA (depicted above in a left to right 5’-3’ po-
i 
ii 
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larity), it will be able to do so through two of the DNA binding domains on either 
monomer, which will be oriented correctly for ssDNA binding notwithstanding its rel-
ative polarity (i.e. folds 3 and 4 / OB2 and OB3 on the left monomer, and folds 1 and 2 
/ αD and OB1 on the right monomer in the above example). Since RAD51 filaments 
grow with a 3’–5’ bias, one of the two sets of RAD51 molecules bound by the BRCA2 
dimer in opposing directions (orange with yellow outline), will then always be able to 
productively engage the ssDNA. This benefit would not be afforded to monomeric 
BRCA2, which might not be effective in 50% of its DNA binding occasions. The dimer 
also seems to help by increasing the interaction surface with ssDNA, and promoting 
maximally stable complexes therewith (see §3.2.10). 
4.3 Polarity of filament growth and strand transfer 
RPA, and presumably also the BRCA2 DBD, preferentially bind DNA with a defined po-
larity. How might then an ssDNA strand, with its defined polarity, bind across a BRCA2 
dimer (i.e. if the DBD atop one monomer will be oriented incorrectly)?  
As reasoned in §4.1, the four DNA binding folds in full-length BRCA2, might instead be 
arranged in a similar compact U-shaped configuration as those of RPA, such that two of the 
four are then facing the ‘right’ direction. 
Therefore, notwithstanding the relative polarity of its binding, the ssDNA would be able 
to engage these subdomains on one monomer (e.g. OB2 and OB3), and the other two in the 
second monomer (αD and OB1) in the same polarity – thus enabling the correct polarity for 
ssDNA binding on either monomer. 
Our determination that BRCA2 exhibits weak binding toward ssDNAs of up to 40 oligo-
nucleotides (§3.2.10), and necessitates >70 nt for strong binding, supports the concept that 
ssDNA contacts the DBD on both monomers and the two act in concert. 
Recombination is initiated at extensive 3’ ssDNA tails created by exonuclease action at 
DNA double-stranded breaks. They serve as a substrate for multiple BRCA2 effectuated 
RAD51 nucleation and initial filamentisation events. These ‘buds’ then extend and merge to 
form a single nucleoprotein filament that shall instigate homologous pairing and exchange. 
Our analyses of the BRCA2–RAD51–ssDNA quasi-complex, reveal BRCA2 to be situat-
ed at the 3’ end of each emergent RAD51–ssDNA filament, thereby corroborating the model 
in which such filaments grow in the 3’–5’ direction – congruous with the polarity of RAD51-
mediated strand exchange128,129. 
One prospect is that BRCA2 ‘caps’ one terminus of the nucleoprotein filament (i.e. the 3’ 
end), and blocks its dissociation, whilst allowing it to self-polymerise and extend at the other 
 - 117 - 
end. Since neither BRCA2 nor RAD51 display any preference for binding at either the ssD-
NA/dsDNA junction or the 3’ terminus of the resected ssDNA tail86,87 and would thus likely 
bind internally, RAD51 polymerisation in the 3’–5’ direction might beg a situation whereby 
several nucleotides at the far 3’ ssDNA end itself fail to be covered by RAD51 (see Fig. 2 
for reference). However, this is not a problem, as a wholly coated ssDNA tail without a 3’ 
protruding end, is not requisite for strand pairing130,131. In fact, it has been demonstrated that 
RAD51 can promote incipient ssDNA-dsDNA pairing interactions at either 3’ or 5’ extended 
ssDNA tails132,133. Though once achieved, only the invading 3’ end can serve as a primer for 
DNA repair synthesis. 
Incidentally, the U. Maydis Brh2 protein exhibits a distinct bias toward binding ss-/ds- 
DNA junctions, and promotes RAD51 filamentisation at the 3’ ssDNA overhang, i.e. whilst 
BRCA2 evidently lacks such a preference (§1.5)85–87. Given that BRCA2 appears to cap the 
3’ terminus of the RAD51–ssDNA filament, which then extends in a 3’–5’ direction relative 
to the bound DNA – implies that some differences exist between these orthologues. Though 
whether they reflect genuine mechanistic diversity, or are a product of different experimental 
conditions is not entirely clear. 
Whilst there might not necessarily be a direct relationship between the polarities of fila-
ment growth and strand transfer (that occurs a while later in the process), it is worth noting 
that in RecA filaments, which extend in the 5’–3’ direction, the polarity of strand transfer is 
too 5’–3’134–136. Therefore, not least there is a certain consistency amongst the two. 
We reason that the differential directions of filament growth and strand transfer for RecA 
and Rad51, relate to the positioning of an additional domain on opposite sides of the central 
core in each case (§1.4.2), which gets stabilised only upon filament formation. 
Explicitly, RAD51 harbours a supplemental N-terminal domain, whilst RecA contains a 
C-terminal extension. These are situated on opposite sides of the ATPase core relative to the 
single-stranded DNA. With RAD51, filamentisation entails a β-strand connecting the 
ATPase domain and the N-terminus that is ordinarily disordered, but is stabilised upon pack-
ing against the core domain of an adjacent monomer (§1.4.3). This interaction is thereby 
enhanced toward the growing N-terminal end of the filament, i.e. the 5’ direction.  
By comparison, intersubunit interactions in RecA filaments further involve a loop, i.e. 
one that is also only ordered in the filament. This is located to the C-terminal flank of the 
central domain, such that subunit addition in the 3’ direction would stabilise the loop, and 
subsequent interactions. 
Hence, owing to disparate domain configurations of RecA and Rad51, these filaments ex-
tend with opposite polarities.  
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All in all, our results imply a mechanism for BRCA2 tumour suppressor mediated repair 
of DNA double-stranded breaks by homologous recombination (see Fig. 32). A dimer there-
of binds two sets of RAD51 molecules, each arranged optimally for its loading onto ssDNA 
(derived via end-resection) and initial filament formation – given the right polarity of bound 
ssDNA, which it binds across its top surface. Upon ssDNA binding, one set always binds 
thereon, because of the directionality imposed thereby (an advantage only available to di-
mers). A RAD51 nucleoprotein filament then extends in the 3’–5’ direction, dictated by its 
molecular architecture, leaving BRCA2 to cap its 3’ terminus. The highly substoichiometric 
ratios of BRCA2 necessitated for RAD51 filament nucleation, suggests that BRCA2 dissoci-
ates upon the nascent nucleoprotein filament undergoing extension, and is subsequently 
recycled in order to initiate the formation of further such filaments – thereby serving as a 
molecular chaperone for RAD51 filament assembly. 
 
Figure 32. Further mechanism. Structure data, observations of multiple nucleation sites 
along single tracts of DNA, polarity of nucleoprotein filament growth out of BRCA2, 
and the extremely low amounts of BRCA2 relative to RAD51 required to promote the-
se, among others indicate a mechanism whereby the BRCA2–RAD51 complex binds at 
several points along end-resected 3’ ssDNA tails, and stimulates RAD15 filament for-
mation in a 3’–5’ direction therefrom. These emanate from one monomer and cause 
the BRCA2 dimer to partially dissociate from the RAD51–ssDNA filament, and then 
self-extend to link up with similarly nucleated filaments downstream in the 5’ direc-
tion, displacing BRCA2 altogether and creating a single long nucleoprotein filament. 
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The dissociated BRCA2 can be utilised to further catalyse the reaction, contributing to 
its efficiency. This scheme presumably facilitates the formation of longer RAD51–
ssDNA filaments that are desirable for productive strand pairing, homology search, 
and D-loop formation. 
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